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DEVELOPMENT AND UTILIZATION OF A MACAQUE-BASED MAMMOSPHERE  
 




Human breast cancers are thought to commonly arise from progressive neoplastic 
changes to the adult stem cells within the normal mammary gland. Research in this area of breast 
carcinogenesis currently relies heavily on the acquisition of mammary gland stem cells from the 
tissues of rodents and humans. While a great deal of information has been gained utilizing these 
models, there remain large gaps in our knowledge of breast cancer due to certain limitations with 
these species. The relevance of rodents as models for human breast cancer has been brought into 
question by notable differences between rodents and humans with regard to genetics, biology and 
mammary gland carcinogenesis. In contrast, the utility of human-derived samples is limited by 
ethical concerns and by the restricted availability of mammary tissues from women.   
Macaque monkeys are closely related to humans phylogenetically and these animals 
develop mammary gland tumors that are comparable to human breast cancers. Furthermore, 
mammary gland tissues can be easily collected from any demographic of animal. Despite their 
potential, only minimal breast cancer work has been undertaken in the macaques to date and 
research techniques common to both rodents and human are lacking for these species.   
This dissertation describes the optimization of a commonly-used mammary gland stem 
cell isolation technique, mammosphere culture, for the rhesus macaque (Macaca mulatta) and 
provides validation as to the reliability, relevance, and usefulness of this assay for human studies. 
Data obtained from this research demonstrated that the mammosphere culture technique is highly 
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reproducible between homologous macaque tissue samples. This work also found that mammary 
gland biopsies collected from different anatomical locations on the same monkey share 
comparable mammosphere-forming ability and mammosphere-differentiation ability 
(collectively, the mammosphere potential). Finally, these initial studies identified macaque 
mammospheres to have proliferative and differentiating properties that are nearly identical to 
those described for human mammospheres.   
This dissertation also describes a series of macaque studies performed using the 
optimized mammosphere culture technique. In the first study, mammary gland tissues were 
obtained from female macaques in different reproductive demographics and the mammosphere 
potential of these animals was compared. The results suggested that the mammosphere potential 
of nulliparous mammary glands is significantly greater than that of multiparous mammary glands 
and that this difference is likely due to greater ratios of mammary gland stem cells within the 
nulliparous mammary gland. These data also suggested that there are differences in the 
mammosphere potential of mammary glands collected from animals at different stages of the 
reproductive cycle. An additional study comparing the mammosphere potential of young-
multiparous and multiparous macaques collected during the menses stage of the menstrual cycle 
supported the parity-related findings of the first study. Data from the second study also identified 
significantly larger ratios of senescent cells in the mammosphere cultures of multiparous 
macaques as compared to young-nulliparous macaques. Finally, a study comparing the effects of 
ionizing radiation on mammospheres derived from young-nulliparous and multiparous macaques 
was performed. This last study found that stem cell-like cells of the young-nulliparous mammary 
gland were more resistant to the lethal effects of ionizing radiation than were those of the 
multiparous gland. 
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The findings of these three studies are notable in that young-nulliparous girls are known 
to have a higher susceptibility to radiation-induced breast cancer than are multiparous women 
and these studies provide the first direct evidence as to the potential mechanistic reasons behind 
this observation. Specifically, as macaques appear to be relevant models for the study of the 
human breast, these data suggest that the increased susceptibility of young-nulliparous girls to 
radiation-induced carcinogenesis could arise from: 1) higher number of mammary stem cells 
within the breast; 2) a decreased predilection of these stem cells to undergo senescence; and 3) a 
decreased sensitivity of these stem cells to the lethal effects of ionizing radiation.   
In summary, macaque mammospheres appear to be relevant models for the study of the 
human breast. Use of this model allows for the study of mammary gland tissues from some 
demographics of interest (e.g., prepubescent individuals) that are impossible to investigate 
utilizing human tissues. The mammosphere culture techniques and data described in this 
dissertation serve as a foundation toward the use of macaques in future breast cancer research 
projects and other study data from this dissertation has provided novel insight as to the increased 
























First, I would like to individually thank the members of my Graduate Committee to 
include EJ Ehrhart, Bob Ullrich, Mike Weil, Sue VandeWoude and Gary Johanning for sticking 
it out with me all through these years and for never having given up on me, or at least not letting 
me know they had given up on me. I am so grateful and at awe to have had such distinguished 
scientist watching me and guiding me through this process. Thank you! 
I am also thankful to all my colleagues at Colorado State University from the Ullrich 
Laboratory in the Environmental and Radiological Health Science Department for their help in 
turning a veterinarian into a research scientist. Most especially, I am grateful to Tonya Magers 
and Rebekah Klingler for their friendship and for their constant insight, support, and guidance in 
my initial laboratory studies. 
I am indebted to Bruce Bernacky and Chris Abee for recruiting me to the Keeling Center 
for Comparative Medicine and Research (KCCMR) and for ‘showing me the light’ with regard 
to nonhuman primates. I am also grateful to these two individuals for their help in getting me 
research funding at KCCMR and for allowing me access to the monkeys that made all this 
research possible. 
Other individuals from KCCMR have also been instrumental in my progress as a scientist 
over these last several years. I would like to thank Feng Wang-Johanning, Gary Johanning and 
Pramod Nehete for their collegiality and for sharing their knowledge and laboratory resources 
with me. I want to thank Larry Williams for his guidance and instruction with regard to 
biomedical statistics. I need to thank Wally Baze and the KCCMR Pathology Section as a whole 
for their constant encouragement and for allowing me the time to pursue this educational 
 
 vi  
 
endeavor. I am extremely grateful to Josh Plummer for his scientific knowledge, technical 
expertise and computer savvy which helped keep my projects moving forward. I am likewise 
extremely grateful to Luisa Velez for keeping my laboratory in a constant state-of-ready, for 
helping me keep all of my study data organized, and for her willingness to assist in nearly any 
aspect of the research project. I am grateful to Nancy Otto for her help with immunohistological 
staining and to Anna Maria Escherich for her efforts in reviewing and editing this dissertation.  
A special thank you to Mark Cline of Wake Forest University, for his willingness to 
review my work and to share his expertise related to the reproductive tissues of the macaque.        
Finally, I need to acknowledge my sources of financial support for this work. My initial 
period of learning and laboratory exploration was covered by monies provided by a NIH/NCI 
Postdoctoral Fellowship (Radiological sciences basic to cancer research, environmental and 
radiological health sciences) under Robert Ullrich. The rhesus-based research projects were 
thereafter supported by two grants from the Cattlemen for Cancer Research organization through 
the KCCMR. I cannot express how deeply grateful and indebted I am to both of these funding 
sources and I will do my utmost best to ensure that their investment in a developing scientist is of 






























This work is dedicated to my children Kennedy, Bonnie and Colter for all the lessons they teach 
me and for their never ending curiosity which pushes me daily to never stop searching for 
answers. This work is also dedicated to my parents Kenny and Becky Wilkerson for inspiring a 
solid work ethic in me, for encouraging me to learn on my own, and for giving me the courage 
and confidence to attempt feats well-beyond my perceived abilities. First and foremost, however, 
this work is dedicated to my wife Nicole. She is the only member of the ‘Wilkerson Team’ who 
was actually recruited into the position and is truly our team’s Most Valuable Player. I am 
eternally grateful to her for keeping our family functioning and happy for all of these years while 



















 viii   
 











Radiation-induced Breast Cancer…………………………………..……………………14 
Animal Models in Breast Cancer Research………………………………...……………17 
Acquisition of Mammary Gland Stem Cells and Progenitor Cells for Research………..26 
Summary and Research Outline…………………………………………………...……..β8 
References……………………………………………………………………………………..…γ1 
Chapter 2: Development and Validation of a Novel Model for Breast Cancer Research  
Introduction………………...…………………………………………………………….45 




Chapter 3: Vaginal Cytology of the Rhesus Macaque 
Introduction………………...…………………………………………………………….96 




Chapter 4: Proliferation, Differentiation, and Radiosensitivity of Mammary Epithelial Cells 
Derived from Multiparous and Nulliparous Rhesus Macaques  
Introduction………………...………………………………………………...…………117 




Chapter 5: Research Summaries, Ongoing Studies and Future Directions 
Introduction………………...…………………………………………………………...159 
Research Summary.……………...…………………………………………………......159 
Ongoing Research and Future Directions ……………………………………………...161 

















Breast cancer remains a prominent cause of morbidity and mortality to women in the United States despite 
advances in diagnosis and treatment. This chapter reviews the background on human breast cancer in addition to 
information on the development, morphology and physiology of the mammary gland as each of these topics relates 
to contemporary theories on breast cancer carcinogenesis. It provides background on radiation-induced breast cancer 
and introduces some current technologies and animal models that are relevant to the ongoing study of breast cancer. 
Finally, this chapter outlines my research interests and describes how I have incorporated the use of the 
aforementioned technologies and research models into this dissertation on breast cancer carcinogenesis.   
Mammary Gland 
Human mammary gland morphology. The mature human breast consists of approximately 15-25 lobes 
that originate and radiate out from the nipple as illustrated in Figure 1. These lobes are embedded within abundant 
fibrous and fatty tissue stroma. At the most basic anatomic level, the lobes of th  lactating breast are composed of 
large numbers of glandular alveoli and branching ducts and ductules that function to produce and transport milk 
respectively. Each lobe generally functions as a distinct glandular unit with all alveoli, ductules, and ducts that 
comprise an individual lobe feeding into a single secretory pore within the nipple.110, 214   
At the microscopic level, the glandular portion of the breast can be subdivided an  described utilizing a 
variety of anatomical terms to denote functionality and/or location. With relevance to this discussion, the structural 
components of the breast will be divided into the following subunits, starting with the most externally located 
structures and proceeding inward       extralobular ducts, intralobular ducts, intralobular ductules and alveoli (Figure 
2). Likewise, the stromal component of the breast will be divided into the intralobular stroma and interlobular 
stroma for this review (Figure 2).   
The extralobular ducts are tubular structures that are lined by 1-2 layers of columnar to low cuboidal 
epithelial cells, known as the ductal epithelium.110, 214 The ductal epithelial cells, in turn, overlie a basal layer of 
myoepithelial cells and a basement membrane which is surrounded by interlobular stroma. Interlobular stroma is 






Figure 1. Illustration of the gross anatomy of the human breast from the anterior (A) and lateral (B) views 
demonstrating the radial distribution of the glandular lobes from the nipple and the distribution of the fibrofatty 
tissue within the organ. 
 
 
Figure 2. Illustration of the subgross anatomy of an individual breast lobe. Constituent parts of the mammary gland 
lobe include secretory pore, extralobular ducts, intralobular ducts, intralobular ductules and alveoli. Lobes are 
subdivided into lobules which are invested within an intralobular stroma (green). The fibrofatty material comprising 





loose fibrous connective tissue, collagen and elastin fibers.110, 214 Most of the tissue comprising the non-lactating 
human breast is interlobular stroma. 
At the level of the lobular subdivisions, both the lobules and the ductal sysem become enveloped within a 
highly cellular form of stroma that lacks a fatty component, and which is referred to as intralobular stroma (Figure 
2). Endothelial cells, leukocytes and large numbers of fibroblasts comprise the bulk of the cellular components 
within the intralobular stroma.110, 214 The junction at which the ducts are invested in intralobular stroma is the point 
where the ducts are considered to be intralobular ducts. Besides being invested in intralobular stroma and being 
slightly smaller in caliper than the extralobular ducts, the intralobular ducts are essentially indistinguishable from the 
extralobular ducts under standard microscopic examination. In the post-pubescent female, most of the intralobular 
ducts are further subdivided into the highly branched, thinly-lumened structures known as the intralobular ductules, 
which eventually terminate as clusters of spherical alveoli. At the microscopic level, the ductules generally have 
smaller lumens than ducts and are lined by only a single cell layer of ductal epithelium, but otherwise have a layer of 
myoepithelium and a basement membrane similar to what was described earlier for the ducts (Figure 3).110, 214 
 
 
Figure 3. Cellular composition of the mature ductule and alveolus. Note the contact of the alveolar luminal cells 
with the basement membrane through the gaps in the myoepithelial cell layer. 
 
The alveolar lumens are lined by a single layer of cuboidal to columnar epithelial cells, called alveolar 
epithelium, which overlie a basal myoepithelial cell layer and basement membrane, similar to what is seen in the 
ducts/ductules. Unlike the ducts and ductules, however, the myoepithelial cells of the alveoli frequently have small 
gaps between adjacent cells allowing for areas of direct contact between the alveolar epithelium and the basement 




The functional unit of the breast is the considered to be all of the alveolar and ductal components within the 
intralobular stroma of one lobule and this structure has collectively been termed the terminal duct-lobular unit 
(TDLU). In the non-pregnant, parous female, the majority of TDLUs contain around 40 alveoli that are situated on 
numerous intralobular branching ductules and ducts.110, 214, 219, 221 These have been referred to as Type 2 TDLUs or 
Lobules type 2/3 by different investigators.110, 219, 221 In contrast to mature parous females, the breasts of mature 
nulliparous females are primarily composed of TDLUs that are less developed. These immature TDLUs are 
recognized to have shorter ducts, smaller numbers of intralobular ductules, and typically have 10 or fewer alveoli 
per lobule. These TDLUs have, in turn, been referred to as Type 1 TDLUs, Lobules type 1, or terminal end ducts 
(TEDs).110, 214, 219-221 An example of a TED is illustrated in Figure 2.  
While the aforementioned patterns of breast development are accurate generaliti s, it is also important to 
understand that marked variations i  glandular development can occur between breasts, and even between 
lobes/lobules within the same breast. Developmental homogeneity within the breast has been primarily correlated to 
the number of full-term pregnancies a woman has undergone and, to a lesser extent, advanced age.110, 214, 219, 220 To 
that, multiparous women tend to have less developmental variability between th individual lobes of their breasts 
than do nulliparous women and, likewise, aged nulliparous women have less variability than do younger nulliparous 
women.   
Human mammary gland development and physiology. The mammary gland is a unique organ in that the 
majority of morphologic and physiologic development occurs outside of the womb, with the most significant of 
these changes taking place throughout puberty and pregnancy. Each human mammary gland begins development in 
utero as a placode of ectodermal cells that extend thin ductular structures into the underlyi g mesenchyme to form 
the breast bud.110, 214 Shortly after parturition, the breast bud comes to rest as a collection of short, blunt-ended ducts 
with only small numbers of branching ductules and alveoli; similar in histological appearance to what was described 
of the TEDs in the adult breast.110, 221   
To this point, the development and morphology of the male and female breast buds in humans are identical 
and remain so until puberty. In males, the breast tissue typically never progresses beyond this stage and eventually 
undergoes glandular regression due to androgen secretions.110, 214 In females, the onset of puberty begins to 
transform the epithelial ductular structures of the immature mammary gland into the individual lobes of the mature 




interlobular stroma of the adult mammary gland.76, 110, 214, 221 With increased amounts of systemic estrogen, the 
fibrous and fatty tissues of the interlobular stroma are the first components of the female breast to expand. This is 
followed shortly thereafter by extension and differentiation of the glandular components of the breast f om the 
apical aspects of the adolescent TEDs.76, 214 The invasion of the glandular network into the fibrofatty stroma and 
extralobular branching of the ducts are primarily driven by systemic strogen while intralobular ductular branching 
and alveolar formation are largely driven by systemic progesterone.26, 76, 108, 110, 214, 221 In conjunction with expansion 
of the ductal elements of the breast, a glove of hormonally-responsive i tralobular stroma is also formed around the 
individual TDLUs. This stroma, in turn, produces additional paracrine factors recognized to b  essential for 
complete maturation of human TDLUs.110, 214 Continued development and maturation of the female breast is 
recognized to occur for at least 10 years following the onset of puberty.214   
Even after puberty, other recurring morphological and physiological changes occur within the constitutive 
cell populations of the breast in accordance with the various stages of the menstrual cycle. In the typical 28-day 
menstrual cycle (with onset of menses denoted as Day 0), the menses stage (Days 0-3) is generally recognized to be 
the stage with the lowest proliferative activity in the mammary gland.86, 156, 214, 272 In contrast, the stage of the 
menstrual cycle with the highest proliferative ability remains a subject of debate. At least one study suggests the 
highest proliferation rates occurs in the early-follicular (proliferative) stage of the cycle (Day 3-7)178 while other 
studies have identified the late-follicular stage (Day 8-14)97, 214 and the luteal stage (Day 15-20)170, 214, 272 to have the 
highest amount of cellular growth. While these results appear to contradict one another, it is proposed that most of 
the confusion generated by this research has occurred due to measurements of different epithelial cell 
subpopulations within the mammary gland.214 In short, what is evident from the combined results of these studies is 
that both the alveolar and ductal epithelial populations of the human mammary gland undergo profound proliferative 
changes throughout the menstrual cycle. Further support as to a cyclic variation within the mammary gland 
epithelium is provided by observations that the number and pattern of cells immunoreactive for sex hormone 
receptors is highly variable with the stage of the menstrual cycle. Per this parameter, th  arly-follicular stage of the 
cycle has the highest number of estrogen receptor (ER)-positive epithelial cells while the late-follicular stage of the 
cycle has the highest number of progesterone receptor (PR)-positive epithelial cells.41, 214   
Pregnancy is another period of significant change to the mammary gland, with the most notable 




pregnancy-associated breast development first begins with the transformation of large numbers of TEDs into Type 2 
TDLUs.110, 214, 217, 218, 221 This occurs through the extension and branching of ductules into the intralobular stroma and 
through alveolar formation due to rising concentrations of progesterone. Later, as systemic levels of prolactin 
increase, the Type 2 TDLUs differentiate into their lactating phenotype, known as Lobule type 3/4 or Type 3 
TDLUs through the proliferation of small ductules and alveolar epithelium (alveologenesis). Ultimately, each typical 
Type 3 TDLUs will contain 80 or more alveoli.26, 108, 110, 214, 219-221 While differentiation of the TEDs and Type 2 
TDLUs occur to some extent in all pregnancies, these processes do not occur evenly throughout the breast. 
Consequently, not all available TDLUs within the breast are utilized for lactation and some TEDs are maintained 
throughout each pregnancy, although with each successive pregnancy fewer and fewer TEDs are present within the 
breast.26, 108, 110, 214 At weaning, the systemic prolactin levels drop and the breast undergoes involutio  f large 
numbers of alveoli and intralobular ductules through apoptosis, phagocytosis, and desquamation of cells into their 
respective lumens. Following involution, the majority of Type 3 TDLUs typically assume a Type 2 TDLU 
morphology.110, 214, 221  
Cellular constituents of the mammary gland. The bulk of the mammary gland is composed of 
populations of terminally-differentiated myoepithelial and luminal epithelial cellsthat are thought to be highly 
limited in their proliferative capacity. However, within the breast there also exist at least some persistent and highly 
proliferative cells, as confirmed by the dynamic ability of the mammary gland to repeatedly lactate and involute 
through multiple pregnancies.123, 270 These proliferative cells are recognized to be populations of adult stem cells and 
progenitor cells.139, 185, 208   
Per the most-widely accepted definition, adult stem cells are multipotent, proliferative cells that are capable 
of both symmetrical and asymmetrical cell division (Figure 4). Through symmetrical division, adult stem cells 
produce two exact copies of themselves and thereby maintain or promote the proliferative capacity of the organ.  
Through asymmetrical division, adult stem cells produce one stem cell and one daughter-cell. The daughter-cells, in 
turn, undergo either partial differentiation to serve as proliferative progenitor cells or terminal differentiation to 
serve as the individual functional units of the organ.123, 139, 146, 243   
The existence of an adult stem cell in the mammary gland, the mammary gland stem cell (MSC), has been 
firmly established for both rodents and humans utilizing in vivo methodologies. Specifically, murine transplantation 






Figure 4. Symmetrical and asymmetrical division of the mammary gland stem cell and the proposed cellular 
hierarchy present within the glandular cells of the human breast. Nine distinct cell populations have been identified. 
 
gene-inactivation studies of the breast have established that individual TDLUs are clonl in origin.262 In addition, in 
vitro work has further substantiated the existence of MSCs.  In these studi s, individual proliferative cells obtained 
from the rodent and human mammary gland have been demonstrated to be capa le of producing large, mixed-
colonies composed of ductal epithelium, alveolar epithelium and myoepithelium when grown as cell cultures.71, 139, 
230, 243  
In addition to MSCs, a variety of other proliferative cell populations, the progenitor cells (PCs), have also 
been identified to exist within the mammary gland. While the exact number and organization of these cell 
populations is still debated, current research suggests that there are no less than five unique mammary gland PC-




known as multipotent progenitor cells (MPCs), is able to produce mixed-colonies composed of ductal epithelium, 
alveolar epithelium and myoepithelium similar to those seen with the MSCs. Unlike the MSCs, however, this 
population is unable to self-renew and is therefore more limited in its proliferation capacity. As such, MPCs form 
only small outgrowths when transplanted into cleared rodent mammary gland-fat pads or when plated as cell 
cultures. Another of these PC populations has been shown to be capable of forming bilineage colonies composed of 
both ductal epithelium and alveolar epithelium. These cells are referred to as the luminal-restricted progenitor cells.  
The remainder of human PCs are more restricted in their colony-forming ab lities and only produce a single 
differentiated-cell type, that being either alveolar epithelium, ductal epithelium, or y epithelium. These three PC-
types, in turn, are collectively referred to as lineage-restricted progenitor cells.  
There is evidence that while MSCs appear to be responsible for initiating breast development and 
maintaining the proliferative capacity of the mammary gland, the PC populations likely contribute to the bulk of the 
routine glandular proliferation. This is proposed to be the case, in that MSCs are estimated to make up only 0.01-
0.03% of the cells within the human breast and therefore appear too limited n distribution to account for all of the 
diffuse proliferative changes that occur with pregnancy and throughout the menstrual cycle.139, 243, 270 Other research 
suggests that while MSCs are currently recognized to be long-lived cells within the mammary gland, it is likely that 
in vivo these cells persist, for the most part, as non-proliferative cells in a tate of cellular quiescence.17, 20, 139, 208, 238, 
243, 270, 271, 282     
Breast Cancer 
Breast cancer incidence rate and classification. The term “breast cancer” is frequently used to describe a 
multitude of different benign and invasive neoplasms affecting the breast, although for clinical and epidemiological 
purposes the use of the term breast cancer is often reserved to refer tomore invasive forms of the disease.297 
Accordingly, the use of the term “breast cancer” in this review will be limited to refer to the more refined definition 
of invasive disease. As men account for only around 1% of all breast cancer cases worldwide there is much less is 
known about the disease in men and, as such, this review of will focus only on mammary gland disease as it occurs 
in women.111, 213   
As per the National Cancer Institutes-Surveillance, Epidemiology and End Results (NCI-SEER), it is 
estimated that within the United States approximately 1 in 8 women will be diagnosed with breast cancer during her 




their histological appearance, their hormone-receptor status, and as to whether or not they overexpress the Human 
Epidermal Growth Factor Receptor-2 (HER-2) gene. More than 99% of the histologically-confirmed cases of breast 
cancer within the United States over the last decade have been diagnosed as carcinomas. Over 97% of these 
carcinomas have, in turn, been characterized to be of an epithelial (luminal) phenotype with only a small percentage 
classified as myoepithelial (basal) in origin. Of the luminal carcinomas, approximately 71% were identified as 
infiltrating duct carcinomas, 11% were mixed infiltrating duct-lobular carcinomas and 8.5% were lobular 
carcinomas. The remaining 9.5% of carcinomas were classified into a number of other small categories.111, 270 
Around 70% of human breast cancers have been identified to be hormonally-responsive neoplasms, possessing 
either ER, PR or, more typically, both.27, 169, 192, 270 Notably, breast cancers that lack hormone-receptor expression 
tend to be more clinically and histologically aggressive in nature than tumors demonstrating ER and/or PR 
positivity. Finally, overexpression of the HER-2 genes has been identified in approximately 30% of human breast 
cancers and, when found, is frequently associated with more invasive forms of the disease.192, 250 
Breast cancer cellular composition. Human breast cancers, like most other solid tissue tumors, are 
frequently comprised of a phenotypically and/or genotypically heterogeneous mixture of neoplastic cell types.62, 68, 
270, 280 While most breast cancers contain large numbers of neoplastic cell types that are incapable of significant 
independent proliferation, these tumors also typically contain at least a small population of cancer cells that are 
highly proliferative.5, 62, 198, 271, 280 Investigations into the proliferative cell populations of breast cancers have, in turn, 
shown that the bulk of the proliferative neoplastic cells are fairly limited in their ability to differentiate. This has 
been best demonstrated in transplantation experiments where the tumors formed by theseproliferative cells were 
identified to be composed of only one (or a few) of the cell-types found within the original cancer.5, 6, 44, 62, 68, 72, 146 
However, there are also other, smaller populations of proliferative cells identifed within most breast cancers that 
have the ability to produce tumors in mice which fully recapitulated all of the heterogeneous cell types found within 
their tumors-of-origin. In light of these proliferative and multipotent differentiation capabilities, this last cell 
population has been termed the cancer stem cells (CSCs).5, 6, 62, 68, 299  
Cancer stem cells in breast cancer. Cancer stem cells are currently of great interest to breast cancer 
research for a number of reasons. First, as per their proliferative and multipotent differentiation capabilities, th  
CSCs are proposed to represent the archetype cell for their respective cancers and, to that, are thought to be the 




they are derived.5, 36, 68, 72, 105 Second, in that research has suggested that many CSCs are resistant to anchorage-
dependent apoptosis (anoikis) and could be capable of surviving as single cells in vivo, it is also proposed that CSCs 
play a significant role in cancer metastasis.68, 127 Third, as there are data to suggest that CSCs are more resistant to 
the effects of irradiation and/or chemotherapeutics as compared to the more-differentiated cells of the breast cancer, 
the CSCs have been likewise proposed to be the primary cell population responsible for cancer recurrence.6, 12, 68, 174, 
198, 282, 293, 299 Finally, there are breast cancer studies which have correlated an increased ratio of CSCs to a higher 
(more malignant) histological grade.43, 79, 84, 196, 271  In short, this information suggests that increased knowledge of 
the CSCs in general is likely to be beneficial toward developing effective preventative, diagnostic, prognostic and 
therapeutic methodologies for breast cancer patients in the future. To that, identifying the normal mammary gland 
cell populations which most-commonly give rise to the CSCs and elucidating the mechanistic changes that govern 
the formation of the CSCs is likely to provide valuable insight toward these goals.36, 68, 72, 79, 105, 196, 237   
Although the origin of the mammary gland cancer CSCs is currently u known, there is evidence to suggest 
that CSCs often arise as a result of neoplastic transformation of the MSCs. In women it has been demonstrated that 
ductal carcinomas most frequently arise within the TEDs of the breast, the lobul -type known to contain the highest 
numbers of MSCs.27, 154, 216, 220 Rodent studies have likewise identified the terminal end buds (TEBs), the anatomical 
structure of the rodent mammary gland with the highest concentrations of MSCs, to be the primary site of 
carcinogenesis.49, 115, 220, 222, 223 As is further described in the Breast cancer risk factors section below, lifestyles 
associated with decreased numbers of TEDs/MSCs (e.g., multiparity) and lifestyles associated with a decreased 
time-of-retention of undifferentiated-TEDs/MSCs (e.g., early age at first full-term pregnancy) are also both 
associated with a decreased risk for developing breast cancer. Additional support for an MSC-origin to the CSCs is 
the finding that MSCs and the breast cancer CSCs share a number of cell surface markers that are not readily 
identified on most of the more-differentiated cell types within the normal mammary gland.6, 62, 71, 84, 108, 128, 147, 153, 270 
Finally, the finding that MSCs and breast cancer CSCs tend to show similar patterns of expression in cell signaling 
pathways such as Notch, WNT, hedgehog, Bmi-1 and TGF-beta also lend cr dence to the proposal that MSCs are a 
common cell-of-origin for the CSC.5, 27, 72, 84, 123, 152-154, 230, 282  
Neoplastic transformation of the MSC has, in turn, been proposed to involve an initiation event followed by 
sequential promotion and progression stages as is classically described for the multistage process of carcinogenesis 




fate of MSCs is recognized to be highly dependent on paracrine communication with the glandular and stromal cells 
of the immediate niche. That is to say, signaling factors excreted by the cells of the niche determine if MSCs will 
remain quiescent, undergo symmetric cell division, or undergo asymmetric divis on with differentiation.26, 123, 139, 270 
As such, while genetic mutations to the MSCs are thought to be the most likely in tiating event toward neoplastic 
transformation, it has also been proposed that initiation of the MSCs could arise as a r sult of genetic and/or 
epigenetic alterations occurring to the cells constituting the niche. Studies which have demonstrated the 
transforming effect of the aberrant niches on both CSCs and normal ste cells are highly supportive of this 
position.139   
Regardless of how initiation occurs, the initiated MSCs are hypothesized to follow one of three main 
carcinogenesis pathways:71, 74, 133, 158, 160, 209, 260 1) an initiated MSC may produce daughter-cells that are capable of 
undergoing terminal-differentiation down only one line of its multipotent capabilities; 2) an initiated MSC may 
produce daughter-cells that are incapable of undergoing complete terminal different ation down any lineage; or 3) an 
initiated MSC may undergo only symmetrical division. Examples of the potential pre-neoplastic and neoplastic end-
products for each of these pathways are provided below. Collectively, these thr e pathways are thought to be able to 
account for essentially all of the phenotypical manifestations of breast cancer as it is currently known to occur in 
humans. The fact that MSCs are generally recognized to be long-lived provi es additional support to these 
hypothesized carcinogenesis pathways, as significant periods of time would likely be required for the initiated MSC 
to acquire the multiple changes needed to achieve complete carcinogenesis.44, 71      
Per the first pathway, a MSC is initiated in such a way that when it undergoes asymmetrical division only 
one type of terminally-differentiated cell is produced, regardless of the needs of the tissue. Additional alterations to 
the initiated MSC, or its niche cells, over time could promote the initiated MSC to acquire other neoplastic 
properties, such as a loss of contact-inhibition, which would thereby result in tumor formation of the MSC progeny. 
Further alterations to the MSC or niche could then lead to the production of cells with an increased neoplastic 
potential and so on. In this scenario, clonal-cell aggregates from each pre-neoplastic/neoplastic step of the MSC 
carcinogenesis process accumulate within the tissue leading to a breast cancer composed of a highly heterogeneous 
cell population. As such, this pathway provides a means by which to account for the well-established biologic 




238, 280 This proposed mechanism also helps address a common question as to how the sex hormone-receptor negative 
MSCs and MPCs might be able to produce breast cancers that are predominantly hormonally responsive.27   
Per the second pathway, a MSC is initiated in such a way as to produce daughter cells that are unable to 
undergo complete terminal differentiation. As with the first pathway, additional alterations occurring to the initiated 
MSC or the niche over time could then lead to tumor formation, although in this scenario the neoplasm would be 
comprised of PCs or PC-like cells with more proliferative potential. As these tumors could theoretically be derived 
from any PC population within the cellular hierarchy, this pathway can a count for the variation in histologic 
appearance, sex-hormone status and biological aggressiveness that exists between breast cancers. Similar to what 
was described above, further alterations occurring within the initiated MSC or niche over time could ultimately 
result in the development of PCs with greater neoplastic potential and to the formation of a breast cancer omprised 
of a highly heterogeneous cell population. While all of the alterations leading to breast cancer in this pathway could 
occur within a single MSC, another possible outcome is that one of the partially-transformed PCs derived from the 
MSC could, itself, become further altered. In this instance, the PC would then ultimately become the cell-of-origin 
for the CSC within the breast. This is mentioned as a possibility in that some breast cancer CSCs have been 
observed to have variable expression of the MSC-associated cell-surface markers CD24, CD29, CD44, and CD133, 
and the early PCs (e.g., MPCs and luminal-restricted PCs) have been proposed as a possible alternative cell-of-
origin.27, 79, 114, 123, 196 
Per the third pathway, a MSC is initiated in such a way as to only undergo symmetrical cell division. 
Additional mutations to the MSCs or the niche could then promote the developm nt of MSC-rich tumors while 
further malignant transformation could ultimately result in the formation of a CSC with only marginal differentiating 
capabilities. In this pathway all of the neoplastic transformation could occur within a single cell, although it is 
equally possible that any one of the cells in the pools of identically-initiated MSCs could ultimately become a breast 
cancer CSC. With increased numbers of initiated stem cells, the third pathway might be expected to produce tumors 
with higher rates of promotion and progression than tumors originating through the first two pathways. Additionally, 
in that the CSCs of this scenario have minimal potential for differentiation, it might also be anticipated that the 
aggressive and metastatic potential of cancers originating via this pathway would be greater as well. This is stated as 
such, in that that most of the neoplastic cells originating by the third pathway would be CSC-like cells and 




Finally, it is plausible that breast cancers derived directly from the MSCs would be more likely to be sex hormone-
receptor negative. Consistent with these lines of thought, highly aggressive and rapidly metastasizing breast cancers 
have frequently been identified to contain higher ratios of CSCs and these breast cancers are commonly negative for 
sex hormone receptors.27, 79, 196, 297    
Breast cancer risk factors. Only 5-10% of breast cancers diagnosed within the United States have been 
identified to be hereditary in nature.213 Mutations within the breast cancer susceptibility genes BRCA-1 and BRCA-
2 are the two most commonly identified genetic alterations in people and, by some estimates, can increase the risk of 
breast cancer in women by as much as 40 percent over those of the general population.27, 297 Of note here though, is 
the fact that BRCA-related breast cancers are much more likely to have a myoepithelial phenotype and/or lack sex 
hormone receptors than are non-hereditary forms of the disease.27, 155, 297    
With regard to the most-common (hormonally-responsive), non-hereditary forms of breast cancer in 
women, there are a number of factors that have been associated with an incre se in the lifetime risk for developing 
the disease. These factors include: increased-age at first pregnancy; nulliparity; early menarche; late menopause; 
total-attained-number of menstrual cycles; oral contraceptive use; estrogen-progesterone hormone therapy following 
menopause; total-attained age; obesity; and exposure to radiation.7, 26, 27, 38, 82, 112, 131, 132, 140, 162, 164, 175, 199, 220, 224, 258, 294, 
297 Furthermore, primiparous women have also been estimated to have an pproximate 10% higher long-term risk of 
developing breast cancer than multiparous women.7, 162 Of all these factors, increased-age at first pregnancy is 
widely recognized to be the most significant risk factor related to the development of breast cancer in the general 
population of women within the developed world.6, 27, 65, 130, 140, 172, 220, 270   
While the details of just how each of these risk factors plays into breast cancer carcinogenesis is currently 
unknown, it is notable that many can be directly linked to prolonged exposure to sex hormones. To expand on this 
point, the risk factors of early-menarche, late-menopause and total-attained-number of menstrual cycles, all increase 
the number of endogenous sex hormone fluctuations that a woman experiences over her lifetime. On the other hand, 
oral contraceptive use and hormonal therapy in post-menopausal women both have the potential to artificially 
increase the total-attained-number of menstrual cycles through exogenous mechanisms. Irrespective of the source, 
sex hormones are recognized mitogens that are known to contribute to the malignant transformation of DNA-
damaged cells.27, 38, 130, 213 This occurs as sex hormones directly, or indirectly, stimulate cells to increase their rates of 




avoid apoptosis.46, 69, 88, 92, 103, 115, 116 Through this process, the misrepaired or unrepaired DNA mutations the  
become “fixed” within the genome leading to formation of “initiated” cells. Sex hormones can also contribute to the 
progression of carcinogenesis by stimulating the initiated cells to proliferate and produce pools of mutated progeny 
which, along with the originally-initiated cell, are then available for further neoplastic transformation.213  
The data above also suggest that maturation of the breast through pregnancy, espe ially an early-life 
pregnancy, is likely to reduce the overall risk of breast cancer formation in women. These human data are supported 
by numerous studies in rats and mice which have also demonstrated a protective effect of pregnancy on the 
mammary gland. In these experiments the mammary glands of parous rodents, and rodents that were experimentally 
“matured” through the use of exogenous hormones, were shown to be less susceptible to the ffects of chemical 
carcinogens than were the glands of nulliparous animals.27, 101, 176, 220, 234, 249, 256 Although just how pregnancy confers 
protection remains uncertain, some hypotheses propose that the reduced risk is, at least in part, due to decreasd 
numbers of MSCs within the breast.27, 65, 213, 215, 270 As previously discussed, the nulliparous breast is comprised of 
large numbers of TEDs which are proposed to contain large numbers of MSCs.154, 216, 220  During a woman’s first 
pregnancy the majority of the TEDs within the breast are recruited to terminally-differentiate into a lactational 
phenotype. With each successive pregnancy, more and more TEDS are recruited from the reserves, leading to 
smaller numbers of MSCs within the breast as a whole. While the ratios of MSCs between nulliparous and 
multiparous women have not yet been directly compared, some studies performed in mice have demonstrated 
significantly more functional MSCs in nulliparous mice as compared to multiparous animals.235 Likewise, studies in 
the rat have also documented that cells obtained from the parous mammary gland have less overall potential for 
proliferation than do those acquired from nulliparous glands and sugge ts that lactation may decrease the numbers of 
MSCs in the mammary gland of this species as well.27 
Radiation-induced Breast Cancer 
Ionizing radiation as a carcinogen. Exposure to ionizing radiation is a well-established cause of breast 
cancer in women.4, 35, 47, 135, 142, 213, 271 Historically, the majority of the carcinogenic effects of radiation on mammry 
gland cells have been thought to occur as a result of direct genetic damage.159, 160, 245 More recently, however, it has 
been appreciated that epigenetic modifications of the genome also play into the developm nt f many radiation-
induced cancers.48, 66, 115, 159, 160, 261, 271 These epigenetic changes are found to occur through the direct exposure of 




the same microenvironment through a process that has been termed the non- argeted “bystander effect”.48, 66, 159, 160, 
226  
Regardless of which type of radiation-induced damage is initially sustained, exposures to ionizing radiation 
followed by, or in conjunction with, factors that promote cellular proliferation are now understood to be 
significantly more oncogenic than are exposures to ionizing radiation alone.115, 213, 245 This is supported by 
epidemiological studies which have identified an increased risk of breast cancer in women who were exposed to 
radiation and were likewise identified to have elevated levels of endogenous hormones.115 Additionally, rodent 
studies have also demonstrated that the incidence of radiation-induced mammary tu ors could be increased if 
irradiation of animals was followed by exogenous hormonal stimulation.213 The exacerbation of radiation-induced 
damage through increased proliferation is believed to occur by the same mechanisms as previously described in the 
Breast Cancer Risk Factors section above.   
Ionizing radiation and risk factors for breast cancer. Utilizing data obtained from the medical 
establishment and atomic bomb survivors, it has been well-established that the risk of developing breast cancer after 
radiation exposure is inversely correlated with age.4, 35, 47, 135, 142, 257 The population of females most frequently 
reported to be at the greatest risk are those individuals who were exposed to radiation at less than 20 years of age. 
Likewise, the linear dose response to ionizing radiation has also been determind to be most pronounced within this 
same demographic of women.213  
In addition to a decreased-age-at-exposure, other risk factors have also been identified to be significant 
with respect to the development of radiation-induced breast disease in humans. In particular, women who are 
exposed to radiation and then remain nulliparous or give birth to their first ch ld late-in-life are known to be at 
greater risk than are similarly-exposed women who undergo a first full-term pregnancy at a younger age.32, 35, 141, 172, 
213 A decreased risk of radiation-induced breast cancer has also been independently associated with both multiparity 
and prolonged lactation where radiation exposure occurred at a young age, and either the multiparity or the 
prolonged lactation-history occurred before a woman reached 20 years of age.141    
Interestingly, these risk factors for radiation-induced breast cancer are similar in nature to many of those 
described for the hormonally-responsive breast cancers in the general popul tion. As such, a role for MSCs in 
radiation-induced disease is also possible in that, with age, and with each successive pregnancy, fewer and fewer 




responsive breast cancer in the general population, the risk factors described here also implicate exposure to sex-
hormones as critical to the development of radiation-induced disease. Taken together, these risk factors could be 
interpreted to suggest that the incidence of radiation-induced breast cancer is correlated with: 1) the number of 
MSCs present within the breast at the time of exposure; 2) the duration of time for which MSCs are maintained as 
undifferentiated cells following irradiation; and 3) the number of proliferative events (e.g., menstrual cycles) a 
woman undergoes following irradiation.220, 282 In support of a MSC-origin to radiation-induced breast cancer, one rat 
study has demonstrated that radiation-induced mammary cancers in rats most co monly arise in the TEBs, an area 
known to be high in MSCs.49 In support of the idea that  reduction in the MSC numbers is related to a decreased 
risk of mammary gland cancer, another rodent study has shown that hormonally-induced terminal differentiation of 
the mammary gland immediately following irradiation resulted in a decreased incidence of tumor formation.115   
While it cannot be said with certainty that MSCs are the cell-of-origin for most radiation-induced breast 
cancers, there are aspects of MSC biology that make them an attractive candidate toward this hypothesis. MSCs are 
currently thought to be long-lived and have a high proliferative potential. The longevity of these cells provides the 
intrinsic means by which further progressive and promotional oncogenic events of the initiated cells could occur, as 
radiation-induced breast disease is appreciated to often takes decades to manifest itself.27, 146 The high proliferative 
potential of the MSCs, in turn, provides the intrinsic methods by which mutations could be fixed into the genome 
and then passed on to progeny.   
Additional information to suggest that MSCs may be common cells-of-origin for radiation-induced breast 
disease comes from studies looking at the response of these cells to irradiation. Research utilizing human breast 
cancer cell lines and mouse mammary cell lines has shown that the MSCs, as well as some MPCs, are more resistant 
to radiation-induced death, apoptosis, and senescence than are the more-differentiated cell types within these cell 
cultures.27, 40, 125, 198, 293 These results have been used to propose that MSCs are more resistant to the le hal effects of 
radiation than are other cell populations of the breast and therefore are more likely to accumulate radiation-induced 
mutations. Finally, as previously discussed, MSCs are known to be highly influenced with regard to proliferation 
and differentiation by the cells comprising their niches. To that, it has been proposed that MSCs may be more prone 
to carcinogenesis through non-targeted, bystander effects originating from irradiated niches than would other, more-





Animal Models in Breast Cancer Research 
Historical perspective and future needs of laboratory animal models for breast cancer research. 
Relevant animal models of human breast cancer are crucial to understanding he complex interplay of genetic, 
epigenetic, and molecular alterations that lead to the neoplastic transformation of mammary gland cells. To date, the 
bulk of this work has been accomplished through the use of mouse models and, to a lesser extent, rat models. The 
importance of the rodent contributions to the overall understanding of the cellular mechanisms associated with 
mammary gland cancer cannot be overstated. However, the relevance of some rodent-based research findings to the 
human condition have been brought into question based on two main issues: 1) the distant phylogenetic relationship 
between rodents and man; and 2) the fact that the majority of spontaneously-occurring rodent mammary gland 
tumors do not morphologically or physiologically resemble the most common forms of breast cancer in women. 33, 
100, 255  
With the creation and use of genetically modified animals and other contemporary research techniques, 
investigators have been able to produce mammary tumors in rodents that are more representative of the human 
disease. However, the failure to recognize molecular changes in humans that have been identified as critical toward 
the initiation and/or progression of mammary cancer in some genetically-altered mic  continues to raise concerns as 
to the overall utility of these models toward the study of human breast cancer.33, 100   
While rodents will almost certainly remain essential toward the study of breast cancer, the use of adjunct 
animal models are likely to prove useful in areas of research where the rodent models have shown to lack relevance. 
Consequently, the ideal adjunct breast-cancer animal models would have a closer phylogenetic relationship to 
humans, they would have a reproductive morphology and physiology more similar to women, and they would 
develop spontaneous mammary gland disease that is more representative of human breast dysplasias and cancers.   
Genetics and relatedness of nonhuman primate animal models. The rhesus macaque (Macaca mulatta) 
monkey has been found to share ~93% of its total genetic sequence identity with humans.95 Furthermore, the rhesus 
macaque is identified to have ~97% average orthologous similarity to humans at both the nucleotide and amino acid 
sequence levels. In contrast, the orthologs of humans and laboratory mouse (Mus musculus) share only ~85% and 
~88% average nucleotide and amino acid sequence similarity, respectively.42, 95, 276 
The rhesus macaque and cynomolgus macaque (Macaca fascicularis) are closely-related nonhuman 




These two monkey species can interbreed to produce fertile offspring and by some genetic analyses demonstrate 
only 0.34-0.40% sequence divergence between their genomes.295 This is notably similar to the 0.31% sequence 
divergence that has been identified to exist between the Chinese-origin and Indian-origin rhesus macaque-
subspecies, and is likewise similar to the 0.40% variation that can exist between individual humans.295 Due to their 
marked interrelatedness and the fact that the morphology and physiology of the rhesus and cynomolgus macaque 
mammary glands have been identified to be nearly identical, the generic term “macaque” will be utilized throughout 
the remainder of this review when referring to mammary gland information pertinent to both species.50, 56, 291 
Differences between the two species will be directly stated, where known to exist, and the generic term “macaque” 
will not be utilized herein to refer to other species of monkey from the genus Macaca.      
Morphology of the human, macaque and rodent mammary gland. At the gross anatomic level, humans 
and macaques both have one pair of mammary glands overlying the thorax, with the bulk of the glandular tissue 
within each mammary gland located cranial and lateral to the nipple.56 Rodents, by comparison, have numerous 
pairs of mammary glands organized into chains along the ventrum that exend from the thorax to the pelvis, with the 
largest of these glands located adjacent to the inguinal area.   
At the subgross level, the macaque and human mammary glands are once again similar while, as before, 
both are conspicuously different from those of rodents. In humans and macaques, each mammary gland is composed 
of multiple lobes that are largely independent of adjacent lobes with each lobe communicating to the external 
environment through its own individual duct and secretory pore.56 In contrast, mice are described to have unilobular 
mammary glands as there is less physical and physiological separation between the individual lobules and all 
ductules within a single mammary gland converge into a single large duct prior to joining the secretory pore.253    
At the microscopic level, there are also distinct differences in the rodent gland as compared to those of the 
human and macaque.56, 263 In particular, while macaques and humans have large distinct clusters of alveoli t the 
distal aspects of the TDLUs, rodents lack TDLUs and instead have small glandular arrangements known as alveolar 
buds located over the entire ductal system.27, 270 Furthermore, the prominent intralobular layer of fibroblastic cells 
that surround and provide critical molecular signals to the TDLUs of humans and macaques is not present in rodent 
species.110, 237 Finally, the cytokeratin profile and hormonal expression of the macaque and human mammary gland 
are also identified to be highly similar to one another, while rodent glands have been specifically noted to be 




Development and physiology of the human, macaque and rodent mammary gland. Studies looking 
into the development of the macaque mammary gland have identified the response of proliferating and 
differentiating cells to exogenous hormones to be nearly identical to those of the human, whereas there are notable 
differences to the mammary gland development in mice.55 As one example, the role of prolactin on the mammary 
gland in humans and macaques appears to be almost wholly limited to the initiation and maintenance of 
lactogenesis, while in mice, prolactin is known to be essential to early developmental steps of the gland.129, 134, 279 
Additionally, the expression of ER and PR within the cells of the developing macaque mammary gland are nearly 
indistinguishable from what is currently known to be the case for women.13, 56, 110, 288   
Even beyond the developmental stages, there remain stark differences betw en the mammary glands of 
rodents as compared to those of humans and macaques. This is proposed to be in large part due to the marked 
physiologic variations in the type of female reproductive cycles that exists between rodents and those of humans and 
macaques.244, 279 Specifically, mature rodents undergo a 4-5 day estrus cycle throughout w ich they retain a 
functional corpus luteum. As a result of the intact corpus luteum, rodents also maintain significant levels of serum 
progesterone throughout their entire cycle. Humans and macaques, in contrast, both share a 25-3  day menstrual 
cycle in which the corpus luteum undergoes regression in the absence of pregnancy. Resultantly, the progesterone 
levels in these species tend to fluctuate to a greater extent than in rodents.41, 253 Additionally, macaques and women 
are known to have equivalent serum levels of circulating estrogen throughout the phases of the menstrual cycle and 
both have been labeled as “high-level estrogen secretors”.21 Female rodent levels of systemic estrogen, on the other 
hand, are generally considered low, reaching just 10-16% of the serum concentrations found in macaques and 
humans.179, 253 Finally, the proliferative responses of the macaque mammary gland to pharmacological estrogen and 
progesterone compounds is essentially identical to what is known to occur in women and provides yet another 
example of the similarities in mammary gland physiology between the two.52, 54, 289-291    
Consistent with the similarities between the human and macaque reproductive cycles and sex hormone 
levels, macaques have been identified to have profound proliferative cyclic changes to both the ductal and alveolar 
mammary gland epithelium throughout the menstrual cycle.41, 244 This is in contrast to those of the rodent estrus 
cycle where proliferation is currently recognized to be almost entirely limited to the alveolar epithelium.237 Further 
analysis of the macaque mammary glands have also demonstrated significant differences in the expression of ER 




With regard to lactogenesis, the morphological and physiological changes that occur in the macaque 
TDLUs throughout pregnancy, lactation, and involution are essentially identical to those of humans.56, 291 In contrast, 
most changes to the rodent gland during lactogenesis are focused on the alveolar bud structures and are more limited 
with regard to ductal proliferation.56, 291 Further research has also shown that the increase in glandular tissue and 
volume of milk produced, on a per-body-weight basis, is highly similar between humans and macaques.56 Other 
studies have identified the composition of milk from humans and macaques to be highly similar, while the milk mice 
produce is known to be substantially higher in protein.157, 225 
Spontaneous mammary gland disease in nonhuman primates. A number of case reports and reviews 
have documented the occurrence of spontaneous mammary gland lesions in a variety of nonhuman primates with 
most describing hyperplastic and neoplastic changes remarkably similar to those identified in humans.9, 15, 59, 93, 98, 113, 
161, 180, 240, 284, 291, 296 Rhesus macaques and cynomolgus macaques account for most of theecases, with a variety of 
baboons (genus Papio) and lesser numbers of other monkey species making up the remainder of the eports. The 
numbers of cases identified for each species is largely in line with the popularity of these animals as research models 
and, as such, macaques are not necessarily thought to be predisposed to mammary gland disease over other monkey 
species.  
With regard to macaques in particular, a number of reports have also noted the occurr nce of spontaneous 
ductal hyperplasias similar to those found in humans. While spontaneous malignant neoplasms in the macaque 
mammary gland have been documented more frequently than have hyperplasias, this is thought to be due to a 
reporting bias. This view is supported by the observation that hyperplasias of the macaque mammary gland have 
been identified with much more frequency than have cancers when groups of older study-animals were 
systematically examined for such lesions.50, 252, 266 Specifically, the occurrence of ductal dysplasia, to include both 
the common and atypical form, has been reported to be around 3% in juvenile macaques in one study, and ranges 
between 6-40% in breeding-aged macaques.50, 252, 266, 291 The variation in the data obtained from the older monkeys is 
due, in large part, to the fact that while some studies examined only a few histologic slides of the mammary gland 
for evidence of hyperplasia, other studies evaluated entire mammary glands as whole-mount preparations. Research 
projects examining human breast tissue from age-demographics of women that are analogous to the aforementioned 
macaque studies are rare. However, one project utilizing reduction mammoplasty tissues identified ductal dysplasia 




rodents is highly variable with regard to the rodent strain examined and, unlike humans and macaques, the 
dysplasias in these species tend to be alveolar in origin.33, 107  
The majority of the spontaneously-occurring, macaque mammary gland cancers identified in the literature 
were classified as infiltrative ductular carcinomas (IDC) (n=17) and ductal carcinoma i  situ (DCIS) (n=11), while a 
smaller number (n=3) were classified as lobular carcinoma in situ (LCIS).59, 60, 113, 143, 240, 291 There was also a single 
case of squamous cell carcinoma and  single case of malignant myoepithelioma of the mammary gland described, 
while the remainder of the cases were reported simply as either carcinoma ( =4) or adenocarcinoma (n=1). These 
findings are consistent with those of the human disease, in that early all of the cancers were classified as 
carcinomas, and also in the fact that ductal disease predominated over lobular disease in these animals. This is in 
contrast to findings in the mouse and rat, where alveolar (lobular) carcinomas and fibroadenomas are the most 
common spontaneous tumors of the mammary gland, respectively.33, 100, 107, 255   
Additional findings from macaques that correlate well with the human data include an increased incidence 
of mammary gland lesions with age, and the observation that metastasis of mammary cancer to the lymph nodes is 
common.59, 60, 113, 143, 240, 291 Of note here is that while the incidence of mammary gland c cer in rodents is also 
identified to increase with age,  the lung is the primary site of mammary gland metastasis in rodents. Fi ally, in 
some of the macaque case reports, the mammary gland carcinomas were treated surgically and/or medically. In these 
cases, the treated macaques were noted to have a similar disease progression, recurrence and prognosis as might 
have been expected of humans with similar forms of the disease.59, 113, 240 
In the most exhaustive examination of spontaneously-occurring, macaque mammary gland cancers to date, 
two D.V.M. pathologists and one M.D. pathologist jointly characterized the mammary gland lesions of 35 monkeys 
and identified a number of similarities between the macaque and human conditions.291 Akin to what has been found 
in humans, some macaque mammary cancers demonstrated a continuum from atypical ductal hyperplasia to DCIS to 
IDC. Furthermore, with regard to DCIS, four out of the five major morph logical classes of human DCIS were also 
identified within the 35 macaques examined here. The IDCs of these monkeys also correlated well histologically 
with those seen in humans, were describable using human classification shemes, and ranged from low- to high-
grade morphology. Further examination of these lesions utilizing immunohistochemical stains yielded even more 
similarities between macaque and human mammary gland disease and included: 1) a significantly increased 




sex steroid receptors in 60% of carcinomas; 3) expression of HER-2 in 40% of carcinomas; 4) selective loss of sex 
hormone receptors and increased expression of the HER-2 in higher grad  carcinomas; and 5) loss of E-cadherin 
expression in LCIS lesions.233, 250, 291 Of note here is that, in contrast to these macaque findings, the vast majori y of 
spontaneously-occurring rodent mammary tumors do not match up well with the human classification schemes, are 
hormone independent, and lack relevant HER-2 expression (other than a few tr nsgenic animal models).33, 107, 108, 200 
In addition to its other contributions, the aforementioned study on spontaneously-occurring macaque 
mammary gland cancer was also significant in that it was the first published report to propose an incidence rate for 
mammary gland cancer in these species. While historically, mammary gland cancer has been considered a rare 
disease of macaques, this group reported a 6.1% incidence rate based on data obtained from a population of aged, 
control animals located at a single institution. Although this number is lower than the ~12% incidence rate of breast 
cancer found within the general population of the United States, this number is in agreement with the 4-8% 
incidence rate proposed to be the case for lower-risk populations of women.87 The comparison of the incidence rates 
in these macaques to those of the lower-risk populations of women was reasoned to be appropriate, in that the 
animals utilized in this study were not obese, and nearly all of these animals were either ovariectomized or 
multiparous (all three factors associated with a lower incidence rate of breast cancer in women). To date, there have 
been no other reports utilizing similarly aged-macaque populations to challenge the incidence rates proposed by this 
group. The reasons as to the anecdotal underestimation of spontaneously-occ rring mammary gland disease in 
macaques prior to the publication of this paper are proposed to be multifactorial and include: 1) most macaques that 
are utilized in research are young animals and therefore most are not alive past middle-age when the incidence of 
mammary gland disease has been shown to be highest for these animals; 2) ny of the macaques that are kept for 
lengthy research projects are ovariectomized in order to minimize hormonal fluctuations (an intervention that is also 
likely to reduce incidence of mammary gland disease); 3) the vast majority of macaques that are kept for long 
periods of time are breeding-colony animals and the females in these colonies are often multiparous and are very 
young when bred for the first time (both factors of which are likely reduce their incidence of mammary gland 
disease); and 4) historically, most macaques that are kept as breeding animals never u dergo exhaustive post-
mortem examinations to include a detailed inspection of the mammary glands.251, 291 
Hormone-induced mammary gland disease in nonhuman primates. Numerous hormonal-replacement 




the same time, many of these same studies have also produced large numbers of mammary gland lesions in the 
macaque.51, 52, 54, 55, 59, 83, 90, 244, 251, 252, 265, 266, 287, 289-291 Of the studies for which the data have been best characterized, 
long-term hormone therapy in macaques has produced hyperplastic lesions with incidence rates 3-4 times those 
found in controls.252, 266 Other research has documented DCIS and ductal carcinoma incidence rates between 9-15% 
in hormonally-treated animals. 252, 265 The fact that some of these studies utilized hormone doses similar to those 
routinely prescribed to women, and that the macaque cancer incidence rates then met or exceeded those of the 
general human population, lends further credence to the proposal above that macaques may have lower spontaneous 
incidence rates of mammary gland disease due to a decreased risk-exposure. The hyperplastic and neoplastic lesions 
identified in these macaques were almost entirely ductal in origin, similar to what was described above in the 
spontaneously-occurring mammary gland cancers of macaques. Additionally, when cancerous lesions were 
identified in these animals, nearly all of these were reported to be carcinomas. Finally, in these reports, most cancer 
metastases were found within the lymph nodes and the majority of the mammary gland cancers that were examined 
using immunohistochemical techniques were identified to be ER-positive.83, 291   
Animal models of radiation-induced breast carcinogenesis. Of the numerous carcinogens utilized 
toward the study of breast cancer in laboratory animals, ionizing radiation is one of the few that is also known to be 
a significant cause of cancer in people.30 Additionally, unlike most chemical carcinogens, ionizing radiation has also 
been shown to produce a wide spectrum of pre-neoplastic and malignant mammary gland lesions in some animal 
models that are comparable to progressive stages of human breast disease.2, 30, 81, 108, 115, 151, 174, 185, 232, 264   
Rodents have contributed greatly to the understanding of radiation- nduced disease in general. However, 
the use of these animal models toward the study of radiation-induced, human breast carcinogenesis is proposed to be 
less than ideal for several reasons.115, 245 At the forefront of these concerns is the fact that most radiation-induced 
mammary gland tumors of rodents are phenotypically different from the most common radiation-induced cancers of 
humans. Similar to what was described for the spontaneously-occurring mammary gland cancers, rats frequently 
develop fibroadenomas and adenocarcinomas of the mammary gland fol owing irradiation, while most mouse 
models of radiation-induced disease develop alveolar-centric cancers. Also similar to what was previously 
described, only a very few strains of rodents routinely express sex hormone receptors within their respective, 
radiation-induced mammary gland tumors.100, 115, 181, 255 Radiation-induced breast cancer in humans, by contrast, is 




Another issue with the use of rodents in radiation-based research is that the data as to the rodent 
demographics with the highest-risk of developing radiation-induced mammary gland disease is not entirely 
consistent with the human findings. As an example, some studies have reported adult rats to be more susceptible to 
the development of radiation-induced mammary gland cancers than are younger animals.115, 213 This has led 
researchers to speculate that there may be significant differences in the cell populations and/or molecular pathways 
susceptible to radiation-induced disease between rodents and humans.30, 117 Specifically, it has been proposed that 
radiation-induced mammary gland carcinogenesis in the rodent species is likely associated with the TEB-to alveolar 
transition phase of mammary development, while the ductular-expansion phase of mammary development is 
proposed to be the most radiosensitive phase in women. Th  predisposition of the rodent alveoli to radiation 
induction is further supported by studies in which pregnant and/or lactating rats were found to be significantly more 
susceptible to mammary gland cancer development than were other demographics of an mals.115, 213  
One last issue with the use of rodents in radiation-based research arises from the observation that, unlike 
humans, parity does not appear to be protective of radiation-induced mammary gland disease in the rodent.115, 213 
This information is especially disconcerting in light of the fact that parity is well-recognized to be protective of 
mammary gland cancers induced by a variety of chemical carcinogens.27, 65, 101, 115, 176, 220, 234, 249, 256 The full 
implications of these findings are unknown, but again suggest that different cell populations and/or physiologic 
mechanisms may underlie mammary gland disease in rodents as compared to humans.   
The rhesus macaque has been used with some frequency in radiation-based research,11, 16, 30, 37, 64, 78, 109, 184, 
186, 187, 204, 241, 269, 286, 292 although little is known about the long-term effects of irradiation on the macaque mammary 
gland due to several factors. First, much of the macaque-based radiation research to d te has been focused on the 
acute effects of high-dose, total body irradiation and, as per their design, these studies have not contributed any 
information as to the long-term effects of radiation on the macaque mammary gland.16, 184 Second, even where 
macaques have been kept for longer periods of time following exposure to high-dose, total body irradiation, there 
are essentially no mammary gland cancers reported for these animals. Critical to the interpretation of this 
information, however, is the knowledge that much of this long-term data was acquired from follow-up studies on 
macaques that survived aninitial high-dose, total body irradiation experiment29, 30, 109, 286, 292 while other long-term 
data has come from high-dose, total body irradiation research that concentrated on individual organ systems other 




may be confounded by the fact that information was only acquired from the individual animals that were most 
resistant to the effects of acute, high-dose total body irradiation and also by the fact that none of these long-term 
projects were mammary gland-specific research. This last piece of information being important as essentially 
nothing is described in these studies as to the means by which the mammary glands were examined for pre-
neoplastic/neoplastic disease and it is plausible that mammary lesions could have been overlooked if a thorough 
gross dissection was not performed or if the microscopic examination of the mammary glands was based only on a 
few histological slides rather than whole-mount sections. Finally, even where long-term macaque studies have been 
performed using lower doses of radiation that may have been more conducive to mammary carcinogenesis,37, 78, 204, 
241, 269 there are only a few cases of mammary gland cancers reported.37, 78 Importantly though, most of these studies 
utilized focused irradiation techniques that greatly limited secondary exposure t  the breast and there was essentially 
nothing mentioned in these reports as to the means by which the organ systems, outside their own interests, were 
examined for neoplastic growths.204, 241, 269   
What is known about rhesus macaques and irradiation is that the acute response of the e animals to high-
dose total body irradiation has been identified to be essentially identical to those of the human with regard to the 
gastrointestinal and hematopoietic systems.16, 109 Furthermore, it has also been reported that the long-term, excess 
relative risk for cancer development following X-irradiation is similar between humans and macaques.16, 109 Finally, 
while the numbers are few, there are at least two reports related to the development of ammary gland cancer in the 
rhesus macaque following irradiation. In the first case report, a single animal was exposed to fractionated total-body 
irradiation at 0.25 Gy every-other-week for over two years (20 Gy total). The animal then developed mammary 
gland ductal carcinoma with lymph node metastasis within a year of completing irradiation.37 In the second case 
report, a single rhesus macaque was administered routine estrogen injections for a three year period prior to having a 
radioactive silver (110Ag) disk implanted in the subcutaneous region of the skin overlying the mammary gland. 
Three years following the implantation, the animal developed a carcinosarcoma of the mammary gland adjacent to 
the site of disk. Of note here is that none of the other monkeys entered in this same estrogen trial study were exposed 
to radiation and none of the other animals developed breast cancer.78 
In summary, in spite of their potential limitations, rodents continue to be he primary animal models 
utilized for the study of radiation-induced mammary disease of humans due to the fact that no better animal models 




minimal at this time, there is no definitive data to suggest that macaque mammary glands are resistant to radiation-
induced carcinogenesis. To that, investigations into macaques as a radiogenic model of human breast cancer are 
warranted given the similarities between macaques and humans with regard to enetics, reproductive physiology, 
and mammary gland-disease and due to their similar acute and long-term responses to irradiation.245    
Acquisition of Mammary Gland Stem Cells and Progenitor Cells for Research 
Enrichment and isolation of MSCs and PCs. Due to the possibility that MSCs and/or PCs are common 
cells-of-origin for breast cancer CSCs, there is currently much interest in acquiring these cell populations from the 
mammary gland for study. Through the use of fluorescence-activated cell sorting (FACS), many different human 
and murine mammary gland cell populations have been isolated and examined. The sorting of these cells has come 
primarily through the use of a variety of cell-surface markers, namely CD24, CD29, CD31, CD44, CD45 and CD49, 
although a number of other cell-identifying qualities have also been utilized such as: aldehyde dehydrogenase 
activity; retention of the label bromodeoxyuridine; and efflux of Hoechst 33342 dye.6, 27, 71, 96, 127, 147, 230, 232, 239, 243, 254 
While several independent studies using different FACS-gating techniques have purported to isolate populations of 
MSCs, there have been major phenotypical and physiological discrepancies described between cells isolated by the 
different groups.2, 79, 108, 127, 144, 150, 206, 230, 243, 293 Based on these findings, it has been proposed that different 
subpopulations of MSC-like cells may coexist within the breast and that the subpopulations acquired using these 
techniques likely represent different states of activation of the MSCs at the time of isolation.79, 293 Accordingly, there 
is currently no consensus as to definitive FACS biomarkers for human or murine MSCs and, at best, FACS can only 
be said to “enrich” for MSC-like cells.230 While the use of these cell sorting techniques is useful toward the isolation 
of highly specific cell populations from the breast for study, it is also po sible that this level of specificity could 
limit our understanding of breast carcinogenesis as a whole. This is because brea t cancer CSCs have been 
demonstrated to exhibit a variety of surface markers and thus breast cancer CSCs may be derived from more than 
one subpopulation of MSCs and/or even some early PC-populations.71, 79 As such, if research becomes too focused 
on just one, or a few, subpopulations of proliferative cells then it is ent rely possible that biomedical research could 
miss out on relevant data toward carcinogenesis if the FACS-selected cell populations are not inclusive of all of the 
MSC/PC-types that are readily susceptible to neoplastic transformation. 
A cell culture method for the acquisition f MSCs and PCs from mammary tissues that is less limited in its 




research.71 The nonadherent mammosphere culture technique (hereafter referred to as “mammosphere culture”) 
utilizes the stem cell properties of anchorage-independence, apoptosis resistanc  and high proliferation index to 
isolate MSCs, and some less-differentiated (early) PCs, from the bulk of the mammary epithelium.71, 74 In short, 
primary mammospheres are created as mammary gland tissue is mechanically and enzymatically dissociated into 
single-cell suspensions, and then placed into serum-free media within ultralow attachment cell-culture plates. In the 
absence of serum and with no surface to attach to, the more-different ated mammary epithelial cell types in the 
plates undergo anchorage dependent apoptosis (anoikis), while the MPCs, and some early PCs, persist and 
proliferate to form free-floating spherical colonies. Secondary mammospheres can then be created from these 
primary cultures by mechanically and enzymatically dissociating the primary mmospheres back into single cell 
suspensions, and then allowing the cells to form spheres once again in serum-free media within ultralow attachment 
plates. This same process can then be repeated to create tertiary mammospheres and so on, as desired. The rationale 
behind creating the secondary mammosphere cultures and later-stage cultures is hat some research suggests that 
with each passage of the sphere-forming cells there are higher ratios of MSCs in the cultures as the PCs undergo 
senescence due to their limited proliferative ability.71, 74, 155 
Another possible advantage of mammosphere cultures over FACS-based methods is at the cell 
suspensions used for mammosphere cultures do not require the addition of antibodies, reagents or dyes to obtain the 
cells-of-interest. While most of these cell-markers are generally considered to have negligible physiologic effects on 
the cells to which they are applied, there are minimal experimental data to confirm these assumptions. As such, there 
is a possibility that at least some of these reagents could confound study res lts through unidentified alterations in 
cell function.79, 139  
Mammosphere cultures in research. The use of mammosphere cultures toward the isolation of MSCs and 
PCs has been well characterized using human breast tissues.71, 74, 139, 155, 185, 226, 270 In these studies, mammospheres 
were routinely grown and examined as both primary and secondary cultures. The identity of the cells comprising 
individual spheres was largely determined by growing the cells in a variety of culture conditions, and then 
examining the outgrowths for differentiation utilizing immunohistochemical staining methodologies. One study 
found that around 68% of primary mammospheres obtained from humans were able to undergo multi-lineage 
differentiation, and thus, were proposed to be of MSC or MPC origin, while the remaining spheres were identified to 




identified to be capable of multi-lineage differentiation.71 Additional work demonstrated that when single cell 
isolates were plated in low cell densities, the vast majority of primary and secondary spheres in these cultures were 
clonal in origin.43, 71, 74, 85 These same studies, and others, further demonstrated that most mammospheres derived 
from low-density platings contained, on average, 1.3 sphere-reforming cells (the MSC) per sphere while the 
remainder of the cells comprising these spheres appeared to lack characteristics of MSCs.71, 79 Together, this 
information suggests that dissociated cell suspensions produced between the primary and secondary mammosphere 
cultures provide a means by which highly-enriched populations of MSCs can be obtained.71, 74   
Mammosphere culture techniques have also been utilized to evaluate the murine mammary gland with 
some frequency. The results from most of these studies are comparable to those of humans with regard to: 1) the 
ratios of the MSCs identified within the mammary gland (0.02-0.07%); 2) the clonal identity of low-density derived 
mammospheres; and 3) the numbers of multi- ineage and lineage-specific sphere types found in primary and 
secondary cultures.26, 138, 146, 147, 172, 236, 243   
Summary and Research Outline 
Breast cancer remains a prominent cause of cancer-related morbidity and mortality of women in the United 
States and relevant animal models are still needed toward the study of this disease. Macaques are more similar to 
humans than are laboratory rodents with regard to genetics, mammary gland morphology and reproductive 
physiology. Additionally, macaques have been shown to spontaneously develop pre-neoplastic lesions and 
mammary gland cancers similar to those f humans whereas most rodent models do not. Finally, the incidence rate 
of mammary gland disease within some populations of research-macaques has been identified to be similar to those 
of the low-risk human population in the United States.  
Mammary gland stem cells and, to a lesser extent PCs, continue to attract at ention as possible cells-of
origin for breast cancer CSCs. Research animals that can provide MSCs and PCs that are most similar to those f 
humans are arguably the models most likely to advance the science in this area. I propose, based on the cumulative 
information provided above, that carcinogenesis studies utilizing macaque-deriv d MSCs and PCs are likely to be 
more relevant to human breast disease than are identical studies in which the MSCs and PCs are acquired from 
laboratory rodents.  
An ideal modeling system for breast cancer carcinogenesis would, amongst other factors, be one that could: 




and 3) reduce the number of experimental confounders. The collection of mammary gland tissue from humans is 
limited by ethical concerns and it is notable that the vast majority of the human tissues utilized for research are 
obtained as a byproduct of reduction mammoplasties. As such, collection of mammary gland from adolescent 
females, a life-stage of great interest to carcinogenesis research, is rarely performed and longitudinal studies of 
breast changes in individual women are all but impossible.22 The clinical and family histories of women undergoing 
reduction mammoplasty procedures are frequently incomplete and other variables, such as diet and lifestyle choices 
(e.g., smoking), that may affect cancer risks are largely unknown.22 Fi ally, as the different phases of the menstrual 
cycle are appreciated to lead to significant morphologic changes in the cells comprising the human mammary 
gland,86, 97, 156, 170, 178, 214, 272 it is plausible that variations in the collection-time between individuals, with regard to the 
phase of the menstrual cycle, could confound comparative studies. In contrast, mammary gland biopsies can be 
easily collected from macaques at any age and biopsies can also be collected from the same animal at multiple time 
points throughout its life. Furthermore, as the medical histories and pedigree of th se animals are generally well 
known, confounders such as numbers of pregnancies and familial histories of cancer  be accounted for while 
other research variables, such as diet and lifestyle choices, are essentially not an issue. Lastly, the timing of 
mammary gland biopsy collection to specific stages of the menstrual cycle in the macaques is easily accomplished 
and, in theory, can further reduce variation between the biopsy samples. Based on this information, I propose that 
carcinogenesis studies utilizing macaque-derived MSCs and PCs have the possibility of producing more significant 
data with regard to human breast cancer than identical studies in which MSCs and PCs are acquired from highly-
variable human tissue sources.  
There are currently no published data to indicate that MSCs/PCs have yet been isolat d from any 
nonhuman primate species. I therefore undertook an aim to develop and validate a mammosphere culture technique 
for the rhesus macaque with the goal of obtaining MSCs and PCs for u e in biomedical research. I describe this 
process in detail in Chapter 2. In Chapter 3, I describe a cytology method that I validated in the rhesus macaque to 
aid timing of mammary gland collections to a specific stage of the menstrual cycle.  
As fundamental differences are known to exist between the nulliparous and multiparous mammary gland, I 
undertook an aim to quantify, characterize and compare the MSCs/PCs collected from both nulliparous and 




Ionizing radiation is an established cause of breast cancer in women. Despite the fact that macaques have 
been described to be similarly susceptible to the effects of radiation as humans, basic data as to use of these animals 
for studies on radiation-induced breast cancer is lacking. Therefore, I undertook an aim to examine the effects of 
ionizing radiation on MSCs/PCs collected from both nulliparous and multiparous female macaques which is also 
described in Chapter 4.   
In conclusion, there is evidence to suggest that macaques are relevant animal models for the study of 
human breast cancer and that use of these animals could open up avenues of res arch that are currently inaccessible 
using tissues derived from either humans or rodents. The work included in this dissertation represents the 
development of novel experimental techniques in macaques that are applicable tow rd the study breast cancer and 
also provides baseline data on the macaque mammary gland that are essential to the continu d use of these animals 
in research. This work also represents the first descriptive and comparative experiments performed on mammary 
gland stem cell populations from any nonhuman primate species and, beyond the information gained from these 
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Breast cancer remains a significant cause of mortality for women in the Unit d States with the majority of 
these deaths attributable to recurrence or metastasis.6, 111 Most breast cancers are composed of highly heterogeneous 
neoplastic cell populations.6, 62, 68, 73, 270 Contemporary evidence suggests that a small subpopulation of the neoplastic 
cells within breast tumors known as the cancer stem cells (CSCs) represent th  archetype cell for each cancer.  In 
light of their multipotent potential, the CSCs are considered to be the cell population most likely responsible for 
cancer recurrence and metastasis.6, 44, 62, 73, 74, 146, 280, 299 Hypotheses as to the origin of the CSCs propose that these 
cells frequently arise from mutations to the mammary stem cells (MSCs) and/or multipotent progenitor cells (MPCs) 
that exist within the normal mammary gland.73, 196, 209, 260 This has sparked interest into the acquisition of these two 
particular cell populations for study. While there are currently no methods available by which to obtain pure 
populations of MSCs or MPCs, a number of cell markers and functional assays have been utilized to sort cells 
obtained from mammary gland digests to enrich for these specific cell popuati ns.67, 79, 84, 96, 147, 196, 206, 230, 243   
A cell culture technique, commonly called mammosphere culture, has also been ext nsively utilized to 
obtain similarly-enriched cell populations from the mammary gland from bth humans67, 71, 73, 85, 196, 206, 231 and 
rodents.147, 208, 293 Briefly, single-cell suspensions obtained from digested mammary glands are placed in specialized, 
serum-free media and are cultured in ultralow attachment plates to take advantage of the fact that MSCs and some 
MPCs are identified to be anchorage independent cell types.68, 74 Under these conditions, the MSCs and some MPCs 
proliferate as free-floating spheres (mammospheres). In contrast, the vast majority of the other, more-differentiated, 
mammary cell types acquired from the tissue digests undergo anoikis (anchorage-dependent apoptosis). 
Mammosphere studies have demonstrated that when these initial (primary) mammospheres are dissociated back into 
single-cell isolates and allowed to proliferate under the same conditions, secondary mammospheres are formed. 
These secondary mammosphere cultures have, in turn, been identified to be composed of populations of cells that 
are even more highly enriched for stem cell-like cells than are the primary mammosphere cultures.71 
Historically breast cancer research has relied heavily on rodent models for the study of breast cancer. 
Rodents may not be ideal research models however, as spontaneously-occurring mammary gland cancers in these 




that even when rodents can be manipulated through experimental techniques to develop cancers more representative 
of the human disease, there still exist significant genetic, physiologic, and morphologic differences between humans 
and rodents.33, 100 These differences have brought into question the relevance of diagnostics and treatments 
developed in rodent models that are to be utilized for human breast disease. Human breast tissues, typically obtained 
as byproducts of reduction mammoplasties, have also been utilized with some frequency in the study of breast 
cancer. However, there are limitations to the usefulness of the human-derived tissues as well. These include the lack 
of availability of samples and the fact that there is an inherent variability between individual donors as a result of 
environmental, genetic, and life-style differences.22 Other limitations associated with the use of the human derived 
tissues are the limited demographic age-range of the women undergoing reduction mammoplasty and, logically, the 
inability to perform longitudinal carcinogenesis studies on the individuals themselves.22  
Rhesus macaques (Macaca mulatta) have mammary glands that are morphologically and physiologically 
similar to humans.56, 288 Additionally, although female rhesus macaques do undergo a seasonal period of 
reproductive inactivity, during their reproductively-active times of the year these animals undergo a regular 
menstrual cycle that is similar in length and form to that of the human.10, 31, 50, 63, 244, 267, 279   Recent investigations 
suggest that some macaque species have breast cancer incidence rates similar to those of certain human 
populations.291 It was also reported in these same studies that the preneoplastic and neoplastic mammary gland 
lesions of most macaques were comparable to those of humans. As macaques re common research animals, large in 
size and long-lived, they are likely to prove useful toward the study of breast cancer. Despite their potential, the 
utilization of these animals in breast cancer research is still limited, in large part, due to the fact that little work has 
been done to validate commonly used research techniques for these species. 
This study describes the modification of the mammosphere culture technique for us  in the rhesus macaque 
and also describes the first mammosphere studies performed using nonhuman primate tissues. One major aim of this 
project was to optimize a mammosphere culture technique for the rhesus macaque. The hypothesis being that viable 
and reproducible mammosphere cultures could be obtained from this species. Minor goals associated with this first 
aim were to collect mammary gland weights for the species and also to investigate wheth r or not the mammosphere 
potential was similar throughout the entire macaque mammary gland. A second major aim of this study was to 
validate the rhesus macaque mammosphere culture as a relevant assay by which to study the human breast. The 




those described for human-derived mammospheres. A third major aim of the study was to investigate what effect 
that age, parity-status, and stage of the menstrual cycle may have on mammosphere formation and function. The 
hypothesis being that at least some of these parameters would have an effect on th  numbers and/or function and/or 
morphology of mammospheres produced in this species.  
Materials and Methods 
Animal model. Biological specimens were collected from 41 female, Indian-origin, rhesus macaques. 
Thirty-nine of these animals (Animal #s 1-39 in Table 1) originated from the breeding colony at The University of 
Texas, MD Anderson Cancer Center, Keeling Center for Comparative Medicine and Research (KCCMR) in 
Bastrop, TX. Throughout the timeframe of this project, the KCCMR breeding colony maintained an ongoing census 
of approximately 600 adult female macaques. The KCCMR breeding colony has been a closed colony since 1983 
and no outside animals have contributed to the genetic lines since that time. The colony has been documented 
through serological means to be Specific Pathogen Free (SPF) for Cercopithecine Herpesvirus 1, Simian 
Immunodeficiency Virus, Systemic T-lymphotrophic Virus and Simian Retroviruses 1, 2, and 5 since 1991. The 
final two animals included in this study (Animal #s 40 and 41 in Table 1) were originally procured from an external 
source and were maintained at the KCCMR, in a study setting outside of the breeding colony, for approximately 2 
years prior to their euthanasia. These two animals were seropositive for Cerc pithecine Herpesvirus 1 at the time of 
their death but were clinically normal and were SPF otherwise. Signalment and medical history were collected for 
each study animal. A Body Condition Score (BCS) was also assigned to each study animal based on published BCS 
parameters for the rhesus macaque.58 The BSC was a consensus score agreed upon by at least two individuals 
(veterinarians and/or veterinary technicians) experienced in nonhuman primate work. Information pertaining to each 
animal utilized in the study is presented in Table 1. The KCCMR is fully accredited by the Association for 
Assessment and Accreditation of Laboratory Animal Care International (AAALACI) and all animals utilized in this 
study were housed in full compliance with the recommendations provided in the Guide for the Care and Use of 
Laboratory Animals (ILAR).182  All tissue collection methods used for this study were reviewed and approved 
through The University of Texas, MD Anderson Cancer Center Institutional Animal Care and Use Committee 
(IACUC).  
Mammary gland biopsies. In vivo mammary gland biopsies were collected from a total of four animals 




Table 1. Macaques collected for the mammosphere studies represented a wide range of demographics. Definition of 
table terms. Animal #: order processed in the study. Process: N=necropsy; B=biopsy. Age: rounded to nearest 
quarter year. Wt (kg): Body weight in kg. BSC: body condition score (as detailed in text). Class (parity): 
N=nulliparous; P=primiparous; M=multiparous. Stage (reproductive status per uterus/ovary histology): M=menses 
phase; F=follicular phase; L=luteal phase; I=inactive phase; P=pregnant or peri-parturient; Cy=polycystic ovaries. 
Lact: (lactating, per gland histology for necropsies or per clinical evidence of lactation for biopsies): Y=yes; N=no.  
Fibrous (qualitative amount of fibrous connective tissue within the mammary gland histologically): 0=minimal; 
1=mild; 2= moderate; U=unknown (histology not available). Infants: number equals number of live births. Mam wt 
(g): average weight of each gland for necropsied animals or weight of biopsy for biopsied animals in grams; 
U=unknown.  Animals listed as “opportunistic” were euthanized as part of study that was unrelated to this project.   
 
 
and the skin of the chest was shaved and surgically prepped for the biopsy pr cedure. Using aseptic surgical 
technique, a 2-3 cm incision was made in the skin over the craniolateral aspect of one mammary gland. The 
underlying mammary gland tissue was dissected free from the adjacent soft tissue structures and ligated with suture 
at the proximal and distal ends. The biopsy was removed and placed into an ice-chilled solution of commercial 
media (Complete Epicult-B Basal Medium [Human]; StemCell Technologies, Vancouver, BC, Canada) 
Animal # Process Age (yr) Wt (kg) BCS Class Stage Lact Fibrous Infants Mam wt (g) Relevant reproduction history  Cause of death/euthanisia  
1 N 2.25 2.87 3 N I N U 0 1.79 N/A opportunistic
2 N 17 9.68 3.5 M P Y U 13 10.77 Dam and full-term fetus died at parturition parturition 
3 N 14 5.76 3 M L N U 4 5.18 None trauma 
4 N 13 8.95 4 M P Y 0 10 11.62 Dam died 1 day postpartum parturition
5 N 16.5 6.3 3.5 M I N 0 12 5.61 None cancer 
6 N 2.5 2.8 3 N I N 0 0 2.14 N/A trauma 
7 N 19.25 5.3 2.5 M I N 2 10 4.64 None cancer
8 B 19.5 6.12 3.5 M U Y U 7 0.532 Biopsy 1 month post-weaning  biopsy technique (alive)
9 B 4 5.25 3 P U N U 1 0.398 Biopsy 3 months post-weaning  biopsy technique (alive)
10 N 22.5 6.26 3 M P Y 0 11 11.79  Dam died 1 month post-abortion cancer 
11 N 4.5 5.6 3.5 P P Y U 1 U Dam died carrying second trimester fetus cardiac disease
12 N 11 5.61 2.5 M I Y 0 7 9.53 Foster dam amyloidosis
13 N 14 4.99 2.5 M P Y 0 8 6.74 Abortion of second trimester fetus liver abscess
14 N 21.25 5.79 2.5 M I N 2 12 2.9 None  cancer
15 N 17.5 6.32 3.5 M F N 2 12 6.46 None arthritis
16 N 22.5 5.5 3 M P Y 1 16 7.24 Dam and full-term fetus died at parturition  parturition 
17 N 6 4 2 P I N 2 1 U None arthrtitis
18 B 19.75 5.55 3 M U Y U 9 0.776 Biopsy 1 month post-weaning  biopsy technique (alive)
19 B 22.25 5.89 3.5 M U N U 11 1.012 Biopsy 5 months post-weaning  biopsy technique (alive)
20 N 4.25 3.58 2.5 N L N 0 0 2.79 N/A enteritis/arthritis
21 N 12 9.23 4 M P Y 1 8 10.98 Dam died 1 day postpartum trauma
22 N 12.75 7.31 4 M P Y 0 8 13.42 Dam died carrying first trimester fetus trauma   
23 N 21 5.49 2.5 M F N 1 13 7.08 None cancer
24 N 19 6.01 3 M F N 2 12 4.36 None amyloid/arthritis
25 N 18 5.76 2.5 M I N 2 12 6.12 None cancer
26 N 8 5.09 3 N F N 2 0 2.95 N/A opportunistic
27 N 3.5 4.44 3 N F N 1 0 3.22 N/A opportunistic
28 N 16 6.65 3.5 M L N 2 7 6.84 None cancer
29 N 19 5.07 2.5 M P Y 0 11 6.47 Dam died carrying first trimester fetus cancer
30 N 20 5.77 3 M I N 2 2 5 None liver abscess
31 N 8 6.8 3.5 M L N 0 2 8.12 None opportunistic
32 N 22.5 5.2 2.5 M I N U 16 4.81 None opportunistic
33 N 16.5 6.25 3 M F N U 9 4.66 None opportunistic
34 N 17 5.6 3 M F N 2 7 5.92 None opportunistic
35 N 17 5.5 3 M M N 1 11 6.51 None amyloid/enteritis
36 N 18.75 12 5 M Cy N 0 8 U polycystic ovaries pneumonia
37 N 10.75 4.3 2.5 M I Y 0 4 6.15 None enteritis 
38 N 19.75 6.45 3 M F N 1 13 7.8 None arthritis 
39 N 8.75 4.4 2.5 M L N 0 4 4.73 None enteritis 
40 N 4.5 5.05 2.5 N I N 2 0 3.31 N/A opportunistic




supplemented with 5% fetal bovine serum (Fetal Bovine Serum-Advantage; Atlanta Biologicals, Flowery Branch, 
GA) (EB/FBS). The surgical rent in the mammary gland, subcutaneous tissue,and skin were closed with surgical 
suture. Animals were recovered 3-7 days in the veterinary clinic before being returned to their breeding groups. 
Necropsy-derived tissues. Reproductive tract tissues and mammary glands were opportunistically 
collected at necropsy from select animals that died or that were euthanized at the KCCMR due to illness, trauma, or 
that were euthanized as part of IACUC-approved research projects unrelated to this study. Uterine and ovarian 
tissues collected at necropsy were immersion-fixed in 10% neutral buffered formalin (NBF) (LabChem, Pittsburg, 
PA) for a minimum of 72 hours. Following fixation, the tissues wre routinely processed for histologic examination 
by the KCCMR Histology Laboratory and paraffin-embedded sections were cut at 4 μm and stained with 
hematoxylin and eosin (H&E; Poly Scientific R and D, Bay Shore, NY). The uterine and ovarian morphology was 
assessed by two boarded veterinary pathologists to collectively determine the sp cific reproductive stage for each 
animal (Table 1) using histologic parameters as previously described.10, 31, 267 For the collection of mammary tissue, 
one or both glands were dissected free of the adjacent skin, muscle and adipose tissue and then individual glands 
were weighed prior to further processing. A portion of the mammary gl nd tissue was immersion-fixed in NBF and 
processed for histologic examination, similar to that described for the uteri and ov ries. The remainder of the 
mammary gland tissue was collected into an ice-chilled solution of EB/FBS and was utilized for studies involving 
mammosphere optimization, validation, and characterization. Mammary tissues utilized for the mammosphere 
culture techniques had the initial digestion processes begun within one hour of death and the majority of these 
tissues were processed within 30 minutes of death.  
Optimization study design. While only animals with healthy-appearing mammary gland tissues were 
selected for inclusion in the study, there was a wide range of demographic variables (e.g., age, parity, reproductive 
stage, disease state, etc.) across study subjects. In order to minimize the confounding effects of utilizing animals 
from varied demographics to compare different mammosphere culture techniques, a within-subject approach toward 
the optimization of the technique was performed. In this approach, multiple aliquots of homogenized breast tissue 
(defined below) were acquired from one animal. A number of these aliquots were then utilized to explore a single 
modification to the tissue digestion or cell culture technique. For each experiment all of the variables associated with 
the procedure remained constant except one (e.g., trypsin digestion time), so that the most productive modification 




subjects included in the study, there were enough aliquots of mammary tissue acquired from a single animal to allow 
for exploration of multiple modifications to the mammosphere culture protocol. All experiments investigating the 
mammosphere culture techniques were performed using at least two aliquots of mammary tissue per modification 
(e.g., two tissue aliquots from a single animal were utilized to explore each trypsin digestion-time of interest). Also, 
other than the initial experiments conducted using Animal #s 1-4, each modification to the digestion/dissociation 
technique was investigated using tissues derived from a minimum of two different animals. As not all aliquots of 
tissue could be processed simultaneously, intensive efforts were made to rotate the processing order of the individual 
aliquots in attempts to minimize any effects that time-of-processing may have on the outcome of the experiments. 
An illustrative example of this within-subject approach is provided in Figure 1.   
 
 
Figure 1. Within-subject approach toward the optimization of the mammary gland digestion and single-cell 
dissociation. In this example 12 equally-weighted aliquots of homogenized mammary tissue are obtained from one 
animal. Six aliquots (#s 1-6) are utilized to investigate the effect that various centrifugation speeds have on overall 
production (all other procedural variables remained constant). The other six aliquots (#s 7-12) are utilized to 
investigate the effect that variations in trypsin digestion time have on production (all other procedural variables 
remained constant). Each of these experiments were then repeated using tissues from additional animals to 
confirm/refute these results. The Roman numerals to the outside of each aliqout represent a hypothetical processing 
order for each aliqout. 
 
Mammary gland morphology and physiology is dynamic and could vary with anatomic location.196 Based 
on this possibility, homogenized mammary gland tissues, rather than individual mammary biopsies acquired from 
various locations, were utilized in the optimization experiments in efforts t  minimize any confounding effects 
associated with regionalization. The process of mammary gland tissue homogenization is described here in brief. 




The remaining mammary tissue was minced into small pieces (approximately 0.5-2.0 mm3) in a glass petri dish 
using scalpel blades. The minced mammary gland pieces were mixed well in attempts to evenly distribute the tissues 
within the petri dish. Individual aliquots of predetermined weights were collected from the homogeneous mixture 
for use in the optimization experiments.   
The metrics by which modified culture techniques were determined to be either an enhancement or a 
diminishment of the process are detailed in the Results section below. Once a modification to the technique was 
identified to be advantageous toward mammosphere production, this modification was incorporated into the protocol 
for all subsequent experiments. When modifications to the technique demonstrated no appreciable improvement, the 
procedural variation that produced the most rapid results or that was least costly (i.e., utilized the smallest volume of 
enzymatic solution) was selected for use in the final protocol. This pattern of optimization was continued throughout 
the study until such time that no relevant improvement in the success of the protocol could be readily detected.  
Basic methodology. Animal #s 1-3 were utilized to establish the aseptic mammary gland collection 
technique, weighing technique, and biopsy technique. Animal #s 2 and 3 were also cultured as mammospheres using 
protocols and laboratory-prepared solutions as described for the recovery of human mammospheres.71 This was done 
as a proof-of-concept study to demonstrate that mammospheres could be readily recovered from the rhesus macaque 
mammary gland. Published protocols describing the initial digestion methods for human and rodent mammary gland 
tissue are highly varied within and between species.43, 67, 71, 85, 106, 147, 153, 196, 206, 230, 243 Therefore, the six most-
commonly described initial digestion methods were explored using tissues from Animal # 4. In these experiments 
multiple 800 mg aliquots of mammary tissue were placed in 25 ml of the laboratory-prepared enzymatic solutions 
described above and processed as follows: 1) digestion in aluminum foil-covered flasks rotated overnight (16 hours); 
2) digestion in aluminum foil-covered flasks rotated for 8 hours; 3) digestion in sealed flasks rotated for 8 hours; 4) 
digestion in unsealed conical vials for 5 hours with physical agitation every 20 minutes; 5) digestion in sealed 
conical vials on a vial rotator for 2 hours; and 6) digestion in unsealed conical vials for 2 hours with physical 
agitation every 20 minutes. The cells derived from the various digestion processes were then cultured as 
mammospheres using methods as previously described.71 The use of a mechanical grinder (Stomacher® 3500 series, 
Seward Lab Systems Inc., Port Saint Lucie, FL), in conjunction with the digestive enzymes, was also explored as a 




Mammary gland digestion and single-cell dissociation. A number of different mammosphere protocols 
originating from both the human and rodent literature were explored in this study in efforts to identify the optimal 
digestion and single-cell dissociation (digestion/dissociation) technique for the rhesus macaque mammary gland. 
Commercially-available, human-specific enzymatic solutions and medium were utilized for all mammosphere 
culture attempts following Animal # 4. Modifications to the mechanical digestion process, digestion times and 
enzymatic solution concentrations were made throughout these experiments; however, all tissues were processed in 
the same order and utilized the same enzymatic solutions. The only exception to the prior statement is that Animal 
#s 1-9 did not include a red blood cell-lysis step. The procedural order and enzymatic solutions utilized for all 
digestion/dissociation experiments is outlined in the optimized primary mammosphere protocol provided in Figure 
2. The cells were confirmed to be present as asingle-cell suspension, using techniques as previously described.71 
Total cell numbers and cell viability were determined by the trypan blue exclusion a say using a 0.4% Trypan Blue 
Solution (Sigma Life Sciences, St Louis, MO) and a hemocytometer. Cells obtained from the digestion/dissociation 
process were resuspended in a complete mammosphere medium (CMM). The CMM consisted of a commercially-
available cell culture medium supplemented with heparin, hydrocortisone, L-glutamine and a penicillin-
streptomycin-amphotericin solution as detailed in Figure 2.   
Human and rodent mammary gland digestion/dissociation protocols often fail to provide specific ratios of 
tissue weight to digestion solution. As this information was critical to the optimization efforts here, a quantity of 
mammary tissue that could be routinely acquired via biopsy from all demographics of female rhesus macaques, 400 
mg, was ascertained from the initial methodology and biopsy studies in thi project. In turn, the 
digestion/dissociation optimization procedures undertaken in this project were performed utilizing homogenized 
aliquots of mammary gland approximately 400 mg in weight, except where specifically stated otherwise.   
Experiments were performed to identify an optimal initial digestion time for macaque mammary gland tissues and 
also to identify any differences in digestion times that might exist between th  animals from the various 
demographics. Only the duration of the digestion time varied in these experiments and multiple digestion times 
ranging from 2-6 hours were explored for each animal. Additional experiments explored the effects of a number of 
other variables on the protocol including: 1) addition of 5% fetal bovine serum (FBS) to the initial-digestion 
solution; 2) centrifuge speed of the initial tissue digest; 3) trypsin exposure time; 4) trypsin volume; 5) cell-screen 





Figure 2. Optimized protocol for the digestion and dissociation of rhesus macaque mammary gland tissues into 
single-cell suspensions and the initial plating protocols for the cells derived f om these processes. The optimized 
conditions recommended within Figure 2 are based on experimental results as detailed within the text. 
 
Rhesus Macaque Primary Mammosphere Culture Protocol    
(300-600 mg of homogenized mammary gland processed in a 15 ml conical vial)                       
Note:  Technique can be modified to accommodate larger volumes of tissue as described in the text. 
1) Add 300-600 mg of tissue to the initial digestion solution: 7 ml Complete Epicult®-B Basal 
Medium (Human) (StemCell Technologies (SCT), Vancouver, BC, Canada); 0.7 ml 
Collagenase-Hyaluronidase Solution (SCT); 70 μl of 10-4 M Hydrocortisone solution (SCT); 70 
μl 100 X Penicillin-Streptomycin-Amphotericin Solution (MP Biomedicals, Solon, OH); 70 μl 
100 X L-glutamine Solution. (GlutaMAX®; Life Technologies, Carlsbad, CA).  Cap vial and 
agitate.    
2) Loosen lid and place into 37oC, 5% CO2 cell-culture incubator.  Optimal digestion times 
typically vary between 3.0-4.5 hours.  At 20 minutes remove the vial and inspect for 
completeness of digestion (see text).  If not digested, tighten lid and thoroughly agitate sample 
back into solution, loosen lid and replace in incubator. Repeat agitation every 20 minutes until 
digestion is complete.   
3) Once digested, add 7 ml of 1 X HBSS (Sigma Life Science, St. Louis, MO) + 2% FBS (Fetal 
Bovine Serum-Advantage; Atlanta Biologicals, Flowery Branch, GA)  (HBSS/FBS) and 
centrifuge at 200 x g for 5 minutes. Collect the pellet. 
4) Add 5 ml of 37oC, 0.25% trypsin-EDTA solution (Life Technologies) to the pellet and pipette 
up and down for 3 minutes using a 10 ml pipette (Fisher Scientific, Waltham, MA).  
5) Add 5 ml HBSS/FBS and centrifuge 350 x g for 5 min.  Collect the pellet.  
6) Add 2 ml 37oC, Dispase solution (SCT) and 200 µl DNase 1 (SCT) to the pellet and pipette u  
and down for 1 minute with a 10 ml pipette.  
7) Add 5 ml HBSS/FBS, filter solution through a 70 μm cell strainer and flush strainer with 
another 5 ml HBSS/FBS.  Filter this solution through a 40 μm cell strainer (both Fisher 
Scientific) and flush strainer with another 5 ml HBSS/FBS.  Centrifuged 350 x g for 5 min.  
Collect the pellet. 
8) Add 3 ml RBC Lysis solution (SCT) agitate pellet into suspension and let stand for 3 minutes.  
9) Add 5 ml HBSS/FBS and centrifuge 350 x g for 5 min.  Collect the pellet.  
10) Resuspend pellet in 1-5 ml of a premade solution of complete mammosphere medium (CMM): 
500 ml of Complete MammoCult™ Medium [Human](SCT) supplemented with 1 ml Heparin  
Solution (SCT); 5 ml of 10-4 M Hydrocortisone solution; 5 ml 100 X Penicillin-Streptomycin-
Amphotericin Solution; 5 ml 100 X L-glutamine solution.   
11) Confirm single-cell suspension and perform cell counts. 
12) Plate the cells at the desired concentration using CMM in ultralow attachment plates (Corning, 
Corning, NY).   
13) Seal the plate with paraffin tape (Parafilm M®, Fisher Scientific).  
14) Incubate in a 37oC, 5% CO2 cell-culture incubator.  
15) On day 3 of the incubation process, remove paraffin tape from culture plates.  At this same time 
80% of the original media is exchanged for fresh CMM in 100k cultures, 2 ml of fresh CMM is 
added to each well of the 10k well cultures.  No media is added or exchanged for the 1k 




Following the optimization of the procedure for 400 mg of tissue, studies were then performed to expand 
the use of this protocol to other weights of mammary tissues. For some experiments, the volume of the  
digestion/enzymatic solutions utilized remained constant while the weights of the mammary gland aliquots varied. 
In other experiments, the volume of digestion/enzymatic solutions identified to be optimal for the digestion/ 
dissociation of 400 mg of tissue was doubled, tripled, and quadrupled for the p ocessing of 800 mg, 1200 mg, and 
1600 mg aliquots of mammary gland tissue, respectively.   
Primary mammosphere cultures. Primary mammosphere cultures were produced using methodologies 
similar to those previously described.71 In brief, on the same day (Day 0) the mammary gland tissue was digested, 
aliquots of the single-cell suspension were diluted with CMM to create 1 x 103 viable cells/ml (1k) and 1 x 104 
viable cells/ml (10k) suspensions (collectively referred to as low-density mammosphere cultures). Other aliquots of 
the single-cell suspensions were diluted with CMM to create a 1 x 105 viable cells/ml (100k) suspension (high-
density mammosphere cultures). Five ml aliquots of each suspension were plat d into individual wells of flat 
bottom, 6-well ultralow-attachment plates (Corning, Corning, NY). The cell-suspensions were then grown for 7 days 
in a 37oC, 5% CO2 cell-culture incubator. The mammosphere-forming efficiency (MFE), defined as the average 
number of mammospheres (≥ 40 μm in diameter) formed in each well divided by the number of viable cells initially 
plated per well (expressed as percentage), was calculated for each of the suspension  roduced. 
Unpublished studies performed in our lab have demonstrated that the use of a conditioned media can 
promote the growth of rodent-derived mammospheres and therefore the use of conditioned media was also 
investigated for macaques. Conditioned media, in this case, referring to fresh media supplemented with media 
obtained from previously-grown mammosphere cultures. Toward the creation of a conditioned media here, all high-
density mammosphere cultures (starting with Animal # 11) had 80% of the riginal media replaced with fresh media 
on Day 3. For this exchange, the 5 ml of media and cells/spheres from each well were collected into a single conical 
vial (Polypropylene Conical Tube; BD Falcon, Franklin Lakes, NJ) and centrifuged at 80 x g for 1 minute. Four ml 
of the supernatant was collected and refrigerated at 4oC for later use (described below).  Four ml of fresh CMM was 
then added to the spheres/cells and each 5 ml aliquot was plated back into a single well of a 6-well ultralow-
attachment plate and incubated until Day 7. At Day 7 the mammospheres and media were again collected and 
centrifuged and the bulk of the supernatant was again retained. The supernatant collected from the high-density 




and then filtered with a 0.β μm syringe filter (Fisher Scientific, Waltham, MA). The filtered media collected from 
each animal, hereafter termed “conditioned media-1” (CM1), was utilized in other aspects of the research project for 
that same animal.  
Optimization experiments performed on the primary cultures included: 1) addition of 2 ml fresh CMM at 
Day 3; 3) 80% replacement of the original media with fresh CMM at Day 3; and 3) use of plastic paraffin tape 
(Parafilm M®, Fisher Scientific) to seal the culture plates.    
Secondary, tertiary, and quaternary mammosphere cultures. Secondary mammospheres were created 
from the 10k and/or 100k primary mammospheres as detailed in the optimized secondary mammosphere protocol 
provided in Figure 3. In brief, primary mammospheres were collected using a 40 μm cell strainer and transferred 
into conical vials where they were dissociated into single-cell suspensions usng a trypsin-EDTA solution. As 
before, single-cell suspension was confirmed and the total number of viable cells was determined. Five ml aliquots 
of 1k suspensions and/or 10k suspensions were then plated into individual wells of 6-well ultralow-attachment plates 
and grown for 7 days in a 37oC, 5% CO2 cell-culture incubator. Tertiary mammospheres were created from some 
10k secondary mammosphere cultures utilizing a similar approach. Likewise, quaternary mammospheres were 
created using 10k tertiary mammospheres for some animals in the study. The MFE was calculated for each of these 
suspensions. 
Importantly, two independent assays have suggested that the vast majority of human mammospheres have a 
single-cell origin (are clonal) when the spheres are derived from cultures plated at 1 x 103 cell/ml or less.71 Likewise, 
other studies have proposed that nearly all mammospheres are clonal in origin when the cell cultures are plated at 
densities of up to 1000 cells per cm2.84 To that, the 6-well plates (surface area/well=9.2 cm2) and 96-well plates 
(surface area/well=0.26 cm2) prepared as 1k cultures for this project were plated with a 1 x 103 viable cells/ml 
suspension at maximum volumes of 5 ml and 0.2 ml, respectively. These cell d nsities match, or are lower than, 
those proposed to promote mammosphere clonality for human spheres.  
Optimization experiments performed on these cultures included: 1) addition of 2 ml fresh media at Day 3; 
2) 80% replacement of the original media with fresh media at Day 3; 3) supplementation of CMM with CM1; 4) use 
of plastic paraffin tape to seal the culture plates; 5) timing of the primary mammosphere incubation period; and 6) 
trypsin concentration used for primary mammosphere dissociation.  





Figure 3. Optimized protocol for the dissociation of rhesus macaque mammary mammosphere  into single-cell 
suspensions and the initial plating protocols for the cells derived from these processes. The optimized conditions 
recommended within Figure 3 are based on the experimental results as detailed wi h n the text. 
 
Mammosphere size and cellular composition. Images of mammospheres in media were obtained using 
an inverted light microscope (Olympus IX51 microscope, DP70 camera and DP Controller software Version 2002, 
Olympus Corporation, Waltham, MA) and were measured utilizing imaging software (cellSens imaging software  
Version 1.5, Olympus Corporation). Additionally, images of individual cells in media that were derived from 
dissociated 10k mammospheres and images of formalin-fixed, paraffin-suspended, intact spheres were obtained and 
measured using a standard light microscope and its associated software (Olympus BX41 microscope, DP25 camera, 
cellSens imaging software Version 1.5, Olympus Corporation).  
Mammospheres derived from single cells. Studies have demonstrated that human mammospheres can be 
produced from a single cell.71, 85 Experiments were undertaken here to demonstrate that similar results could be 
obtained for rhesus macaque mammospheres. Primary 10k mammospheres from 4 animals were dissociated into 
single-cell suspensions. Each of these suspensions were then diluted and plated into 96-well plates using CMM 
Rhesus Macaque Secondary Mammosphere Culture Protocol   
(5-10 ml of 100k mammospheres or 30-60 ml of 10k mammospheres)                                 
Note:  The same protocol is also utilized for later generations of spheres (i.e., tertiary, quaternary, etc.) 
1) Collect primary mammospheres on days 6-8 into a conical vial and centrifuge at 80 x g for 1 
minute.  Remove supernatant.     
2) Add 2 ml of 37oC, 0.05% trypsin-EDTA solution to the pellet and pipette up and down using
Pasteur pipettes with fire-polished tips for 10-20 minutes until dissociation is confirmed (see 
text). 
3) Following dissociation, add 5 ml of 1 X HBSS + 2% FBS (HBSS/FBS). 
4) Filter solution through a 70 μm cell strainer and flush strainer with another 5 ml HBSS/FBS.  
Centrifuged 350 x g for 5 min.  Collect the pellet. 
5) Resuspend pellet in 1-5 ml of a premade solution of complete mammosphere medium (CMM). 
6) Confirm single-cell suspension and perform cell counts. If small numbers of spheres persist, the 
solution can be passed through a 40 μm cell strainer to remove the intact spheres.  If large 
numbers of spheres persist, the solution can undergo a second trypsin dige tion of 5-10 minutes.  
7) Plate the cells at the desired concentration using CMM supplemented with conditioned media-1 
(see text) at a 4:1 ratio (CMM/CM1) in ultralow attachment plates.   
8) Seal the plate with paraffin tape. 
9) Incubate in a 37oC, 5% CO2 cell-culture incubator.  
10) On day 3 of the incubation process, remove paraffin tape from culture plate.  At this same time, 
2 ml of fresh CMM/CM1 is added to each well of the 10k well cultures.  No media is added to 
the 1k cultures.    





supplemented with CM1 at a 4:1 ratio (CMM/CM1) to obtain wells which contained single cells. Eleven plates were 
made for each animal and single-cell dilution was confirmed independently by two investigators. Only those wells 
confirmed to contain single cells were included in the experiment. A second set of 11 plates were made for each 
animal using media that lacked CM1. All plates were sealed with paraffin tape for three days. On Day 7, the wells 
were examined for mammosphere formation and the MFE of each suspenion was calculated.      
Two-dimensional mammosphere differentiation on collagen. In humans, the ability of low-density 
spheres to differentiate into both the luminal epithelial and myoepithelial lineages has been used as evidence to 
support a mammary gland stem cell and/or early progenitor cell origin to these structures.71 To demonstrate that a 
similar differentiation capacity existed in the low-density spheres obtained from the rhesus macaque mammary 
gland, the spheres and media from some of the 1k and/or 10k mammosphere cultures were harvested at Day 7. 
Following collection, the mammosphere suspensions were centrifuged at 80 x g for 1 minute. The media supernatant 
was removed and the mammospheres were resuspended in 5 ml of complete RPMI 1640 media (Mediatech, 
Manassas, VA) supplemented with 5% FBS,  1% Penicillin-Streptomycin-Amphotericin Solution (MP Biomedicals) 
and 1% L-glutamine Solution (GlutaMAX; Life Technologies) (RPMI/FBS). The newly-created mammosphere 
suspension was transferred into a single well of a standard 6-well tissue cultur plate (BD Falcon) or the contents 
were divided equally into the individual wells of a single multichambered-chamber slide (Fisher Scientific). Prior to 
deposition of the spheres into the plates/slides, the plates and chambered slides used for these experiments were 
coated with a bovine collagen solution (StemCell Technologies) as per the manufacturer’s instructions. These 
spheres were then allowed to grow for 5-10 additional days in a 37oC, 5% CO2 cell-culture incubator.  Cultured this 
way, the spheroid colonies became adherent to the surface of the wells/slides and the cells of the spheroid colonies 
underwent differentiation as the colonies spread over the surface of these vessels. At the end of the incubation 
period, the media was removed and the adherent cells were prepared for visualizat on with either crystal violet stain 
(Sigma Life Science) using standard technique or immunohistochemical (IHC) methods as described below. Spheres 
attached to the surface of the wells were assessed for bilineage (epithelial and myoepithelial) differentiation. The 
mammosphere differentiation-potential (MDP), defined as the number of bilineage spher /well divided by the total-
number of spheres/well (expressed as a percentage), was the metric used to quantify this assay.   
Mammosphere-derived colony forming units. Previous mammosphere-based studies have investigated 




Similar, although not identical, experiments were performed here. For these experim nts 100k primary 
mammospheres were dissociated into single-cell suspensions as described for generational growth above. However, 
instead of plating these cells under mammosphere-culture conditions, the cells were diluted with RMPI/FBS into 1 x 
103 viable cells/ml suspensions. These suspensions were plated in collagen-coated, standard 6-well culture plates or 
chambered slides as described above for the spheres. The cells were then incubated undisturbed for 3-21 additional 
days in a 37oC, 5% CO2 cell-culture incubator. The resultant cultures were observed directly, stained with crystal 
violet stain or fixed with NBF for approximately 30 minutes prior to being processed via IHC methods (described 
below). Individual outgrowths containing more than 50 cells were counted as colonies and these colonies were also 
assessed for bilineage differentiation. The colony forming efficiency (CFE), defined as the average number of 
colonies formed in each well divided by the number of viable cells initially plated per well (expressed as 
percentage), was calculated for each of the suspensions. Additionally, the colony differentiation-potential (CDP), 
defined as the number of bilineage colonies/well divided by the total-number of colonies/well (expressed as 
percentage), was also utilized to quantify this assay.   
Three-dimensional modeling of mammosphere growth and differentiation. Macaque mammospheres 
were embedded within basement membrane extract (BME), as previously described.70 This assay was used to 
evaluate the three-dimensional growth characteristics of the macaque spheres, similar to what has been undertaken 
for human and rodent mammospheres.67, 70, 71, 85  In brief, a commercial BME (BD Matrigel Matrix, High 
Concentration, Growth Factor Reduced; BD Biosciences, Bedford, MA) was obtained and subsequently diluted with 
RPMI to standardize the BME to a 12 mg/ml protein concentration. Spheres and media from mammospheres 
cultures were collected in a conical vial and placed in ice for approximately 15 minutes. The vials were then 
centrifuged at 80 x g for 1 minute and the majority of the supernatant media was removed. A 100 μl aliquot of the 
mammospheres in media was resuspended in β50 μl of ice-cold BME and then approximately 50-1 0 μl of the 
BME-mammosphere suspension was pipetted onto the surface of a well of a standard 6-well tissue culture plate so 
as to form a convex round “bleb”. Frequently, multiple blebs were plated on the surface of the same well and 
aligned so that the blebs did not make contact with one another. The blebs wer  then warmed in a 37oC, 5% CO2 
cell-culture incubator until polymerized. Three ml of RPMI/FBS was added to the wells to completely submerge the 
blebs.  The plates were then incubated for 3-28 additional days in a 37oC, 5% CO2 cell-culture incubator. The 




Mammospheres in BME were observed and imaged directly within the plates using an inverted light microscope or 
were prepared for histologic examination. Spheres were assessed for the presence or absence of significant ductular-
like and/or alveolar-like structures extending from the main sphere body, hereafter referred to as “budding”. The 
mammosphere budding-potential (MBP), defined as the number of budding spheres/bleb divided by the total number 
of spheres/bleb (expressed as a percentage), was the metric used to quantify this assay.   
For histologic examination of the BME-mammosphere blebs, the media was removed fr m the wells and 
NBF was added to the wells to completely submerge the blebs. After approximately 1 hour, the formalin was 
removed and the blebs were carefully lifted intact from the surface of th well using a flat chemistry spatula. A 
single bleb was encased within 2% high melting-point agarose (Difco Agar Noble; BD Medical Supplies, Franklin 
Lakes, NJ) which, after solidifying, was embedded in paraffin for histologic processing. Paraffin-embedded serial 
sections were cut at 4 μm and placed on charged glass slides. The slides were prepared for visualization with H&E 
stain or periodic acid-Schiff stain (PAS; American MasterTech, Lodi, CA) using standard technique or IHC methods 
as described below.   
Lactogenic differentiation of mammospheres and conditioned media-2. Human- and rodent-derived 
mammospheres have been demonstrated to produce the milk protein, -casein, under specific culture conditions.71, 
196, 230 Similar experiments were performed here on BME-encased mammospheres that were cultured in a media 
supplemented with prolactin (#L4021; Sigma-Aldrich, St Louis, MO) as previously described.230 However, also 
crucial to the lactogenic differentiation of macaque mammospheres was the addition of a sec nd substance to the 
media termed “conditioned media-β” (CMβ). Conditioned media-2 was created using the adipose tissue, muscle, and 
lymph nodes trimmed from the necropsy-derived mammary tissue. Briefly, these three tissues were minced and 
homogenized on Day 0 in a manner similar to that described above for the mammary gland. An aliquot of this 
material was mixed with an aliquot of the mammary gland homogenate from the same animal at a ratio of 
approximately 5:1. Between 1-2 g of this mixed homogenate was then placed in a 100 x 20 mm polystyrene cell 
culture dish (Corning) with 25 ml of RPMI/FBS and incubated for 5 days in a 37oC, 5% CO2 cell-culture incubator. 
On Day 5, the media was collected and centrifuged at 350 x g for 10 minutes. The resulting supernatant was filtered 
with a 0.45 μm syringe filter (Fisher Scientific) and was frozen at -80oC until needed for lactogenic differentiation. 
As needed, the prolactin-containing media was supplemented with CM2 at a ratio of 4:1 and then 3 ml of the CM2-




only utilized in an autologous fashion for these experiments, that is, both the CM2 and mammospheres were derived 
from the same animal. The CM2-prolactin media was replaced every 5-8 days throughout the incubation process. 
Mammospheres were prepared for histologic examination (as above) and processed using IHC methods as described 
below.  
Morphologic comparisons. Following the optimization process, mammospheres were cultured from 
animals representing a variety of different demographics and these spheres were observed for differences in 
morphology. Specifically, these observations were made on free floating sphere  in media and also on spheres that 
underwent two-dimensional and three-dimensional differentiation. Observations were also made on the colonies of 
cells produce in the colony forming unit studies.   
Quadrant and reproducibility studies. The mammosphere forming potential from different regions of the 
mammary gland was examined and compared in a number of individual animals. These experiments were also used 
to examine the reproducibility of the mammosphere culture assay. In these experiments, entire mammary glands 
were dissected from the animals and individual glands were divided into quadrants (with the teat serving as the 
quadrant convergence point) based on their anatomical origin: quadrant 1 = craniolateral qu rter; uadrant 2 = 
caudolateral quarter; quadrant 3 = caudomedial quarter; and quadrant 4 = craniomedial quarter. As there was 
appreciably less mammary gland tissue caudal to the level of the teat in most animals, tissues from the medial aspect 
of quadrant 2 and the lateral aspect of quadrant 3 were collected as one unit (quadrant 2/3). Three mammary 
biopsies were acquired from each of the quadrants 1, 2/3, and 4 for both the left and right gland (total = 18 
biopsies/animal). Each biopsy was individually minced and processed u ing the optimized mammosphere protocol. 
The total number of viable cells recovered per mg of tissue weight (TVC) and the MFE of primary mammosphere 
cultures were used to assess the individual biopsies.    
Immunohistochemical  protocols. Plates, chambered slides, and histologic sections of paraffin-embedded 
BME-mammosphere blebs from a number of animals were processed with antibodies to CD10 (putative bilineage 
progenitor cell marker and myoepithelial cell marker),71 smooth muscle actin (SMA; myoepithelial cell marker),71 
cytokeratin 18 (CK18; differentiated epithelial cell marker),67, 71 estrogen receptor-alpha (ER), progesterone receptor 
(PR) and -casein (BC) to assess differentiation of the spheres. These antibodies had been previously validated for 
use in nonhuman primates and each antibody was confirmed to work here utilizing formalin-fixed, paraffin-




were utilized as negative controls. All formalin-fixed, paraffin-embedded tissue ections utilized in this study were 
deparaffinized in xylene and hydrated by graded alcohols to water as is standard histologic procedure. Formalin 
fixed plates and chambered slides were washed twice with 1 x PBS prior to prcessing.    
For CD10, endogenous peroxidase activity was blocked with 3% hydrogen peroxide in water followed by a 
water wash. Antigen retrieval was performed with 10mM Citrate Buffer (pH 6.0) (Polysciences Warrington, PA) in 
a microwave oven. After cooling and a water wash, non-specific antibody bin ing was blocked by incubating slides 
with a blocking reagent (#BS966M; Biocare Medical, Concord, CA). Slides were drained and incubated with CD10 
primary monoclonal antibody (sc#80021; Santa Cruz Biotechnology, Dallas, TX) at a 1:100 dilution for 1 hour at 
room temperature (RT) and then buffer washed. Slides were incubated with biotinylated rabbit-anti-rat IgG (Vector 
Laboratories, Burlingame, CA) at a 1:200 dilution for 30 minutes at RT and then buffer washed. Slides were 
incubated with streptavidin horseradish peroxidase (SA-HRP) (Biocare Medical, Concord, CA) for 30 minutes at 
room temperature and then buffer washed. Slides were incubated with 3,3'Diaminobenzidine (DAB) chromogen 
(Dako Carpinteria, CA) and monitored for stain development. The slides were washed, hematoxylin counterstained, 
dehydrated, cleared and coverslipped for viewing.   
For the CK18, SMA, ER and PR staining protocols, the peroxidase block, antigen retrieval, and non-
specific antibody binding blocking steps were identical. For the BC staining protocol the peroxidase block and 
antigen retrieval were identical but the non-specific antibody binding blocking step was replaced by a 15 minute 
Tween and Albumin incubation as the blocking reagent contains casein which could interfere with interpretation of 
BC expression. The remaining steps of each IHC procedure was similar to that described for CD10 other than the 
specific antibodies and developing reagents required for those protocols. The reagents and specific protocol 
requirements for these processes are provided. The CK18 protocol included: 1) CK18 monoclonal antibody 
(#ab55395; Abcam, Cambridge, MA); 1:250 dilution; 1 hour RT; 2) biotinylated rabbit-anti-mouse F(ab)’(Accurate 
Chemical and Scientific, Westbury, NY); 1:250 dilution; 15 minutes RT; and 3) SA-HRP; 30 minutes RT. The SMA 
protocol included: 1) SMA polyclonal antibody (#ab5694; Abcam); 1:100 dilution; 1 hour RT; 2) Envision plus 
labeled polymer, anti-rabbit-HRP (Dako); 30 minutes RT; and 3) DAB and monitored for stain development. The 
ER protocol included: 1) ER alpha polyclonal antibody (#sc-542; Santa Cruz Biotechnology); 1:500 dilution; 2 hour 
RT; 2) Envision plus labeled polymer, anti-rabbit-HRP (Dako); 30 minutes RT; and 3) DAB and monitored for stain 




4C; 2) Envision plus labeled polymer, anti-MOUSE-HRP (Dako); 30 minutes RT; and 3) DAB and monitored for 
stain development. The BC protocol included: 1) -Casein monoclonal antibody (#MA1-46056; Thermo Fisher); 
1:100 dilution; overnight at 4C; 2) Envision plus labeled polymer, anti-MOUSE-HRP; 30 minutes RT; and 3) DAB 
and monitored for stain development.   
Statistical analysis. Significant results are expressed as mean and standard deviation. Statistical 
significance for all data was set at P<0.05. A univariate analysis of variance (ANOVA) with post-hoc Tukey HSD 
test was used to compare the mammary gland weights and the MFE of mammary gland quadrants. Demographic 
comparisons of the sphere/cell sizes, MFE, MDP, CFE, and CDP along with the paraffin-tape study were performed 
using a t-test (two sample assuming equal variances). Correlations between the individual variables associated with 
the optimally-processed glands were performed using the Pearson correlati n coefficient. These assays, along with 
the intraclass correlation coefficient (ICC) for mammary gland MFE and the principal component analysis (PCA) of 
the optimally-processed glands, were performed using IBM SPSS version 22 (SPSS Inc., Chicago, IL) software.     
Results 
Mammary glands. The four tissue aliquots acquired through the in vivo biopsy technique ranged in weight 
from 398-1012 mg (Table 1). The remaining tissues in the study were acquired via necropsy. On gross examination, 
nulliparous mammary glands were typically organized into fairly distinct lobes while the glandular tissue of 
multiparous animals was more diffusely dispersed across the ventral thor x. Histologically, glandular tissue was 
identified to be homogenously distributed throughout all lobes in nulliparous nimals. In nonlactating multiparous 
animals, the mammary gland tissue cranial to the level of the teat tended to have the densest and most 
homogenously distributed glands while mammary tissue caudal to the level of th  teat occasionally had glandular 
regions that were interdigitated with fibrofatty tissues. Nonlactating multiparous glands also commonly had 
appreciably more fibrous connective tissue and interlobular stroma within the dividual glandular units themselves 
as compared to nulliparous glands. The average weight of each mammary gland was determined for most necropsied 
animals (Table 1). For animals with a BCS between 2.5 and 4.0, the average wight of the gland was calculated as a 
percentage of total body weight (%TBW) and compared across demographics. Statistically significant differences in 
%TBW were identified between nulliparous (0.069 ± 0.003), nonlactating-multiparous (0.093 ± 0.006) and 
lactating-multiparous (0.145 ± 0.010) animals. The lactating demographic included pregnant, postparturient, and 




aspects of the reproductive cycle (i.e., luteal, follicular and menses stages of th  menstrual cycle, and inactive 
phase). No differences in %TBW were identified between the stages/phases of th  reproductive cycle for 
nonlactating-multiparous or nulliparous animals although only small numbers of subjects per reproductive phase 
were available for comparison.  
Digestion/dissociation optimization. The results of the individual experiments are summarized in Table 2 
and the optimized digestion/dissociation protocol obtained from this work is p ovided in Figure 2. The metrics by 
which a digestion/dissociation technique modification was assessed included: 1) Total number of viable cells/mg of 
tissue (TVC); 2) MFE of the tissue-derived, single-cell suspension (primary MFE); and 3) MDP of 10k primary 
mammospheres. Digestion/dissociation optimization was primarily guided by the TVC, in that the higher the TVC 
obtained using a particular modification, the higher the total number of mammospheres that could be ultimately 
recovered. With regard to MFE, it was found that tissue-derived, single-cell suspensions from multiparous glands 
typically produced less than one sphere per 5 ml well when plated as 1k primary mammospheres. As impractically 
 
Table 2.  Summary of the digestion/dissociation optimization study results. For each box, the underlined black 
variable(s) represent(s) the condition found to be most productive. Red (non-underlined) variables were attempted 
but not optimal. Animal #: identification of animal (corresponds to the Animal # in Table 1). Timing: each number 
represents the time (in hours) each aliquot of tissue was initially digested with collagenase solution. For Animal # 4 
a variety of digestion methods were explored with the “s” in βs and 8s referring to “sealed” containers. Tryp (min): 
time of the trypsin digestion in minutes. Cent (x g): numbers represent centrifuge speeds (expressed as gravity) used 
in the initial collection. FBS: the addition or omission of fetal bovine serum to the digestion solution; Y=Yes; N=No.  
Cell screen: the use of 40 μm (40), 70 μm screen (70), or both (both) screen types. Grinder: the use or omission of a 
mechanical grinder in tissue processing; Y=Yes; N=No. Tryp (ml): volume of trypsin used in ml. RBC lysis: the use 
or omission of a red blood cell lysis solution; Y=Yes; N=No. Tissue mass (g): tissue volume in grams that were 
digested similarly to a 400 g aliquot of tissue. Pipette: entries denote where studies were performed looking at the 
effect of different sizes and brands of pipettes (see text for results). DNase: volume of DNase utilized in μl. Ratio 
study: numbers are the volumes of tissue in grams. Digestion of the 800 gram aliquot of tissue was explored using 
both a 15 ml conical vial (80015) and a 50 ml conical vial (80050). 
 
Animal # Timing (hr) Tryp (min) Cent (x g ) FBS Cell screen Grinder Tryp (ml) RBC lysis Tissue mass (g) Pipette DNase Ratio Study 
4 2, 2s, 5, 8, 8s, 16 1, 3, 6
6 2, 3, 4, 5, 6
7 2, 3, 4, 5, 6 80, 200, 350 Y, N size 
10 3, 3.5, 4, 4.5, 5 80, 200, 350 Y, N 40, 70, both Y, N size 
11 3, 3.5, 4, 4.5, 5 80, 200, 350 Y, N
12 3, 3.5, 4, 4.5, 5 40, 70, both 5, 10 Y, N
13 3, 3.5, 4, 4.5, 5 40, 70, both 2, 5, 10
14 3, 3.5, 4, 4.5, 5
15 2, 5, 10 300, 500, 800
16 300, 600, 800 brand 
17 Y, N 300, 600, 800 brand 200, 400
19 brand 200, 400
20 3, 3.5, 4, 4.5, 5 80, 200, 350














high numbers of 1k cultures would have had to be routinely plated for accurate MFE quantification, 10k primary 
mammosphere cultures, rather than 1k cultures, were utilized to determine the primary MFE for study subjects. 
Experiments directly comparing the primary MFE from 10k and 1k cultures found that 10k cultures (multiparous 
Animals #7=0.017, #10=0.014, #15=0.023; nulliparous Animals #6=0.388, #20=0.484, #26=0.222, #27=0.633) 
produced slightly higher MFEs than 1k cultures (#7=0.015, #10= 0.012, #15=0.020; #6=0.366, #20=0.448, 
#26=0.200, #27=0.607). However, the individual 10k and 1k MFE values were significantly correlated to one 
another and both plating densities were found to be equally sensitive at detecting inefficient protocol modifications. 
The use of 10k cultures was therefore deemed to be acceptable toward the optimization process. Ultimately, there 
was minimal variation identified in the MFE from any one animal, regardless of the digestion/dissociation 
modification, and this metric was only occasionally useful toward optimization here. There was even less variation 
in the MDP from any one animal, regardless of the digestion/dissociation modification, and this metric was only 
rarely useful toward protocol selection. The individual instances where the MFE and/or MDP metrics were useful 
toward the optimization of the digestion/dissociation processes are specifically mentioned below.  
Basic methodology experiments utilizing Animal # 4 tissues suggested that initial-digestion times of greater 
than five hours decreases the TVC obtained from tissue and also lowers the MFE of the viable cells. Similar to what  
has been previously described,171 the overnight (16 hour) digestion process also produced larger ratios of spheres 
that were solely myoepithelial in nature and thereby decreased the MDP. Detrimental effects to the TVC and MFE 
were also identified when the digestion process was performed within sealedcontainers. Subsequent timing 
experiments performed in 8 different animals (2 nulliparous, 1 lactating-primiparous, 2 nonlactating-multiparous, 
and 3 lactating-multiparous) did not identify a single optimal digestion time, even within a particular demographic 
of animals.  Instead, the optimal digestion time for individual animals most often ranged between 3.0-4.5 hours. 
Retrospective histologic examination of the mammary glands suggested that longer digestion times are frequently 
associated with higher amounts of fibrous tissues within the mammary gland. Rather than corresponding to a 
specific time, optimal tissue digests were identified to correlate well with a fairly-distinct set of physical 
characteristics. Specifically, at the digestion times that were most productive approximately 25-33% of the original 
tissue volume was still present in the vials as thinly-glandular strands of fibrous material suspended within a 
homogeneous, cloudy-chylous, light pink solution. Additionally, the majority of the solids within the optimally-




Tissue digests collected prior to, or after, this optimal digestion point consiste tly resulted in lower TVC. Tissue 
digests collected well after the optimal digestion point also tended to have a decrease in MFE and a few 
demonstrated a decrease in the MDP similar to that described above for the 16 hour-digestion process.  
Experiments performed looking at the addition of FBS to the initial-digestion olution demonstrated no 
appreciable advantage and, conversely, the addition of FBS was noted to slowdown the digestion process.  
Centrifuge rates of 200 x g were identified as optimal for the initial tissue digest. Tissue digests centrifuged at             
80 x g produced lower TVC while those centrifuged at 350 x g had a notably lower MFE. Trypsin digestion of the 
tissue was identified to be optimal using 5 ml of 0.25% trypsin for 3 minutes. Smaller volumes or decreased 
exposure times led to lower TVC while increased exposure times resulted in lower TVC and MFE. Recovery of 
single cells from the tissue digests was found to be most productive when cells were passed sequentially through 70 
μm and 40 μm cell screens rather than when passed through either screen alone. The addition of a red blood cell 
lysis step proved useful toward quantification of TVC and thereby increased the MFE without appreciably affecting 
MDP. A DNase volume of β00 μl was identified to be optimal for the standard sized tissue aliquots. Increased 
volumes of DNase did not provide any advantage to TVC recovery except in cases wher  cells lysis was excessive, 
such as overexposure to enzymatic solution or as a result of poor pipetting techiqu .  
The use of a mechanical grinder toward mammary tissue digestion was not incorporated into the final 
protocol as this device created large amounts of cellular lysis and negatively ffected the reproducibility of the TVC 
between samples. Tissues were found to be optimally dissociated in the trypsin step of the protocol when a 10 ml 
pipette was utilized. The use of smaller pipette sizes (e.g., 5 ml) or the use of micropipettes typically led to an 
increase in cell lysis. Certain brands of disposable pipettes were also found to increase the incidence of cell lysis due 
to the presence of jagged projections at the pipette opening. Finally, pipetting techniqu  was also identified to affect 
the TVC and reproducibility. The optimal technique involved keeping the tip of he pipette at least 1 cm from the 
bottom of the conical vials and pipetting at a less-than-maximum speed to minimize lysis of the cells.   
Tissue-mass studies found that 300, 500, and 600 mg aliquots of tis ue processed using the same volume of 
digestion/enzymatic solutions as used for 400 mg aliquots yielded comparable TVC, MFE, and MDP. In contrast, 
800 mg tissue aliquots processed the same way had a substantial decline in TVC. In ratio studies, the volume of 
digestion/enzymatic solutions that were identified to be optimal for 400 mg of tissue produced comparable results 




enzymes was doubled or tripled, respectively. However, when the volume of digestion/enzymatic enzymes was 
quadrupled for 1600 mg aliquots or when the 800 mg aliquots were processed in a 15 ml conical vial, rather than a 
50 ml conical vial, the TVC were appreciably lower than those identified in 400 mg aliquots.   
Mammosphere culture optimization. A number of variables were explored to optimize the growth, 
maintenance, and generational capabilities of the mammosphere cultures. The optimized cultur  conditions were 
primarily guided by changes in the MFE and the resultant protocols for plating primary and secondary spheres are 
presented in Figure 2 and Figure 3, respectively.  
High-density primary mammosphere cultures (Animal #s 7 and 10) were id ntified to be most proliferative 
when approximately 80% of the original CMM was replaced with fresh CMM on day 3. Conversely, the addition of 
2 ml of fresh media at day 3 was found to be superior to the 80% media-replacement method for both primary and 
secondary 10k mammospheres (Animal #s 7, 11, and 12). Primary and secondary 1k mammosphere cultures 
(Animal #s 11, 12, and 20) were identified to be most proliferative when no changes were made to the media 
throughout their 7-day incubation process.   
Other experiments (Animal #s 12, 14, 15, and 20) demonstrated that supplementation of CMM with CM1 
at a ratio of 4:1 increased the numbers of 10k and 1k secondary mammospheres an average of 16.2% and 28.4%, 
respectively, within the 6-well plates. In studies performed using 1k secondary spheres (Animal #s 13, 14, 15, and 
20) grown in 96-well ultralow attachment plates (Corning), it was identifi d that the sealing of the plates with 
paraffin tape between days 0-3 of the incubation process resulted in a greater consistency in the MFE between 
individual wells. Specifically, the MFE of the wells around the periphery (edge) of the plate was statistically higher 
in paraffin-sealed plates as compared to plates incubated without the use of paraffin. In contrast, no statistical 
difference in the MFE was identified in the centrally-located wells between paraffin-sealed and unsealed plates. As a 
result of the increased consistency, the overall MFE for each paraffin-sealed pl te was also statistically greater than 
that of unsealed plates. Greater MFE-consistency between wells was also appreciated to occur when paraffin tape 
was utilized to seal mammosphere cultures grown in 6-well culture plates. The use of paraffin tape beyond Day 3 
did not provide any appreciable advantage and, unexpectedly, seemed to inhibit furt er sphere growth in some 
cultures. No appreciable differences in the MDP, MBP or budding morphology were identified for secondary 
mammospheres acquired using CM1 and/or paraffin tape as compared to mammospheres derived from cultures 




Viable cell recovery (VCR), defined as the total number of viable cells recovered from the dissociation of a 
mammosphere culture divided by the number of viable cells originally plated for that culture, was the primary 
metric utilized to gauge the productivity of the dissociation process. Dissociation of primary, and later generational, 
spheres into single-cell suspensions with trypsin required variable amounts f time ranging between 10-20 minutes 
(typically 12-15 minutes). Dissociation of spheres was identified to be most productive at the time point when no, or 
only very minimal, cellular material could be visualized within the Pasteur pipette used for this process. Dissociation 
of primary mammospheres at Day 7 was identified to produce a 41.2% higher VCR, on average, than sphere 
dissociations performed at Day 10 (Animal #s 7-10 and 20). Of note here is that Day 10 spheres often failed to fully 
disassociate even when pipetted for 20 minutes. In other experiments (Animal #s 9 and 10), the use of a 0.05% 
trypsin-EDTA solution for the dissociation process produced a 54% higher VCR, on average, than when a 0.25% 
trypsin-EDTA solution was utilized. No differences in secondary MFE or MDP was identified between the Day 7 
and Day 10 dissociations although the use of a 0.25% trypsin-EDTA solution did appreciably lower the secondary 
MFE as compared to disassociations utilizing a 0.05% solution.   
Mammosphere culture validation. Tissues from 18 animals (Table 3) were processed using the optimized 
mammosphere protocols (Figure 1 and Figure 2). Differences in mammosphere potential were readily apparent 
between the multiparous and nulliparous cohorts for most of the parameters examined in this study. Only three 
nulliparous animals (2 follicular-phase; 1luteal-phase) were available for comparison however. In efforts to 
minimize the effects of a potential confounding variable (reproductive stage), most of the comparisons made 
between the nulliparous and multiparous animals below utilized only the data collected from the eight multiparous 
animals that were in either the follicular phase (n=5) or luteal phase (n=3) of the menstrual cycle.  
The TVC, MFE of primary 10k mammospheres, and MFE of secondary 1k mammospheres (derived from 
100k primary cultures) were obtained for 18 animals (Table 3). The TVC for the follicular/luteal multiparous 
animals (13.26 x 103 cells/mg ± 3.23 x 103 cells/mg) were significantly lower than those of the three nulliparous 
subjects (17.49 x 103 cells/mg ± 2.62 x 103 cells/mg). The MFE for primary 10k mammospheres (primary MFE) was 
0.024% ± 0.003% for follicular/luteal multiparous animals and 0.446% ± 0.208% for nulliparous subjects. The MFE 
for secondary 1k mammospheres (secondary MFE) was 0.511% ± 0.089 % for follicular/luteal multiparous animals 
and 2.144% ± 0.378% for nulliparous subjects. Both of the multiparous MFEs were statistically lower than those of 




Table 3. Macaques of various demographics were processed utilizing the optimized mammosphere techniques.  
Animal #: identification of animal (corresponds to the Animal # in Table 1). Age: rounded to nearest quarter year. 
Class (parity): N=nulliparous; P=primiparous; M=multiparous. Stage (reproductive status): M=menses phase; 
F=follicular phase; L=luteal phase; I=inactive phase; P=pregnant; Cy=polycystic ovaries. TVC: total number of 
viable cells recovered (x 103) per mg of tissue processed. 1oMFE: primary mammosphere forming efficiency (MFE, 
%; see text) of a tissue-derived, single-cell suspension plated as 10K primary mammospheres. 1oMBP: primary 
mammosphere budding potential (MBP, %; see text) of 10k primary mammospheres. 2oMFE: secondary MFE of 
primary 100k mammosphere-derived, single-cell suspension plated as 1k secondary mammospheres. 2oMBP: 
secondary MBE of 1k secondary mammospheres. 2oMDP: secondary mammosphere differentiation potential (MDP, 
%; see text) of 1k secondary mammospheres. CFE: colony forming efficiency (CFE, %; see text) of a 100k primary 
mammosphere-derived, single-cell suspension plated at 3 x 103 cells/well. CDP: colony differentiation potential 
(CDP, %; see text) of the colonies obtained from the CFE.  
  
 
Representative images of Day 7, primary 10k mammospheres in culture media were cquired from three 
multiparous (Animal #s 23, 24, and 28) and two nulliparous animals (Animal #s 26 and 27) and the diameters of all  
spheres ≥ 40 μm were measured (multiparous mean= 61.8 μm ± 23.0, range= 40-194 μm, [n=186]; nulliparous  
mean = 68.0 μm ± 21.2, range= 40-174, [n=305]). The average number of individual cells per sphere was calculated 
using two different methods. First, single-cells in media that had been dissociated from Day 7, primary 10k spheres 
were imaged and their diameters were measured (multiparous mean = 1β.6 μm ± 2.0; [n=39]; nulliparous mean = 
11.β μm ± 2.1 [n=56]). As no statistical differences were identified between multiparous and nulliparous animals 











17 6 P I 9.28 0.021 61.7 0.384 56.7 92.8 1.93 14.7
20 4.25 N L 15.26 0.484 91.6 2.186 87.2 100 9.53 18.2
23 21 M F 11.2 0.021 65.3 0.392 59 96.1 2.07 11.3
24 19 M F 12.37 0.024 67.4 0.506 55 100 2.55 13.2
26 8 N F 16.82 0.222 82.4 1.746 84.7 98.6 8.09 12.2
27 3.5 N F 20.38 0.633 88.9 2.5 82.1 100 8.85 11.2
28 16 M L 9.24 0.023 66.9 0.64 65.3 93.6 3.57 16.3
29 19 M P 17.46 0.084 79.9 0.972 80.9 85.1 5.2 12.9
30 20 M I 8.86 0.011 67.2 0.366 44.3 95.2 1.76 10.9
31 8 M L 18.23 0.02 71.2 0.584 72.9 100 3.04 12.2
32 22.5 M I 11.79 0.019 57.9 0.468 52 97.9 2.42 13.7
33 16.5 M F 15.16 0.027 62.6 0.478 66.2 96.4 2.73 17.9
34 17 M F 9.87 0.025 71.7 0.592 70.7 95.1 3.09 15.5
35 17 M M 15.32 0.017 42.7 0.302 38.4 88.6 1.59 9.8
36 18.75 M Cy 22.73 0.059 65.7 0.572 72.4 88.6 3.1 10.3
37 10.75 M I 9.56 0.016 53.1 0.396 29.7 83.6 1.74 7.9
38 19.75 M F 13.26 0.022 69 0.486 57.6 92.7 2.78 14.6




with regard to their average sphere or cell sizes, these numbers were combined and the average sphere was 
calculated to contain approximately 162 cells. Second, the diameter of individual form in-fixed, paraffin-
embedded, Day 7, primary 10k spheres was ident fied on H&E stained slides (multiparous mean= 8γ.4 μm ± 31.0 
[n=16]; nulliparous mean= 89.4 μm ± 33.6 [n=24]) and the number of cell nuclei present within each cross-section 
of the formalin-fixed spheres above were quantified. The diameter of each sphere was then utilized to determine the 
average diameter of the cells within each sphere (multiparous mean = 14.6 μm ± 1.4; nulliparous mean = 14.γ μm ± 
1.8). As above, the multiparous and nulliparous numbers were combined and the average sphere was calculated to 
contain approximately 214 cells per this method.   
Generational studies produced quaternary mammospheres from 4 of the 6 subj cts processed using optimal 
culture conditions (Table 4). Notably, the two animals that failed to produce q aternary spheres (Animal #s 25 and 
32) were highly multiparous and both were in the inactive-phase of thir reproductive cycle at the time of tissue 
collection. The secondary MFE of the luteal-phase multiparous animals (mean MFE of 0.495% or ~1 mammosphere 
forming unit (MFU)/202 cells plated) in this study was identified to be lower than t t of the nulliparous animals 
(mean MFE of 1.65% or ~1 MFU/61 cells plated). Furthermore, the MFE for all multiparous animals decreased to a 
greater extent through the three generations than did the nulliparous MFEs. A marked decrease in the MFE for all 
generations of spheres in both cohorts was also identified when CM1 was omitted from the mammosphere culture 
media.  
 
Table 4. Generational study identified differences in the MFEs between nulliparous and multiparous animals. 
Animal #: identification of animal (corresponds to the Animal # in Table 1). Animal #s 27 and 28 were cultured once 
using the optimized culture conditions and once in media lacking CM1 (-CM1). Age: rounded to nearest quarter 
year. Class (parity); N=nulliparous; M=multiparous. Stage (reproductive status): F=follicular phase; L=luteal phase; 
I=inactive phase; Infants: number equals number of live births. 2oMFE: mammosphere-forming efficiency (MFE), 
between primary 10k and secondary 1k mammosphere cultures. 3oMFE: MFE between secondary 10k and tertiary 
1k mammosphere cultures. 4oMFE: MFE between tertiary 10k and quaternary 1k mammosphere cultures. 
 







25 18 M I 12 0.32 0.09 0
26 8 N F 0 1.41 1.01 0.94
27 3.5 N F 0 1.88 1.17 1.4
27 (-CM1) 3.5 N F 0 0.92 0.36 0.3
28 16 M L 7 0.47 0.27 0.09
28 (-CM1) 16 M L 7 0.29 0 0
31 8 M L 2 0.52 0.43 0.25




The primary 10k mammospheres of Animal #s 26, 27, 31 and 32 that were utilized in generational studies 
were also utilized in the studies examining the formation of secondary mammospheres from a single cell. On 
average, 73% (range 66-83%) of the plated wells were identified to contain single cells. Under optimal culture 
conditions, the two nulliparous animals produced 10 (# 26; MFE =1.31%) and 15 (# 27; MFE 1.84%) 
mammospheres (mean MFE of ~1.58%). Cultured the same way, two multiparous animals produced 4 (# 31; MFE 
0.51%) and 3 (# 32; MFE 0.42%) mammospheres (mean MFE of ~0.47%). When cultured without CM1, the two 
nulliparous animals produced 4 and 9 spheres (mean MFE of ~0.78%), and the multiparous animals produced 3 and 
1 spheres (mean MFE of ~0.26%). Notably, the MFEs for the secondary sphere  in this study were similar to the 
secondary 1k MFEs derived from the same four animals in the generational study, as reported above. Collectively 
these data differed by less than 3%. This is significant, in that these findings sug est that the majority of the 
mammospheres derived from 1k cultures are likely to be clonal in origin, similar what has been described in human 
mammosphere studies.71, 84 Spheres acquired from the animals in this study (n=27) were encased in BME and 
allowed to undergo differentiation. These spheres demonstrated morphological budding patterns and bilineage 
staining properties at Day 21 that were similar to the small secondary 1k sphere , as described below. 
Bilineage differentiation of spheres on collagen-coated plates was confirmed using IHC methods for all 
generations of spheres although the MDP was most often assessed using crystal violet stain in this study (Figure 4, 
A-D). A minimum of 89 secondary 1k mammospheres were assessed for ach subject at Days 7-9 of the plating 
process and the MDP for 18 animals is reported in Table 3. The secondary MDP for follicular/luteal multiparous and 
nulliparous animals were close in number, although statistically different, at 95.9% ± 2.86% and 99.5% ± 0.80%, 
respectively. Regardless of demographic, the majority of the spheres that attached to collagen underwent a 
significant morphologic change by Day 5 of the plating process. The cells within the spheres themselves transitioned 
from rounded cells with distinct margins to a more elongate, poorly-define  cell population. Additionally, most 
spheres had two distinct populations of cells extending from their base. Epithelial-like cells were clear and rounded 
with distinct cellular edges and stained positive with CK18. Myoepithelial-like cells, in contrast, were elongate-
spindle shaped cells with indistinct margins and were often refractile. Myoepithelial-like cells within the center of 
the colonies typically stained well with SMA although the elongate cells within the sp res, directly adjacent to the 
spheres, and along the leading edge of colonies generally stained more intensely with CD10 rather than SMA. In 




Figure 4. Spheres and single cells plated on collagen-coated wells show bilineage differentiation. A-D Secondary 1k 
mammospheres on collagen-coated wells. A is a crystal violet stain of mammosphere with epithelial (arrowhead) 
and myoepithelial (arrow) differentiation at 4x magnification. B-D are immunohist chemistry stains at 10x 
magnification: B=anti-cytokeratin 18 (CK18); C=anti-CD10; D=anti-smooth muscle actin (SMA). E is a crystal 
violet stain of a bilineage colony formed from a primary mammosphere-d rived single-cell suspension. Epithelial 
(arrowhead) and myoepithelial (arrow) differentiation of the colony at 10x magnification.  Scale bars = β00 μm.   
 
 
base while, less frequently, other spheres failed to produce any appreciable colony growth. Small numbers of 
individual epithelial-like cells, far removed from the base of the sphere, stained positive with ER and PR for all 
subjects in which these assays were attempted.  
The colony forming unit assay was identified to be optimally plated using 3 x 103 viable cells/35 mm well. 
At this cell density, the numbers of colonies produced for both nulliparous and parous individuals allowed for the 
acquisition of a reliable CFE estimate when 6 wells were plated. The CFE and CDP of cells derived from the 
dissociation of primary 100k mammospheres were obtained for 18 animals (Tab e 3). A minimum of 256 colonies 
were then evaluated for each subject between Days 10-14 of the plating process. Nulliparous cultures were most 
often evaluated around Day 10 as the colonies in these cultures were numerous, gr w quickly and tended to overrun 
one another by Day 14. The CFE for follicular/luteal multiparous animals (2.75 ± 0.50%) was statistically lower 
than nulliparous animals (8.83 ± 0.72%). Bilineage differentiation of the colonies was confirmed using CK18 and 
SMA IHC although the CDP was most often assessed using crystal violet stain alone. The morphology of the 
epithelial-like and myoepithelial-like cells produced using this assay was similar to those described for the collagen-
plated spheres. However, unlike the colonies derived from the collagen-plated spheres, most of the colonies formed 
here were uniformly myoepithelial-like in nature. Bilineage colonies (Figure 4, E) typically represented less than 





differences were identified in the CDP between the follicular/luteal multiparous nd nulliparous subjects which 
averaged 14.8% and 13.9%, respectively.   
The ability of BME-embedded mammospheres to undergo budding was confirmed for all generations of 
spheres. The MBP of 10k primary and 1k secondary mammospheres for 18 animals at Day 21 of the plating process 
are reported in Table 3. A minimum of 48 spheres were assessed for each subject. Budding was subjectively 
assessed by direct visualization of the BME-embedded spheres in culture (Figur 5, A-C). Spheres observed to 
produce no projections, or only small numbers of short ductular-like projections, from the main sphere body by Day 
21 were counted as non-budding spheres. Spheres were classified as budding on Day 21 if they were identified to 
have any of the following characteristics: 1) small numbers of individualized, elongated ductular-like projections 
(DLPs); 2) numerous DLPs of any length; 3) DLPs capped with alveol r-like structures; or 4) secondary-body 
formation (defined below). The primary MBP for follicular/luteal multiparous animals was 68.7% ± 3.99% and 
 
   
Figure 5. Spheres placed in BME underwent budding differentiation and, with the addition of prolactin and CM2, 
produced a -casein-containing fluid (milk). Images A-C are secondary mammospheres in basement membrane 
extract at 10x magnification: A=early budding; B=late budding with alveolar-like structures (arrow) at the end of 
ductular-like projections; C=late budding of mammospheres supplemented with prolactin and CM2. This sphere has 
a secondary body from which a ductular-like projection, capped with an alveolar-like structure (arrow) is evident. 
Image D is anti--casein staining of alveolar-like structures, similar to those highlighted in image C at 20x 




87.6% ± 4.73% for nulliparous subjects. The secondary MBP for follicular/l teal multiparous animals was 64.7% ± 
6.63% and 84.7% ± 2.55% for nulliparous subjects. The primary and secondary MBPs for multiparous animals were 
both statistically lower than those of nulliparous subjects.  
The morphological assessment of the mammospheres, as described below, was based on ob rvations made 
using secondary 1k mammospheres although these observations were essentially identical to those identified for the 
primary 10k spheres. Most of the individual BME-encased spheres underwent gowth and differentiation over time.   
At Day 0 of the BME-plating process (Figure 6, row A), spheres were typically composed of densely-packed, 
rounded cells. Most cells within these spheres stained positive for CD10 and cells along the periphery of the sphere 
commonly stained strongly for CK18. Staining with SMA was more variable but was usually weak or absent for 
cells within these spheres. No cells could be definitively identified to be positive for ER or PR in these spheres 
although occasionally very weak staining for one or both of these receptors was appreciated. Mammospheres that 
were cultured for 7 days in mammosphere media, prior to being harvested for BME-differentiation, typically had a 
thin layer of PAS-positive extracellular material (matrix) between the individual cells along the periphery of the 
sphere at Day 0 of the BME-embedding process. When spheres from the same animal were cultured for 10 days in 
mammosphere media prior to being harvested, the volume of PAS-positive material between the peripheral cells at 
Day 0 of the BME-embedding process was subjectively more pronounced. This observation is notable in that 
mammospheres cultured in media for 10 days were consistently more resistant to trypsin dissociation than 
mammospheres cultured for 7 days, as previously discussed above. In turn, it is possible that an increased volume of 
intercellular matrix within mammospheres over time could be associated with an increased resistance to trypsin 
dissociation.   
  By Day 5 of the BME-plating process (Figure 6, row B), the individual cells within spheres had enlarged 
and the cell numbers increased for many spheres as well. Cells were typically more angular with distinct margins 
and the cells stained diffusely for CK18. Staining with CD10 usually diminished or was absent at this time point and 
strong SMA staining started to become apparent in random cells throughout the spheres. No cells were identified to 
be positive for ER or PR in these spheres. Abundant PAS-positive material was often apparent between the 
individual cells throughout the sphere and this material also formed a thin shell around the outside of the sphere. 
Most of the spheres identified as non-budding spheres maintained this morphology t roughout the 21 day incubation 




   
Figure 6. The budding morphology of mammospheres over time often followed a predictable pattern of maturation 
that could be somewhat altered through the addition of prolactin and CM2. Serial section  of secondary 
mammospheres plated in basement membrane extract for 0-21 days (different time periods represented by rows A-
D) at 10x magnification. Sections from each time period were stained with: hematoxylin and eosin (H&E); anti-
cytokeratin 18 (CK18); anti-CD10 (CD10); or anti-smooth muscle actin (SMA). Row C: cavitation of the central 
aspect of the sphere. Row D: numerous small ductular projections extending from the main sphere body and one 
highly-cellular, expansive projection (arrow on H&E). Row E (mammosphere was supplemented with prolactin and 
CM2): vacuolated cytoplasm of the cells in the secondary body of the mammosphere (arrow on H&E) that are 
extending from the main sphere body. Scale bars = 100 μm 
 
Between Day 5 and Day 21 of the BME-plating process, most spheres continued to proliferate and 
differentiate. As early as Day 5, some spheres underwent a central cavitation (Figure 6, row C). In these spheres, 
CK18 staining remained diffuse throughout the main sphere while SMA staining was most intense surrounding the 




typically had at least a few projections from the main sphere body by Day 7 although these varied in appearance. 
Commonly, numerous thin branching DLPs originated from all surfaces of the sphere and this appearance was 
referred to here as “coronal budding” (Figure 5, A and C; Figure 6, row D). In other spheres, only a few, elongate 
DLPs were present (Figure 5, B). For both of these growth patterns, a thin centralized lumen could frequently be 
visualized within larger DLPs. Additionally, large, oblong-cylindrical growths that lacked a lumen and that were 
highly cellular along their leading edge, were also identified to be extending from some spheres (Figure 6, row D). 
With time, many of these larger projections expanded, to form cellular masses confluent with, and nearly as large as, 
the main sphere body. At this point, each of the large growths was referred to here as a “secondary body” and DLPs 
were commonly observed to be originating from these formations (Figure 5, C; Figure 6, row E). Lumen-containing, 
alveolar-like structures that lay atop DLPs were typically identified in approximately 2-7% of the budding spheres 
for most animals. The only notable exception to this being that in two early-pregnant animals (Animal #s 13 and 29) 
alveolar budding was identified to occur in 9 and 13% of budding spheres. In actuality, many of the individual 
budding spheres exhibited a combination of the morphological growth patterns described above and essentially 
every possible combination of these variations was identified within the BME-plated sph res for each animal 
examined. Other than for the alveolar budding mentioned above, no variation in morphological growth pattern was 
appreciated to exist between the different demographics of animals. As mammosphere ize has previously been 
associated with variations in differentiation potential,70, 153 sphere size was compared to variations in budding 
morphology (cavitation, coronal budding, elongate ductal budding, alveolar formati n, and secondary-body 
extrusion) in three animals. Small spheres (~40-60 μm in diameter) were never recognized to undergo cavitation or 
produce secondary-body extrusions, but otherwise the other budding var ations were identified with similar 
frequency throughout spheres of all sizes. Finally, while the overall budding for secondary 1k mammospheres was 
typically slightly lower than the primary 10k mammospheres, the budding of secondary spheres was noted to be 
subjectively, but consistently, more exuberant than that of the primary spheres from the same animal.      
Collectively, IHC-stained spheres derived from a number of animals sugge ted that budding projections, as 
a whole, tend to stain predominantly with CD10 in the early stages of the process. As these projections aged and 
expanded, a diffuse SMA staining predominated these structures. CK18 staining was usually only identified in fully 
matured projections or within the older, more organized, regions of the individual immature projections. Essentially 




indicative of bilineage potential for this assay. Small numbers of cells in the distal aspects of the mature projections 
stained positive for ER, although no ER staining was ever observed within the main sphere body. No cells were 
identified to be PR positive for any of the animals. In budding spheres, abundant, dense PAS-positive material was 
identified between the individual cells and around the periphery of most ain sphere bodies, secondary bodies, and 
budding projections.   
Lactogenic differentiation of BME-encased mammospheres was accomplished using the spheres from two 
multiparous animals. These mammospheres were incubated in media containing prolactin and CM2, as detailed 
above. In these spheres, the cells comprising the alveolar-like formations and sm ll volumes of liquid material 
present within the lumens of these structures stained positive for -casein (Figure 5, D). No cells or material within 
the main sphere body or secondary body of these spheres were identified to stain positive for -casein. Notably, the 
spheres plated using this technique consistently developed a diffuse foamy gross appearance between days 7 and 21 
(Figure 5, C). Histologically, the cells in these spheres and projections were identified to have variably-sized clear 
intracellular vacuoles (Figure 6, row E). Other than their vacuolar nature and the -casein staining of the alveolar 
structures, the morphological variability of these BME-encased spheres resembled those of spheres plated without 
the use of CM2-prolactin. The other staining properties of these spheres were similar to those plated without the use 
of CM2-prolactin with the exception that more cells within the mature projections stained positive for ER and there 
were small numbers of cells identified to be PR-positive. 
The quadrant studies were performed using four animals (Animal #s 26, 27, 30 and 31) which provided 24 
unique mammary gland quadrants by which to assess reproducibility of the mammosphere culture technique. The 
intraclass correlation coefficient (ICC) for the three biopsies from each of the 24 quadrants was identified to be 
0.778 for TVC and 0.914 for primary MFE. In three animals, no statistical differences in the MFE were identified 
between any of the quadrants. In Animal # 30, however, although the MFEs for quadrants 1 and 4 were similar to 
one another, the left and right quadrant 2/3 MFEs were significantly lower than those of quadrants 1 and 4. Notably, 
Animal # 30 was in the inactive phase of the reproductive cycle while the other thre  animals were actively cycling.    
Principle component analysis (PCA) was performed utilizing 17 of the animals (polycystic ovary Animal # 
36 was not included) and the 11 variables listed in Table 3. Three principal components were identified to represent 
approximately 78% of the variance between the subjects. Principal component (PC)-1 entailed Age, Class (parity 




and secondary MFE, and CFE for PC-1 were positively correlated with one another. Primary and secondary MBP, 
secondary MDP and CDP comprised PC-2 (~14% of the variance) and all four variables were positively correlated 
with one another. Stage (reproductive phase) was the only variable identified for PC-3 (~12% of the variance). The 
corresponding vector diagram of the PC-1/PC-2 data is provided in Figure 7.   
 
      
Figure 7. The mammosphere potential of macaques is stratified by parity status, reproductive stage and possibly 
age. A: vector diagram of PC-1/PC-2 data from animals processed utilizing the optimized techniques. Numbers 
within the vector diagram correspond to the Animal #s listed in Table γ. B: same vector diagram as “A” but with 
colored-circle overlay to highlight the reproductive demographics. Reproductive demographics are represented by 
circles of different colors: menses phase = blue; follicular phase = yellow; luteal phase = green; inactive phase = red; 
pregnant = black; white = lactating; circles containing “N” are nulliparous animals.      
 
 
Animals toward the right side of the vector diagram collectively tended to exhibit a higher growth potential 
(primary and secondary MFE and CFE) while animals toward the top of the diagram collectively exhibit higher 
differentiation potential (primary and secondary MBP and CDP). The three nulliparous animals occupy the upper 
right quadrant of the graph and are distinctly removed from the parous individuals. The 8 year-old nulliparous 
animal (Animal # 26) is positioned below and to the left of the younger ulliparous animals and, notably, is situated 
well to the right of the similarly-aged, parous subjects within this data set (Animal #s 17 and 31). Most of the parous 
subjects aligned within an elongated central cluster although the sole lactating animal and sole menses-stage animal 
(Animal #s 37 and 35, respectively) are positioned well below the other animals. The main cluster of parous animals 
is somewhat stratified by “Stage” with the luteal-phase animals positioned higher than all but one of the follicular-
phase animal. Likewise, the follicular-phase animals are positioned higher than all but one of the inactive-phase 




phase nulliparous animals. Finally, there is also a weak trend for the data to be stratified by age. In short, the 
younger animals within each particular reproductive Stage tend to be located to th  right of older animals. 
Discussion 
This work represents the first mammosphere culture technique formally developed and optimized for use in 
any species of nonhuman primate. This work further represents the initial validation process of the rhesus macaque 
mammosphere culture as an assay toward the study of the human breast. Data collected in these studies suggest that 
the mammosphere potential of mammary glands is affected by the reproductive state of the donor and this 
information could open up new avenues of research within mammosphere-based research as a whole. Likewise, the 
novel culture modifications incorporated into the mammosphere protocols produced here and the observations made 
regarding the longitudinal morphologic development of the spheres are also likely to be of general benefit to 
mammosphere research. Finally, the mammary gland weights derived from this work and the data demonstrating the 
physiologic homogeneity of mammary gland throughout a large portion of the organ could prove useful to a variety 
of studies involving macaques.   
The mammosphere culture technique in general has been criticized as a research assay in that, due to the 
numerous steps associated with its use, there is high potential for variability n the data obtained between individual 
investigators.194, 231 Information obtained throughout the optimization processes suggest that this criticism is not 
without merit. With regard to the digestion/dissociation of mammary tissues in part cular, overt changes to the 
protocol (e.g., duration of enzymatic digestions), as well as seemingly-minor variations to the process, affected the 
TVC obtained from homologous tissue aliquots. When this information is considered in light of the fact that the 
possibility for “minor” modifications exists at essentially every step of the process (e.g., digestion vessel size, 
centrifugation speed, pipette size, cell-screening technique, etc.) it can be appreciated that TVC data may not be 
comparable between studies if a detailed standardized protocol is not followed. Although just such a protocol is 
provided above, at least two other factors must also be taken into account with regard to the potential for TVC 
variability. The first is that no universally-applicable time point was identified to be ptimal for halting the initial-
digestion step in all macque tissues. The other factor is that the physical appearance of what defines an “optimally-
digested tissue” is largely subjective in nature. As such, if marked differences in tissue digestion occur between 
individual laboratories due to disparities in the perceived optimal processing time, it s likely that there will be 




can be expected of studies requiring highly-reproducible TVCs (i.e., studie  comparing the mammosphere potential 
between whole glands). Notably, the MFE was identified to be substantially more stabl in regard to most 
modifications of the digestion/dissociation process than was the TVC. This finding is significant because, unlike the 
TVC which has limited research applications, the MFE is likely to be critical for most mammosphere-related 
studies.    
Although MFE was not overtly sensitive to variations in the digestion/dissociati n technique, there were a 
number of potential sources of MFE variability identified in these studies. Central to he issue of MFE 
reproducibility is the standardization as to what constitutes a mammosphere. Consistent with some previously 
utilized standards,67, 147 all tightly-associated, free-floating, spheroid cellular growths, ≥40 μm in diameter were 
counted as mammospheres for this project. Growths composed of loosely-as ociated cells or growths that were 
elongate-amorphous in shape were not counted as mammospheres.   
Even more critical to MFE variability between samples, however, was the discovery that the MFE could be 
influenced by a number of factors associated with culture conditions. The first of these factors was plating density.  
In one study, the single-cell suspensions derived from the mammary glands of seven macaques were plated as 10k 
suspensions and also as 1k suspensions. The average MFE of the 10k cultures for these seven subjects was identified 
to be approximately 10% higher than that of their 1k cultures. This observation is similar to those noted in previous 
mammosphere studies70, 71, 85 and in other types of sphere-forming assays (e.g., neuro al and prostate sphere 
cultures).194 In these reports, the increased sphere formation was suggested to occur as a result of cell aggregation, 
with larger numbers of “aggregate spheres” expected in cultures plated at higher densities. Beyond cell aggregation, 
however, is the possibility that the differences between the MFEs for the 1k and 10k cultures may also be related to 
the concentration of pro-mammosphere growth factors within the culture media.85 As per this mechanism, the 
stem/progenitor cells that are cultured in high-density plates would be expos d to greater concentrations of cellular 
growth factors and, in turn, would be more proliferative (i.e., have a higher MFE) than would similar cells from low-
density plates. The observation that cells plated as 10k cultures, 1k cultures, and single cells all consistently had 
higher MFEs when they were supplemented with CM1 is evidence that growth factor concentration can influence 
the MFE.  
Other potential sources of MFE variability were also identified to be associated with plating conditions. 




within the perimeter (edge) wells of 96-well plates as compared to the center wlls. Sealing the culture plates with 
paraffin tape, as recommended in at least one mammosphere protocol,34 essentially eliminated the regional 
inconsistencies and, in turn, increased the average MFE. With the knowledge that stem cells typically reside in 
niches of the body with extremely low oxygen tension,67, 149 the increased MFE and consistency within the sealed 
plates is proposed to be due to the creation of a hypoxic environment through the use of paraffin tape. In support of 
the proposal that hypoxia may be responsible for the increased mammosphere proliferation, some research has found 
that hypoxic environments promote the maintenance of stem cells in an undifferentiated state and thereby prompt an 
increase in stem cell production.102, 149, 195, 205 Furthermore, other work has also demonstrated that hypoxia leads to an 
increase in the clonal growth of mammary epithelial cells.208 Beyond promoting the stem cells to remain in an 
undifferentiated state, hypoxia may also promote mammosphere proliferation in hese studies by reducing the 
incidence of cellular senescence in the MSCs/MPCs. This proposal is based on th  observation that increased 
oxygen tension has been associated with an increase in senescence for a variety of different cell cultures and that 
increased senescence has been directly correlated with a decrease in the MFE of mamm sphere cultures.67  
 The other potential source of MFE variability related to plating conditions involves the types of plate used 
for the mammosphere cultures. Specifically, in a study of four different animals, 96-well plates and 6-well plates 
were both plated with 1k mammosphere cultures. The average MFE of the 96-wll plates in this project was 
identified to be ~41% greater than that of the 6-well plates. It was subsequently discovered that the cells within the 
96-well plates, but not the 6-well plates, tended to aggregate in groups along the periphery of the wells. A significant 
concave meniscus was identified within the media of the individual wells of the 96-well plates and is proposed to be 
the cause of the peripheral displacement and aggregation of the cells. Despite the fact that these cells were plated 
within the recognized standards of clonal density, it was considered likely that many of the 96-well 
“mammospheres” were actually derived from the aggregation of individual cells rather than being a clonally derived 
outgrowth.   
Collectively these observations suggest that mammosphere cultures that are processed similarly, but not 
identically, have a high potential for variability. In efforts to decrease this var ability, a detailed macaque 
mammosphere culture protocol has been developed and is described above. Furthermore, two recommendations 
aimed at further increasing the reproducibility of this assay are also included here. First, whenever TVC 




the very least, the ratio of tissue to enzymatic solution should be standardized betw en samples within a study. 
Second, efforts should to be made within individual studies to reduce the variability of the subjective components of 
the mammospheres process. This can be achieved by having each subjective st p of the process assigned to a single 
investigator or to a consistent group of multiple investigators who each ev luate the step and then come to 
consensus. Specifically, this information pertains to: the decision as to the c mpleteness of the initial-digestion 
process; the viable cell counts; and the mammosphere counts.   
In line with these recommendations, the reproducibility experiments in this project were performed by a 
single investigator and intensive efforts were made to limit any inconsistencies i  the processing of the individual 
samples. Additionally, the viable cell counts of the initial digests were performed in triplicate and large numbers of 
primary mammosphere wells were plated so as to increase the accuracy of the primary MFE estimates for each 
sample. Executed in this manner, the correlation between the individual samp es collected from each quadrant was 
good for TVC and excellent for the primary MFE. The finding that TVC was more varied was not unexpected as the 
samples utilized for these experiments were biopsies and it is plausible that the ratios of glandular and fibrous tissue 
varied with location. In spite of the numerous potential sources of variability, the MFE data collected in this study 
demonstrated that the mammosphere culture assay can provide highly reliable and reproducible data if conscientious 
efforts are made with regard to sample processing. These data also identified the MFE to be consistent within the 
individual mammary gland quadrants of this species. Additional analyses found no statistical differences in the MFE 
of quadrants 1 and 4 for any of animals and suggest that individual biopsies taken from these quadrants are likely to 
be representative of this region in general. This is significant, in that individual biopsies can be repeatedly collected 
from quadrants 1 and 4 from the same animal over time thereby allowing for longitudinal, mammosphere-related 
studies to be performed. The in vivo biopsies collected as part of this project wer  found to provide ample, viable 
tissues toward mammosphere culture and this information further supports the use of these animals in longitudinal 
studies. Notably, all of the animals utilized for the in vivo biopsy procedures remained active breeder animals within 
the colony and there was no appreciable decrease in milk production of the biopsied glands as assessed clinically in 
subsequent pregnancies.   
Data obtained from this study were compared against similarly processed tissues, cells, and spheres derive 
from humans in efforts to validate the rhesus macaque mammosphere cultu as a relevant assay toward human 




rhesus macaque mammary tissues fell within the TVC ranges reported for human breast (5.0 - 20.0 x 103 cells/mg)106 
suggesting that the mammary glands of these species are similar in cellular composition. Macaque mammospheres 
were found to be similar to those of humans with regard to: mean sphere diameter and size-range (mean=75 μm; 
range = 40-110 μm);67  mean diameter of the cells comprising the spheres (9-15 μm);67 and the numbers of cells 
within each sphere (150-300 cells/sphere).71 Furthermore, undifferentiated macaque mammospheres were identified 
to have strong epithelial (CK18) and weak myoepithelial immunostaining (macaque=SMA; human=cytokeratin-14) 
comparable to that of humans.67 Putative markers for bilineage progenitor cells71 (macaque=CD10; 
human=epithelial specific antigen67) and abundant extracellular material71 were also identified to be diffusely 
distributed throughout the spheres for both species.   
Data pertaining to the differentiation potential of the mammospheres were also compared between the two 
species. In the only human MDP study that could be identified, human tertiary mammospheres had comparable rates 
of differentiation (100%)71 to those of the secondary mammospheres utilized in this study. No human studies were 
identified which directly evaluated the MBP. However, with regard to three-dim nsional culture techniques, the 
macaque and human mammospheres shared similar properties with regard to: formation of ductular- and alveolar-
like structures;67, 71, 85 immunostaining with both epithelial and myoepithelial markers;71 and secretion of -casein-
positive material within the lumens of the alveolar-like structures.71, 196 Per the CDP assay, macaques were identified 
to produce colonies with bilineage differentiation (immunostained with CK18 and SMA) similar to what has been 
reported for the human.71, 196 This parameter, however, was not entirely consistent between the two as the macaque 
CDP was notably lower than what is described in the human study (65-71%).71 While it is possible that there are 
general differences in the types of cells that typically form mammospheres between the two species (i.e., more 
human mammospheres may be derived from MSCs), it is proposed that this discordance is more likely a result of 
culture methodology. First, the media that was used in the human CDP study contained growth factors known to 
promote stem cell maintenance while the media used in the macaque studies favor d cellular differentiation. This 
probably accounts for at least part of the CDP discrepancy as similar variations n media have been noted to alter the 
differentiation ability of other sphere-forming assays.194 Another point of consideration is that the single cells 
utilized in the macaque CDP studies were derived from 100k primary mammospheres while those in the human 
study were derived from 20k primary mammospheres. This difference is important in that most primary 




MSCs/MPCs through the aggregation and subsequent proliferation of linage-specific progenitor cells and/or more-
differentiated cell types.70, 71 Formation of these “aggregate spheres” is known to be promoted through an increase in 
cell-to-cell contact and therefore high-density mammosphere cultures are more likely have higher percentages of 
aggregate spheres as compared to low-density mammosphere cultures.70 Furthermore, as the aggregate spheres often 
lack cells with bilineage potential, it is also logical that high-density mammosphere cultures are more likely have a 
lower CDP as compared to low-density mammosphere cultures. To that, an experim nt utilizing mammary tissues 
from two macaques found that the CDP of 100k primary cultures was ~31.7% lower, on average, than the CDP of 
cells derived from 10k primary cultures. These results support the contention that differences in the cell-densities of 
the suspensions used to create the CDP assays could have also contributed to the discrepancy between the macaque 
and human CDP values, as noted above.      
The proliferative capacities of the mammospheres were also compared between the humans and macaques. 
Notable here, is that none of the human studies utilized for these comparisons de cribed the reproductive status of 
the donors. However, with the knowledge that all the human samples in these studies were derived from reduction 
mammoplasties and the mean age for reduction mammoplasties has been report d to be around 38 years of age,242 it 
is plausible that a large percentage of the tissue donors in these studies were parous individuals. This information is 
important because most of the proliferative parameters in the macaque differed sgnificantly between nulliparous 
and multiparous animals. While the differences between macaque demographics are discussed in more detail below, 
what is important to the discussion here is that many of the comparisons to human data are made with reference to 
the parity-status of the macaque.   
In studies using comparable methodologies, the human primary MFE (0.013%)196 and secondary MFE 
(0.4%)71 were similar to those of the parous macaques but were substantially lower than those of nulliparous 
macaques. As with humans, macaques produced mammospheres that were capable of being passaged over multiple 
generations. Some of the human generational studies reported a marked loss in MFE with each generation85, 196 
which was similar to what was identified for parous animals. Interestingly, other studies identified more consistent 
MFEs,71 or even increases in the MFEs,67 between the successive generations and this was comparable to data from 
the nulliparous animals. Utilizing the secondary MFE values acquired from the generational study and comparing 
them to the average number of cells/sphere in the macaque, each parous m mmosphere was calculated to contain ~1 




mammospheres were calculated to contain ~3 MFUs per mammosphere. These numbers were consistent with the 
ranges (1- 4 MFUs/mammosphere) identified in human studies.71 In the current project it was also demonstrated that 
macaque mammospheres could be derived from singly-plated cells which is s milar to what has been reported for 
human mammospheres.67, 71 No human studies were identified that reported the CFE and therefore no comparis ns 
could be made.   
Collectively, these studies support the proposition that mammospheres derived from macaques are 
comparable to those of humans. While not all macaque data aligned perfectly with every human study, there were 
inconsistencies in methodology that may account for these discrepancies. The proposal that methodology is critical 
to mammosphere potential is supported by the fact that data reported between the human mammosphere studies are 
varied, and at times contradictory to one another, where different methods have been used to process these cultures. 
In turn, macaque mammospheres appear to be a relevant surrogate model to human mammospheres where human 
tissue is unavailable or toward areas of research that are not accessible using huma  tissues. Examples of studies 
where macaque mammospheres might prove useful include investigations into the effects of carcinogens on the 
mammary gland stem cells of young females and any longitudinal study of the breast where repeated biopsies from 
the same individual are required.    
The morphological observations made on the macaque mammospheres suggest that thi  assay produces 
populations of spheres that are highly variable with regard to their individual differentiation potential. Specifically, 
by Day 5 of the differentiation process in BME, notable variations in the morphology of individual spheres became 
apparent that persisted throughout the entire time spheres were maintained in culture. While these variations might 
have been predicted of the primary 10k mammospheres, with the knowledge that some spheres within primary 
cultures are invariably of a non-stem cell/non-bilineage progenitor cell origin (as discussed above with CDP), it was 
surprising to find nearly identical results in the 1k secondary spheres. The 1k results were unexpected because 
mammospheres plated at, or below, 1k have been proposed to be primarily clona  in origin; and also because 
secondary mammospheres are proposed to be comprised of cell populations th t are more homogeneous than those 
of the primary spheres.71, 85 Regardless, the morphological results of this study are consistent with reports which 
collectively propose that the mammosphere-forming cells obtained via this assay are, in actuality, a highly 
heterogeneous population of proliferative bilineage cell types.67, 70, 153, 194 While this lack of specificity has incited 




likely to be useful toward cancer research. That is to say, as we do not yet know he cellular origins of the various 
forms of breast cancers, it may be preferable, at least initially, to collect a wider variety of proliferative cell types for 
study rather than use assays that are too selective and risk missing entire populations of cells that are prone to 
carcinogenesis.   
Beyond budding variability, the morphological observations of macaque mammospheres also identified 
aspects of proliferation and differentiation that may prove useful toward future research. First, if CD10 is truly a 
marker of bilineage progenitor cells as previously suggested,71 then it appears that most macaque spheres in culture 
are predominantly composed of relatively undifferentiated cells within a mantle of epithelial-like cells. It also 
appears that as if the leading edges and less-organized areas of the budding projections are also predominated by 
undifferentiated cells. Expression of SMA and/or CK18 was typically onlyappreciated within the more matured 
(presumed, based on cellular morphology) aspects of the budding projections and there were areas of some budding 
projections that were negative for all three markers. Notably, ER staining a d PR staining (following lactogenic 
differentiation) were commonly identified to occur in the parts of the budding projections that lacked CD10, SMA, 
and CK18 expression. The significance of the expansive, highly-cellular extrusions that were associated with the 
formation of secondary-bodies, and the secondary-bodies themselves, is unknown. Both of these structures 
frequently had strong CD10, SMA, and CK18 expression with each marker demonstrating distinct regions of 
preferential staining. No ER or PR staining was identified within these structures. Whether these structures are 
representative of in vivo physiological processes (e.g., expansion of the terminal end ducts associated with 
mammary gland development) or are artifacts of the in vitro plating process still needs to be explored in future 
studies.   
Lactogenic differentiation of BME-encased macaque mammospheres was accomplished through the 
addition of prolactin to the culture media, as previously described,71, 196, 230 but also required a novel modification to 
the technique. Initially, a number of experiments that incorporated prolactin use at various stages of mammosphere 
development failed to promote lactation in the macaque mammospheres. Based on the kn wledge that the mammary 
gland niche provides hormones and other growth factors that can promote lactogenic differentiation,127, 145, 226, 277 
CM2 was created and added to the media. The addition of CM2 was successful at timul ting lactation ( -casein 
staining) within the alveolar-like structures of the budding spheres but also, unexpectedly, induced intracytoplasmic 




addition of prolactin alone did not appreciably alter the spheres while the addition of CM2 without prolactin resulted 
in vacuolation of the spheres without lactation.   
As to the reason CM2 was required for lactogenic differentiation in the macaque mmmospheres but was 
not in the human experiments is unknown but it is proposed to be relat d to the differences in methodology that 
were utilized to produce the mammospheres themselves. In the macaque studies, the 1k mammospheres were first 
grown in culture and then were encased within BME. In the human studies,71, 196 single-cell suspensions were plated 
into BME which then formed into mammospheres. In an experiment comparing the differences of the BME-encased 
spheres produced by these methodologies, cells acquired from one subject were used to produce mammospheres 
using the human technique and also to produce mammospheres using the macaque technique. Morphological 
analysis of the two sphere populations after 21 days of incubation identified similar immunostaining patterns but 
found that the mammospheres derived from the macaque-method contained a denser and more angular population of 
cells than those derived from the human-method. Furthermore, the sphere  derived from the human-method had 
notably more PAS-positive extracellular matrix within the main sphere bodythan did the spheres derived using the 
macaque-method. While these investigations are only preliminary, the initial observations suggest distinct 
morphological differences in the mammospheres produced using these two methods and this may account for the 
additional growth factors needed in the spheres produced using the macaque technique. Further studies investigating 
the differences in the spheres formed using these two methodologies are warrnted.       
The nature of the CM2-induced vacuoles has yet to be elucidated but the histologic appearance suggests 
that the material is likely lipid. One mouse study has identified “oil-filled adipocytes” within “stromal” 
mammospheres.70 However, these vacuoles were present without any stimulation and the primary mouse
mammospheres of this study may not be appropriate for comparison to the secondary macaque spheres used here.70 
In macaques, secretory fat vacuoles are commonly identified within normal mammary epithelial cells56 and one 
study has identified myoepithelial vacuoles in the immature ducts of young animals undergoing mammary gland 
development.288 This last observation is of particular interest and further investigation int  the possible in vivo 
significance of the mammosphere vacuoles is warranted. In the future, lactogeni -differentiated mammospheres will 
be collected as frozen samples, in addition to being preserved in formalin, to llow for a more complete histological 




Statistically significant differences were identified for most of the mammosphere growth and 
differentiation parameters between nulliparous and multiparous follicular/luteal-phase animals in this study. These 
results are similar to those of another study between nulliparous and multiparous macaques which compared the 
mammosphere potential of biopsies that were collected from animals in the menses phase of t e cycle (Chapter 4). 
Consistent with these macaque data, other research has identified the mammary glands of nulliparous mice to 
contain significantly higher numbers of stem cells as compared to the glands of parous animals.235 Information 
obtained from the PCA supported the parity-related differences in the macaque and furthermore suggested, albeit 
weakly, that the phase of the reproductive cycle may also play a role with regard to mammosphere potential. 
Although ultimately no significant differences in mammosphere potential were id ntified with regard to the phase of 
the cycle, it should be noted that a major limitation of this study was the low number of subjects available for 
analysis from each of the various demographics. Regardless of the lack of statistical significance to the trend above, 
there is literature to suggest that mammosphere potential is likely to vary with the p as  of the reproductive cycle. 
Specifically, there are significant differences in the proliferative capacity of the macaque mammary gland in vivo 
that are associated with distinct stages of the menstrual cycle.50, 244 Additionally, murine studies have found that 
single-cell isolates collected from mammary glands at different stages of the estrus cycle have significantly different 
in vitro proliferative potential.121 Based on this information, and the study trend above, it is proposed that additional 
research into the effects of the menstrual cycle on mammospheres potential is warranted. 
While direct comparisons in mammosphere potential between the individual stages of th  reproductive 
cycle was not possible due to the low numbers of optimally-processed animals in the study, there were some 
observations made with regard to reproductive stage that bear mentioning. The first is that, other than the lactating 
animal, the menses stage monkey is the multiparous subject that was furthest removed from the main cluster of 
animals. Taken by itself, this observation is easily dismissed as individual ari tion amongst animals. However, the 
data obtained from this animal were found to be highly consistent with data obtained from the biopsies of six, 
similarly-processed, multiparous, menses-stage animals in another study (Chapter 4). In light of this information, it 
is proposed that the macaque gland may have overall less mammosphere potential duri g the menses-stage than at 
the two other stages (i.e., follicular and luteal stages) of the active menstrual cycle.  
Other observations with regard to the reproductive cycle involve the inactive-phase animals. Little is 




blood levels of the sex hormones are typically very low. However, even these hormone levels are variable as some 
animals experience irregular or anovulatory menstrual cycles throughout the inactive-phase.50, 279 Consistent with a 
low hormonal state, the inactive-phase animals included in this study tended to have lower mammosphere potential 
than the follicular- or luteal-phase animals. This was illustrated in the vector diagram but is also exemplified in the 
generational studies where the two inactive-phase animals were the only subjects that failed to produce quaternary 
spheres. Consistent with the reports of hormonal variability in the inactive-phase of the cycle, the four subjects 
comprising the inactive-phase cohort were also found to be more divergent on the vector diagram than were the 
animals within the follicular- or luteal-phase cohorts. Furthermore, it is also notable that an inactive-phase animal 
was the only subject in the quadrant studies that was identified to have significant differences in the MFE between 
any of its mammary gland quadrants. Per these observations, and with the knowledge that there is no stage of the 
normal human reproductive cycle that correlates with the inactive phase, the use of mammary gland tissues from 
animals in the inactive-phase of the cycle should likely be avoided where reproducible, human-relevant research 
data are required.    
Although mammary gland was acquired from only one pregnant animal in the formal study utilizing the 
optimized technique, a number of pregnant/early post-partum animals were utilized in the developmental and 
optimization aspect of this project. The general observation for these subjects was that there was little consistency as 
to the mammosphere potential between any two animals in this particular reproductive stage. This information is not 
particularly surprising as pregnancy is a highly dynamic state but, rather, serves as a reminder that if tissues from 
pregnant animals are to be utilized in studies, precise timing of the pregnancies will likely be required to maintain 
reproducibility between subjects.  
There was some study data which suggested that age may also play a role in the mammosphere potential of 
mammary gland cells. The position of the various-aged nulliparous subjects on the vector diagram is particularly 
supportive of this possibility, while the age-comparisons between multiparous subjects within each reproductive 
stage are also intriguing. However, what must be appreciated with regard to the multiparous animal-comparisons is 
that breeding-colony monkeys were used as the tissue donors in this study and older monkeys also tended to have 
produced larger numbers of offspring (greater parity). In short, it is essentially impossible to deduce from these data 




In review, parity status is almost certainly related to mammosphere potential in the macaque and there is 
information to suggest that the reproductive stage and age may also influence th  proliferation and/or differentiation 
capabilities of the mammospheres as well. As such, demographic information to include age, parity-status and 
reproductive stage should ideally be obtained of every macaque donor used for mammosphere cultures to allow for 
appropriate comparisons between subjects and between studies. Furthermore, it is p oposed that if similar 
information can be obtained from human and rodent donors utilized for mammosphere cultures it is possible that 
mammosphere data can be better standardized across species.   
The results obtained from this study have a number of limitations in addition to those previously 
mentioned. First is the issue that the majority of the tissues utilized for this project were derived from animals that 
were euthanized due to disease, trauma or as part of unrelated research studies. As such, it is possible that any of the 
factors associated with the death of these animals may have affected the mammosphere potential of the mammary 
glands utilized for this work. Future studies utilizing tissues collected from clinically-healthy subjects will be 
beneficial at validating the results obtained from this project.   
Information provided above suggest that mammospheres derived from 1k cultures are more likely to be of a  
clonal origin and therefore may provide a more accurate, overall assessment of th  mammosphere potential for any 
given single-cell suspension as compared to mammospheres derived from 10k sphere cultures. To that, the 
mammosphere potential of secondary, and later generational, macaque mammospheres was evaluated utilizing 
mammospheres derived from 1k mammosphere cultures alone. However, the mammosphere potential of primary 
macaque mammospheres was most commonly assessed using mammospheres obtained from 10k cultures and this 
fact constitutes another limitation to the interpretation of the data reported here. The use of 10k-derived, rather than 
1k-derived, primary mammospheres in this study was deemed necessary for two reasons. The first issue, as 
previously discussed in the Results section, was that large numbers of primary 1k mammospheres could not be 
efficiently obtained from the mammary gland tissue-digests of multiparous animals. The second, and more 
problematic issue was that even when multiparous, primary 1k mammosphere  were obtained, these spheres were 
small and ragged in appearance and they had minimal ability to undergo attachment or differentiation as compared 
to the multiparous, primary 10k spheres or the nulliparous, primary 1k spheres. Experiments using macaque tissues 
suggest that the decreased proliferation and viability of the multiparous 1k mammospheres is largely due to 




primary 1k mammosphere cultures from two of the multiparous macaques in this study were supplemented with 
CM1 from another multiparous animal, these 1k cultures produced larger numbers of more viable-appearing 
spheres. These CM1-supplemented spheres had MDP and MBP values that were nearly ide tical to those of the 
primary 10k cultures from the same two animals. Additionally, in these sam  experiments the difference between 
the MFEs for the 1k and 10k cultures was identified to be only 5.2%, rather than the 13.3% when CM-1 
supplementation was withheld. This last finding is significant in that it suggests that the use of 1k primary cultures 
may actually underestimate the primary MFE potential for multiparous macaques. In light of the similarities in the 
differentiation potential between the primary 10k and 1k spheres, in conjunction wi h the previous data that 
demonstrated a significant correlation between the primary 10k and 1k MFEs, the use of 10k cultures was 
considered to be acceptable, albeit not ideal, for the comparison studies here.   
Notably, a number of experimental techniques aimed at obtaining viable primary 1k mammospheres 
cultures from these animals were considered prior to the decision to utilize the primary 10k cultures for this work. 
Unfortunately, it was not possible to supplement the individual primary 1k cultures with their own CM1 at Day 0 of 
the plating process as CM1 is not collected from the primary 100k sphere cultur s ntil Day 3. Additionally, 
experiments showed that supplementation of macaque primary 1k cultures with CM1derived from their own 100k 
cultures at Day 3 of the incubation process only marginally improved mammosphere viability. The possibility of 
routinely using CM1 from other animals to improve the viability of primary 1k cultures was rejected as the 
biologically-active components of the CM1 may vary between subjects and could have confounded the comparison 
studies. In that the deficiency in pro-mammosphere growth factors within the 1k cultures is likely a direct result of 
the ratios of proliferative to non-proliferative cell types within the mammary gl nd single-cell suspensions, 
consideration was also given to experimental techniques that could specifically concentrate proliferative cell types 
(e.g., fluorescence-activated cell sorting (FACS)). However, this approach was also rejected as this would have 
required the selection of specific cell phenotypes that may not be similarly exp essed across the different 
demographics of animals and, as such, could have confounded comparisons s t  the overall mammosphere potential 
between these populations. In short, culture supplementation with CM1 and the use of proliferative-cell 
concentration techniques are both likely to provide further insight into the macaque mammosphere potential in 
future research projects although neither approach was perceived to be superior to the 10k mammosphere culture 




There are some limitations to the interpretation of the morphologic studies of the BME-encased spheres as 
the variation in budding morphology of these spheres was assumed to b  due to differences in the outgrowth 
potential of single cells. As previously discussed, it is likely that at least a small percentage of the spheres in these 
studies were derived from the aggregation and proliferation of two or more cell types.70, 71, 231 Furthermore it is 
possible that some spheres, the larger spheres in particular, could be the byproduct of two or more spheres that 
became adjoined during the mammosphere culture process. The fact that only l rge spheres were identified to form 
secondary bodies is intriguing in this regard and it is plausible that formation of this specific budding structure may 
require the influence of two or more progenitor cell types. The proposition that secondary body-formation may be 
dependent on the contributions of two or more cell types is supported by he observation that no secondary bodies 
were identified in any of the mammospheres that were derived from a single cell plated in a 96-well plate. The 
results of the single-cell studies cannot be considered definitive, however, as only a small number of spheres were 
available for BME-encasement. Larger studies of a similar nature are warranted to i ves igate this proposition 
further.     
Data from the morphological comparisons of BME-encased mammospheres in this study suggested that, 
other than in a few early pregnant females, there was minimal variation in the differentiation-potential between the 
different demographics of animals. There are limits to the interpretation of this work, however, in that the 
characterization of budding morphology was based on a few overt features of th  budding spheres as a whole. Future 
studies which utilize a greater number of parameters to assess differences in budding morphology may identify 
variations in morphology between the demographics that were not appreciated here.   
Finally, the ability of the mammospheres to be formed from a single cell, have sustained generational 
growth, and undergo bilineage differentiation was proposed as evidence that the macaque mammosphere cultures 
represent a population of cells that are enriched for MSCs. However, in vivo transplantation of mammosphere-
derived cells into mice is generally considered the gold standard by which stem cell enrichment is validated.67, 71, 196, 
230, 231 As these experiments have not yet been performed, there are limitations in the interpretation as to the stem 
cell-enriched nature of the macaque mammosphere cultures in general. Studies are currently in progress to address 
this deficiency.   
The first major aim of this project was achieved as a rhesus macaque mmmosphere technique was 




demonstrated to be similar throughout a large, well-defined region of the rgan and the first reported mammary 
gland weights were obtained for this species. The second major aim of this project was achieved insomuch as the 
comparisons between the human and macaque mammospheres did not identify any major differences that would 
preclude the use of macaque mammospheres as models for human research. As with mo t validations of this kind, 
however, minor differences were identified for some assays and are proposed to be methodological in nature. Future 
work is proposed to explore these discrepancies in more detail. Finally, the third major aim was achieved in that 
significant differences in mammosphere potential were identified to be associated with parity-status in the macaque. 
Trends in the data, experimental observations, and comparisons with other studies suggest that mammosphere 
potential may also be affected by the stage of the menstrual cycle and further work is proposed in this area. There 
was minimal data to associate mammosphere potential with age although the numbers of subjects available for these 
analyses were low. The possibility that age could affect mammosphere potential ca not be excluded based on the 
results of this study.      
In conclusion, a mammosphere culture technique was optimized for the rhesus macaque. The resultant 
protocols, along with outcomes of the individual optimization experiments, are described here in detail in efforts to 
promote the use and advancement of this technique. The assay was demontrated to be highly reproducible and 
small biopsies acquired from the cranial aspect of the mammary gland were found to be representative of the region 
in general. Rhesus macaque mammospheres were identified to have properties similar to those of human 
mammospheres and, as such, are likely to be a relevant study model for the human breast. A study utilizing tissues 
from 18 animals demonstrated that the mammosphere potential of mammary glands is likely affected by the 
reproductive state of the animal and it is suggested that this information be taken into consideration when utilizing 
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Rhesus macaques (Macaca mulatta) are widely used as models for the study of human reproductive 
biology and disease as a result of their genetic, morphologic, and physiologic similarities to humans.10, 31, 63, 77, 201, 244, 
267, 279 Of particular importance to the current study is the fact that the menstrual cycle of sexually-active female 
rhesus macaques is generally recognized to be comparable in length (i.e., 25-35 days) and form (i.e., menstruation) 
to that of women. Despite overall similarities, one notable difference between rhsus macaques and humans is 
breeding seasonality. Rather than being reproductively active year round, rhesus typically only exhibit regular 
ovarian cycling and sexual receptivity for one 2-6 month period annually.50, 63, 77, 94, 274, 278, 279 
Research studies that involve sexually-intact macaques may require monitoring of the ovarian cycle in 
order to synchronize the collection of study samples to one specific stage of the cycle. This is performed to 
minimize the difference in sex hormone concentrations between the individual study animals, as varying hormone 
levels have the potential to confound data interpretation.50, 244, 279 Ovarian cycle stage can be monitored with high 
accuracy by to evaluating progressive changes in the serum levels of the sex hormones. Unfortunately, reliable 
assessment of ovarian cycle stage in these animals usually requires that blood be collected from each subject 2-3 
times per week over several months duration.177, 202, 274, 278, 279 This degree of diligence is required as sex hormone 
levels vary significantly between individual subjects and there are currently no established hormone concentration 
standards that accurately identify one particular stage of the macaque ovarian cycle. Serial monitoring of sex 
hormone levels is undesirable for large studies as it can be extremely laborious to acquire the requisite number of 
blood samples. Additionally, the results of hormone assays are often nt immediately available. Finally, as both 
physical and psychosocial stress can lead to disruption of the normal reproductive cycle in nonhuman primates 
(NHPs),3, 94, 148, 188, 202, 274, 279 it is plausible that the stresses associated with repeated blood draws in macaques could 
confound reliable study data collection. Novel approaches toward the timing of the varian cycle that are less work-
intensive and that are less stressful to the individual animals and their social gr ups are desirable and are likely to be 
useful to many facets of research involving these species.183, 279   
 Routine monitoring of vaginal cytology has been investigated as a less stressful and less work-intensive 




technique can accurately identify each of the six most commonly-define  stages of the macaque menstrual cycle 
(i.e., menses, early-follicular, late-follicular, ovulatory, early-luteal and l te-luteal stages) have not been 
encouraging. This is because studies have found that certain stages of the macaque cycle are indistinguishable from 
one another by vaginal cytology alone and, importantly, these “indistinguishable stages” tend to be the stages that 
are typically of greatest interest to researchers (i.e., late-follicular, ovulatory and early-luteal stages).10, 63, 124, 165, 173, 
177, 183, 201, 281 However, if a researcher is able to utilize tissue samples that are synchronized t  one of the other three 
stages of the macaque cycle (i.e., menses, early-follicular, late-luteal stages) then the use of vaginal cytology to 
manage synchronization of sample collections may still be a viable option.  
 Synchronization to the menses stage of the cycle via vaginal cytology is an attractive option for research 
projects that have no need for their study samples to be collected during either the follicular or luteal stage. This is 
because previous work in macaques has suggested that the vaginal cytology of the menses stage is distinct from the 
other stages of the active cycle.63, 173, 183 Furthermore, in that this stage is also associated with vaginal bleeding 
(menstruation), daily cageside observations to inspect the perineum of the animals, and/or daily vaginal swabbings 
can serve as minimally invasive means by which macaques can be presum tively identified to be within the menses 
stage of the cycle.77, 165, 183, 202, 244, 274, 278, 279 
 While the identification of vaginal-derived blood in regularly-cycling NHPs may serve as a presumptive 
diagnosis of the menses stage of the cycle, there are other causes of vaginal bleeding in these species that should be 
ruled out if the research results might be affected by variable hormone levels between study animals. Anovulatory 
cycles are documented to occur in many NHP species and these cycles can result in vaginal bleeding that is similar 
in character to the menses stage of a normal ovulatory cycle.63, 77, 165, 173, 274 Anovulatory cycles are potentially 
problematic for studies, in that the animals experiencing these cycles typically lack a fully-functional corpus luteum 
and therefore have hormone levels that are notably different from ovulating animals .63, 202, 274, 278, 279 Other common 
reproductive tract pathologies of NHPs such as vaginitis, leiomyomas, ovarian cysts, and endometriosis, can also 
potentially produce vaginal bleeding that might be confused with menstruation.39, 57, 60, 126, 183, 283, 298 Finally, for any 
female animals that are cohoused with sexually-intact males, there is also the potential for pregnancy-associated 
vaginal bleeding to be confused with menstruation. This could present itself as either non-pathologic gestational 




 Comprehensive vaginal cytology-studies are described in the rhesus macaque which utilized vaginal smears 
prepared with Shorr stain63 and hematoxylin and eosin (H&E) stains173 although a review of the literature found that 
most macaque vaginal cytology studies have utilized classical Papanicolaou (Pap) stains.51, 124, 165, 177, 183, 244 Pap 
stains are also recommended in industry-standard guidelines as they reliably produce high quality cytologies.268 
However, Pap stains are relatively time-consuming and complicated to prepare19, 120, 183 and are therefore unsuitable 
for certain research situations where short turnaround times are required. There is consequently a need to identify a 
rapid staining technique which can produce vaginal cytologies that are of Pap stain diagnostic quality.  
Romanowsky-type stains are the most popular stains in veterinary medicine19, 120, 207and are frequently 
utilized to process the vaginal cytologies of dogs14, 197, 203, 227-229 and laboratory rodents.61 Additionally, at least one 
specific Romanowsky-type stain has been reported to be equivalent to the classical Pap stain with regard 
interpretation of vaginal cytologies in the baboon.136 A modified procedure for Diff-Quik® (a Romanowsky-type 
stain) has been demonstrated to produce rapid cytological specimens of comparable quality to those of Pap stains for 
a wide variety of tissue types in domestic veterinary species.120 In light of these previous successes, it is plausible 
that the modified-Diff-Quik® (MDQ) staining might also serve as a means by which rapid and reliable vaginal 
cytology results can be obtained for the rhesus macaque. 
The current project evaluates the utility of a novel, rapid-staining (MDQ) technique for use in rhesus 
macaque vaginal cytology. The first aim of this project was to use MDQ-stained vaginal cytologies to define the 
cytologic parameters of the menses, follicular, periovulatory, and luteal stages of th  menstrual cycle in 
reproductively-active rhesus macaques, with the hypothesis that MDQ vaginal cytology can be utilized to accurately 
and reliably identify the menses stage in reproductively-active rhesus macaques. An additional aim of this project 
was to identify the MDQ vaginal cytology parameters that were characteristic of the rhesus macaque: 1) during the 
reproductively-inactive period of the year; 2) when pregnant; 3) when undergoing anovulatory cycles; 4) following 
abortions; 5) when affected by reproductive tract disease. The hypothesis of this aim was that MDQ vaginal 
cytology characteristics can be used to reliably differentiate the menses stage from: 1) animals in the inactive stage 
of the reproductive cycle; and, 2) animals with other potential causes of vaginal bleeding. Successful completion of 
these aims is expected to result in the identification of specific vaginal cytology parameters by which future tissue 





Materials and Methods 
Animal model. Biological specimens were acquired from a total of 53 female, Indian-orgin, hesus 
macaques. In vivo vaginal swabbings were collected from nine clinically-healthy pregnant animals that ultimately 
carried their infants to term; and from five animals that had undergone a spontaneous abortion. Additionally, vaginal 
swabbings and ovarian and uterine tissues were opportunistically collected at necropsy from 39 animals of 
reproductive age. These macaques were animals that either died or were euthanized due to illness or trauma, or were 
euthanized as part of other research projects unrelated to the current study. All of the pregnant animals, abortive 
animals, and 37 of the necropsied animals originated from the breeding colony at The University of Texas, MD 
Anderson Cancer Center, Keeling Center for Comparative Medicine and Research (KCCMR) in Bastrop, TX. 
Throughout the timeframe of this project, the KCCMR breeding colony maintained an ongoing census of 
approximately 600 adult female macaques. The KCCMR breeding colony has been a closed colony since 1983 and 
no outside animals have contributed to the genetic lines since that time. The colony has been documented through 
serological means to be Specific Pathogen Free (SPF) for Cercopithecine Herpesvirus 1, Simian Immunodeficiency 
Virus, Systemic T-lymphotrophic Virus and Simian Retroviruses 1, 2, and 5 since 1991. The final two animals 
which provided necropsy-derived specimens were animals originally procured from an external vendor, although 
they had been maintained at the KCCMR for approximately 2 years prio to euthanasia. These final two animals 
were seropositive for Cercopithecine Herpesvirus 1 at the time of their death but were clinically normal and were 
SPF otherwise. Signalment and medical history were collected for each of the study animals. The KCCMR is fully 
accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International 
(AAALACI) and all animals utilized in this study were housed in full compliance with the recommendations 
provided in the Guide for the Care and Use of Laboratory Animals (ILAR).182  All tissue collection methods used for 
this study were reviewed and approved through The University of Texas, MD Anderson Cancer Center Institutional 
Animal Care and Use Committee (IACUC).  
Vaginal swabbings and vaginal impression smears. In vivo vaginal swabbings from the pregnant and 
abortive animals were performed as the animals were maintained under anesthesia in the KCCMR veterinary clinic 
for routine physical and ultrasound examinations. Ultrasound examination was utilized to diagnose animals as 
“pregnant” and fetal measurements were utilized to estimate gestational age. Ultrasound examination was also 




gestational ages of the abortive pregnancies were determined from the results of the previous ultrasound 
examination in which the dams had been determined to be pregnant. The abortive animal swabbings utilized in this 
study were all collected within 8 hours (range 1-8 hours) of the time that the abortive animals had been noted as 
having bloody discharge from the vagina. Necropsy-derived vaginal swabbings were collected within 1 hour of the 
death of the animal with many of the swabbings collected immediately following euthanasia. Vaginal swabbings 
were collected in a manner similar to that previously described for NHPs. 10, 51, 124, 136, 173, 177, 183 A cotton-tipped 
applicator (swab) was moistened slightly with 0.9% saline solution and then gently inserted into the vagina until it 
made light contact with the cervix and then the swab was retracted approximately half that distance. The swab was 
rolled against the vaginal walls with slight pressure to obtain a smear that was repre entative of the vaginal vault 
midway between the cervix and vaginal opening. After removal, the swab was rolled along a glass slide to create 
multiple linear impression smears. A minimum of two swabs and slides were prepared for each animal. The smears 
were allowed to air-dry thoroughly at room temperature. The slides were prepared for cytologic examination 
utilizing a modified Diff-Quik® (EK Industries, Joliet, IL) protocol.120 This technique used the same three staining 
solutions as the standard Diff-Quik® technique but increased the exposure to each solution to 20 dips/solution and 
included an additional xylene step (5 dips) at the end of the process once the slides had dried.     
Necropsy-derived tissue collections and histologic assessment. The uterine and ovarian tissues collected 
at necropsy were immersion-fixed in 10% neutral buffered formalin (LabChem, Pittsburg, PA) for a minimum of 72 
hours. Following fixation, the tissues were routinely processed for histologic examination by the KCCMR Histology 
Laboratory and paraffin-embedded sections were cut at 4 μm and stained with hematoxylin and eosin (H&E; Poly 
Scientific R and D, Bay Shore, NY). The uterine and ovarian morphology was assessed by two boarded veterinary 
pathologists who collectively determined the specific reproductive stage for each animal using histologic parameters 
as previously described.10, 31, 267 
Vaginal cytologic assessment. Review of the vaginal impression smears was performed by a boarded 
veterinary pathologist and two certified medical technologists. The mean score of the three examinations was 
reported for each parameter. Similar to previous studies, 10, 51, 63, 177, 183 the vaginal smears were examined under light 
microscopy to qualitatively assess the number of erythrocytes, leukocytes, and bacteria, and also the amount of 
mucus and cell clumping present throughout each slide. Each of these parameters was then scored between 0 (lowest 




performed on the vaginal epithelial cells of the impression smears. This was done using a back and forth meandering 
approach in a minimum of three separate regions per slide. Individual cells were classified as either parabasal, 
intermediate, or superficial cells based on morphologic parameters as previously described for NHP vaginal 
cytologies 10, 51, 124, 163, 173, 183, 244 and as detailed in Figure 1. Similar to other macaque vaginal cytology studies,51, 244 a 
maturation value of the vaginal epithelial cell population was calculated for each subject as follows: (Parabasal cell 
number x 0.2) + (Intermediate cell number x 0.6) + (Superficial cell number x 1.0) /300 = Maturation Value (MV).  
   
 
Figure 1. MDQ-vaginal cytology cellular morphology allows identification of distinc  cell types. Image A are 
parabasal cells. These cells have rounded edges, basophilic cytoplasm and contain a rounded, centralized nucleus
composed of ropy to clumped chromatin. The diameter of the nucleus of these cells is approximately one-third or 
more the size of the cell diameter. Image B and C are small intermediate cells. These cells are round (Image B) to 
ovoid and can have angular projections (Image C). The cytoplasm is slightly basophilic to eosinophilic.  The nucleus 
is round to ovoid and has ropy to clumped chromatin. The diameter of the intermediate cell nucleus is notably less 
than one-third the size of the cell diameter. Image D and E are large intermediate cells. These cells have angular 
margins, pale cytoplasm and ovoid nuclei with ropy to clumped chromatin.  Superficial cells are keratinized cells 
with angular margins. Image F is a superficial cell with a small pyknotic nucleus. Image G is a uperficial cell with 
a pyknotic nucleus surrounded by a perinuclear halo. Image H is an anucleate superficial cell.  MDQ-images at 100 
x magnification were collected from animals in the menses stage of the cycle (note background erythrocytes and 
occasional polymorphonuclear leukocytes). Scale bars = 25 µm. 
 
Vaginal cytology comparisons and statistical analysis. As previously described, the histological 
characteristics of the reproductive organs of necropsied animals, and the ultrasound findings of pregnant and 
abortive animals, were utilized to define the reproductive stage of each study subject. The MDQ vaginal cytologies 
collected from animals in the menses, early-follicular, late-follicular, periovulatory, ea ly-luteal, and late-luteal 
phases of the active menstrual cycle were quantitatively and qualitatively compared to one another. The MDQ 
vaginal cytologies from menses stage animals were also quantitatively and qualitatively compared to MDQ vaginal 




anovulatory menstruation animal and one animal with polycystic ovaries. Statistical comparisons of the various 
reproductive stages were performed using a t-test (two sample assuming equal variances) through IBM SPSS 
version 22 (SPSS Inc., Chicago, IL) software. Statistical significance for all data was set at P<0.05.  
Results 
Ovarian and uterine histological assessment. Results of the uterine and ovarian histological evaluation 
for each necropsy-derived study animal are provided in Table 1. There were 28 animals identified to be in a 
reproductively active stage of the menstrual cycle at the time of their death.These animals were classified into the  
 
Table 1. Vaginal cytologies obtained from various demographics of rhesus macaques. Definition of table terms. 
Animal #: order processed in the study. Asterisks (*) indicate the two study animals that did not originate from the 
KCCMR breeding colony. Age: rounded to nearest whole year. Class (parity): N=nulliparous; P=primiparous; 
M=multiparous. Stage (reproductive status per uterus/ovary histology): M=menses stage; Fe=follicular stage (early); 
Fl=follicular stage (late); PO=periovulatory stage; Le=luteal stage (early); Ll=luteal stage (late); AO=anovulatory 
menstruation; I=inactive phase; Cy=polycystic ovaries. MV: calculated Maturation Value of the vaginal epithelial 
cell population (see text). RBC: red blood cell/erythrocyte qualitative count. WBC: white blood cell/leukocyte 
qualitative count. Bacteria: qualitative bacterial cell count. Clumping: qualitative assessment of the amount of cell 
clumping.  Mucus: qualitative assessment of the amount of mucus present. For all qualitative counts/assessments a 
score of 0=lowest number/amount and γ=highest number/amount. Animals listed as “opportunistic” were euthanized 
as part of a study unrelated to this project. 
  
Animal Age (yr) Class Stage Infants MV RBC WBC Bacteria Clumping Mucus  Cause of death/euthanisia  
1 14 M Ll 4 87.2 0 0.33 1.33 0.33 0 trauma 
2 17 M I 12 33.6 0 0.67 1.33 2.61 3 cancer 
3 19 M I 10 64.8 0 2 2.67 3 2.33 cancer
4 11 M I 7 99.7 0 1.67 3 2.67 2 amyloidosis
5 21 M I 12 100 0 1 2.33 3 0.67  cancer
6 15 M M 7 51.8 2.33 3 1.33 2 2 trauma 
7 18 M Fl 12 99.1 0 2 3 3 2 arthritis
8 6 P I 1 81.2 0 1 2.33 2 0.33 arthrtitis
9 4 N Ll 0 90 0 0.33 1.33 1.67 1 enteritis/arthritis
10 21 M Fe 13 66 0 2.33 3 1 3 cancer
11 19 M Fl 12 98 0 3 2 3 1.67 amyloid/arthritis
12 18 M I 12 74.4 0 2.67 1.33 2.67 3 cancer
13 8 N Fl 0 99.6 0 2.33 2 2 1 opportunistic
14 4 N Fl 0 100 0 3 3 3 2 opportunistic
15 16 M Ll 7 71.2 0 0 2 1.33 2 cancer
16 20 M AO 2 88.9 2 0.67 3 2 1.67 liver abscess
17 11 M M 4 71.2 1.33 2 2.33 2.33 2 cancer
18 8 M Ll 2 81.6 0 1.67 2 2 2 opportunistic
19 23 M I 16 98.8 0 2 2 1.67 2.33 opportunistic
20 17 M Fl 9 99.2 0 3 3 3 3 opportunistic
21 17 M PO 7 99.6 0 1 2.33 1.33 1 opportunistic
22 17 M M 11 60.4 3 3 2.33 1.33 2 amyloid/enteritis
23 19 M Cy 8 100 0 3 3 3 2 pneumonia
24 11 M I 4 100 0 0.33 2.67 3 1.67 enteritis
25 20 M Fe 13 73.6 0 2 3 1.67 2 arthritis 
26 9 M Le 4 97.6 0 0.67 2 1 1 enteritis 
27* 5 N I 0 30.5 0 0.33 0.67 2 2 opportunistic
28* 6 N Le 0 99.5 0 0.33 2 0.67 1 opportunistic
29 13 M M 7 64.8 3 3 1.33 2 2.33 opportunistic
30 8 P M 1 72.6 3 2 1.33 0.33 1 opportunistic
31 7 N Le 0 74.6 0 0 3 1.33 2 opportunistic
32 9 N Fe 0 86.3 0 0.33 1 0 1 opportunistic
33 7 N M 0 55.3 3 2 1.33 0.33 2 opportunistic
34 7 M Fl 2 98.6 0 3 2 2.67 2.67 opportunistic
35 10 M Fe 2 96.5 0 2.67 2 2 3 opportunistic
36 12 M PO 2 99.3 0 2 3 3 0.67 opportunistic
37 8 M Ll 2 75.3 0 1 3 0 2 opportunistic
38 6 N Le 0 98.9 0 2.67 2.67 2.33 3 opportunistic




following cohorts: 6 menses stage; 6 late-follicular stage; 5 early-luteal stage; 5 l t -luteal stage; 4 early-follicular 
stage; and 2 periovulatory stage. The histologic parameters use to define the individual stages of the active 
menstrual cycle were similar to those previously described.10, 31, 267 A brief summary of the defining characteristics 
of each stage is provided. The menses stage animals had ovarian follicles that were small or undergoing atrophy and 
a corpus luteum (produced during the previous menstrual cycle) that was also undergoing atrophy; the uterine 
endometrium was undergoing hemorrhage with cellular degeneration and sloughing. The early-follicular stage 
animals had several developing secondary and/or early-tertiary ovarian follicles and a largely-atrophied corpus 
luteum; the endometrium was densely cellular, moderately thickened, and contained elongate, straight, narrow 
glands. The late-follicular stage animals had tertiary and/or Graafian follicles in at least one ovary; the cellularity of 
endometrium was less dense than the early-follicular stage, markedly thickened, and the glands often became 
coiled/tortuous toward the end of this stage. The periovulatory stage animals had a recently-ruptured Graafian 
follicle in the ovary, that was either cavitated or blood-filled (corpus hemorrhagicum); the cellularity and thickness 
of the endometrium was similar to that of the late-follicular stage and it had coile /tortuous glands. The early-luteal 
stage animals had a developing corpus luteum in one ovary; the cellularity and thickness of the endometrium was 
similar to that of the late-follicular stage and it had coiled/tortuous glands that contained small amounts of 
proteinaceous fluid. The late-luteal stage animals h d a well-developed corpus luteum in one ovary; the cellularity 
and thickness of the endometrium was similar to that of the early-follicular stage and it had coiled/tortuous glands 
that contained abundant proteinaceous fluid.  
There were nine necropsied macaques identified to be in the reproductively inactive phase of the cycle at 
the time of their death. The defining histological characteristic of these animals was the lack of follicle formation 
and the absence of a corpus luteum in the ovaries. One necropsied macaque was identified to be undergoing 
anovulatory menstruation. Histologically, this animal lacked a corpus luteum in the ovaries; the endometrium had 
mild hemorrhage and sloughing of the surface cells, but the endometriu  was thin and densely cellular. One  
necropsied macaque was diagnosed with polycystic ovaries by the presence of numerous fluid-filled cysts 
throughout both ovaries. 
General findings of MDQ-vaginal cytology. The vaginal cytology findings for each of the necropsied 
macaques are provided in Table 1. The MV, qualitative erythrocyte counts, qalitative leukocytes counts, qualitative 




found to be the most useful parameters for the identification of specific menstrual cycle stages and reproductive 
states. The qualitative bacterial count was highly variable within all cohorts, was not indicative of any particular 
stage or state, and therefore is not discussed further in this report. The qualitative assessment of mucus volume was 
also highly variable within most of the cohorts, was of minimal diagnostic utility, and therefore is only discussed in 
the few states/stages where this parameter was determined to statistically significant. The leukocytes identified 
within the smears of this study were almost exclusively polymorphonuclear cells (neutrophils) except where 
specifically mentioned otherwise below.   
MDQ-vaginal cytology and comparisons across stages of the active menstrual cycle. Summaries of the 
changes to the vaginal cytology throughout the menstrual cycle of the rhesus macaque are provided in Figure 2. The 
vaginal cytology of the menses stage was the most distinctive stage of the active menstrual cycle due to the presence 
of abundant erythrocytes. The stage was also unique in that the menses vaginal cytologies were the only cytologies 
of the active cycle in which degenerate epithelial cells were present. In addition to the presence of the occasional 
degenerate cell, the epithelial cell population of the menses stage was characterized by h gh numbers of intermediate 
cells, moderate numbers of parabasal cells and small to moderate numbers of superficial cells. In that similar ratios 
of vaginal epithelial cells were only identified in the early-follicular stage vaginal cytologies, the menses stage had a 
 
 
Figure 2. MDQ vaginal cytology identified morphological characteristics that were distinct for several stages of the 
rhesus macaque menstrual cycle. The flow diagram represents the progressive changes in the vaginal cytology 
throughout the menstrual cycle. Each box is titled with the Stage of the cycle and the individual parameters utilized 
to characterize the stages are provided in rows below the title. The final row under each Stage describes other 
features common to that stage. For each parameter, the mean score for all animals in that Stage are provided, as are 
the ranges (in parentheses) where applicable. Parameters: MV=calculated Maturation Value of vaginal epithelial cell 
population (see text). WBC: white blood cell/leukocyte qualitative count. RBC: red blood cell/erythrocyte qualitative 
count. Clumping: qualitative assessment of the amount of cell clumping. For all qualitative counts/assessments a 




MV that was significantly lower than every stage of the active cycle except th  early-follicular stage. The menses 
stage was even further distinguished from the two luteal stages of the cycle in that the qualitative leukocyte counts 
of the menses stage were significantly greater than those of either the early-lut l or late-luteal stages.  
Early-follicular stage vaginal cytologies had MVs and qualitative leukocyte counts that were statistically 
similar to every other stage of the active cycle. Despite this fact, early-follicular vaginal cytology was distinct from  
the vaginal cytology of all other stages of the active cycle due to the presence of small to moderate numbers of 
parabasal cells in the absence of erythrocytes. 
Late-follicular vaginal cytology had statistically higher cell-clumping values than did the vaginal cytologies 
of the menses, early-follicular and late-luteal stage. The late-follicular stage was also distinct from these three stages 
in that the late-follicular vaginal cytology was comprised of high numbers of superficial cells, very few intermediate 
cells, and almost no parabasal cells. These differences resulted in late-follicular MVs that were statistically greater 
than those of the menses and the late-luteal stages; and late-follicular MVs which were also typically greater, 
although not significantly, than the MVs of early-follicular vaginal cytologies.  
In contrast to the comparisons of the previous three stages, the late-follicular vaginal cytology was 
essentially indistinguishable from the vaginal cytologies of the periovulatory and early-luteal stages in that all these 
stages were dominated by superficial cells that frequently formed large clumps. Differentiation between these three 
stages was also confounded by the fact that the MVs and cell-clumping values for these stages were also statistically 
similar. Although the early-luteal stage had statistically lower qualitative leukocyte counts than did the late-follicular 
or periovulatory stages, the ranges of this parameter between the three stages markedly overlapped one another. 
Likewise, although the periovulatory-stage had statistically lower mucus vol mes than did the late-follicular stage, 
the mucus volume values overlapped between the two stages. As per the overall similarities between the these 
stages, and the fact that leukocyte counts and mucus volumes could not be relied upon for precise stage 
identification, the vaginal cytologies from the late-follicular, periovulatory, and early-luteal stages were all classified 
within a single, cytologically-distinct “periovulation phase”.  
The late-luteal stage vaginal cytology had a MV, and qualitative leukocyte counts, that were significantly 
lower than those of the late-follicular stage. However, the late-luteal stage vaginal cytology was most 
distinguishable from the vaginal cytologies of the periovulation phase, the menses stage and the early-follicular 




superficial cells. The general lack of parabasal cells in this stage was also useful for differentiating the late-luteal 
stage from the early-follicular stage (the stage with which the late-luteal stage was most likely to be confused). 
Illustrative examples of the histologic and vaginal cytology findings associated with the menses stage, early-
follicular stage, periovulation phase, and late-luteal stage are provided in Figure 3.  
            
 
Figure 3. The MDQ vaginal cytology is distinct for three stages and one phase of th rhesus macaque menstrual 
cycle. Column 1 is histology of the ovary at 4 x magnification (scale bars = 500 µm). Columns 2 and 3 are histology 
of the uterus at 4 x (scale bars = 500 µm) and 10 x (scale bars = 200 µm) magnification, respectively. Column 4 is 
images of the typical MDQ vaginal cytology for each stage at 50 x magnification (scale bars = 40 µm). Row A: 
Menses stage of the cycle. A1-A3: Ovarian and uterine histology as previously described in the text. A4: Vaginal 
cytology contains abundant erythrocytes within a mixture of parabasal, and intermediate cells with only small-
moderate numbers of superficial cells present; there is typically moderate to marked numbers of leukocytes 
(neutrophils predominately) present. Row B: Early-follicular stage of the cycle. B1-B3: Ovarian and uterine 
histology as previously described in the text. B4: Vaginal cytology lacks erythroc tes and consists of a mixture of 
parabasal, intermediate and superficial cell types; low to moderate numbers of leukocyte are present. Row C: 
Periovulatory phase of the cycle (collectively, the late-follicular, periovulatory, and early-luteal stages). C1-C3: 
Ovarian and uterine histology as previously described in the text. C4: Vaginal cytology is composed almost entirely 
of superficial cells and these cells often form large clusters (clumping); leukocyte numbers are highly variable 
throughout this phase. Row D: Late-luteal stage of the cycle. D1-D3: Ovarian and uterine histology as previously 
described in the text. D4: Vaginal cytology contains abundant intermediate cells which frequently outnumber the 




MDQ-vaginal cytology from animals outside of the normal active-menstrual cycle. Vaginal cytologies 
collected from the nine rhesus macaques identified to be in their annual period of sexual inactivity (“inactive (I)”; 
Table 1) varied widely in their cytologic parameters (MV=30.5-100; WBC=0.33-2.67; Clumping 1.0-3.0).  
Importantly, however, erythrocytes were notably absent from all of these vaginal smears. Consistent with these 
findings, the vaginal cytologies obtained from animals in this cohort resembled every stage of the active-menstrual 
cycle except the menses stage. Inactive-phase cytologies were also distinct from the menses stage cytologies in that 
the inactive cytologies had statistically lower quantitative leukocyte counts and statistically greater amounts of cell 
clumping. 
The single animal identified to be undergoing an anovulatory menstruation (Animal # 16) had a qualitative 
erythrocyte count that fell within the ranges of the menses stage animals from ovulatory cycles. However, the 
qualitative leukocyte count (0.67) of that vaginal cytology was lower than any of the true menses stage vaginal 
cytologies. Furthermore, the cytology of the anovulatory menstruation nimal had high ratios of superficial cells that 
resulted in a MV that was greater in value (88.9) than any of the cytologies from the menses stage animals.  
The vaginal cytology from the polycystic ovaries-animal (Animal # 23) had no erythrocytes. Additionally, 
the vaginal cytology of this animal was consistent with the periovulation phase of the cycle with a MV (100) and 
qualitative cell clumping value (3.0) that were greater than any of the menses stage animals.    
MDQ-vaginal cytology of pregnancy and abortion. Vaginal cytologies were collected from nine 
pregnant animals. Six animals were in their first-trimester of pregnancy and three animals were in their second-
trimester of pregnancy. The results of these evaluations are presented in Figure 4. Erythrocytes were notably absent 
from all of the pregnant animal vaginal cytologies. The mucus volume and qualitative leukocyte counts of pregnant 
animals were significantly lower than the mucus volume (mean=1.8 (range= 1.0-2.33)) and leukocyte counts of the 
menses stage animals. While at least a few parabasal cells were identified in all of the pregnant animal cytologies, 
the ratios of the vaginal epithelial cells were highly variable between the individual subjects. A summary of the 
predominate cell types for the nine pregnant animals is as follows: 1) two first-trimester vaginal cytologies were 
predominated by parabasal cells; 2) four first-trimester and two second-trimester vaginal cytologies were 
predominated by intermediate cells; and 3) one second-trimester vaginal cytology was predominated by superficial 




MVs of both the menses stage animals and the first-trimester pregnancies, while the MVs of the menses stage and 
the first-trimester pregnancies were statistically similar. 
 
  
    
Figure 4. The MDQ vaginal cytology of pregnant macaques is distinct from the vaginal cytology of menses stage 
macaques. The Left Box is the collective findings of the vaginal cytology from six first-trimester pregnancies. The 
Right Box is the collective findings of the vaginal cytology from three second-trimester pregnancies. For each 
parameter, the mean score for all animals in that trimester are provided, as are the r nges (in parentheses) where 
applicable. Parameters: MV= calculated Maturation Value of vaginal epithelial cell population (see text). WBC: 
white blood cell/leukocyte qualitative count. RBC: red blood cell/erythrocyte qualitative count. Clumping: 
qualitative assessment of the amount of cell clumping. For all qualitative counts/asses ments a score of 0=lowest 
number/amount and 3=highest number/amount.   
 
Vaginal cytologies were also collected from five animals that were identified to have undergone 
spontaneous abortions. Four of these animals were in their first-trimester of pregnancy and one animal was in its 
second-trimester of pregnancy. The first-trimester abortions (Figure 5) had qualitative erythrocyte counts, qualitative 
leukocyte counts and cell-clumping values that were statistically similar to those of actively-cycling menses stage 
animals. However, first-trimester abortive vaginal cytologies did have some features that differentiated them from 
menses stage vaginal cytologies. First, the MV of abortive vaginal cytologies was significantly higher than those of 
the menses stage. This was due to the fact that abortive vaginal cytologies were dominated by superficial and 
intermediate cells with only small numbers of parabasal cells identified. Second, the umb rs of degenerate 
epithelial cells were subjectively greater in abortive smears as compared menses smears. Third, the overall cell 
staining qualities of the abortive vaginal cytologies was generally poor. Finally, macrophages/foamy macrophages 
were commonly identified in the abortive vaginal cytologies while these cells wre rare in all other vaginal 






        
Figure 5. The MDQ vaginal cytology of first trimester-abortive macaques is distinct from the vaginal cytology of 
menses stage macaques. Image on left is representative of vaginal cytology as identified in four first-trimester 
abortions at 50 x magnification (scale bars = 40 µm). There are large numbers of neutrophils and degenerate cells; 
large to moderate numbers of erythrocytes; and moderate numbers of macrphages. Intermediate and superficial 
cells are the prominent vaginal epithelial cells identified and these cells tend to be pale staining as compared to 
vaginal cytology derived from other animals. The Right Box is the collective findings of the vaginal cytology from 
four first-trimester abortions. For each parameter, the mean score for all animals in that trimester are provided, as are 
the ranges (in parentheses) where applicable. Parameters: MV= calculated Maturation Value of vaginal epithelial cell 
population (see text). WBC: white blood cell/leukocyte qualitative count. RBC: red blood cell/erythrocyte qualitative 
count. Clumping: qualitative assessment of the amount of cell clumping. For all qualitative counts/assessments a 
score of 0=lowest number/amount and 3=highest number/amount.  
 
The vaginal cytology of the sole second-trimester abortion also had qualitative erythrocyte counts (3.0) and 
a cell clumping value (1.33) that fell within the ranges of the vaginal cyto ogies of the menses stage of the cycle. 
However, this vaginal cytology was different from those of the menses stage animals in that it had a qualitative 
leukocyte count (1.66) that was lower than any of the menses stage vaginal cytologies and it was also dominated by 
superficial cells which resulted in an extremely high MV (98.9). Finally, althoug  the second-trimester abortive 
animal had much smaller numbers of macrophages than did the first-trimester abortive animals, the numbers of 
macrophages in the second-trimester vaginal cytologies was still subjectively greater than what was seen in those of 
the menses stage vaginal cytologies.  
Discussion 
This is the first study to directly compare reproductive tract histology and vginal cytology from various 
stages of the reproductive cycle in the rhesus macaque. This is also the first study to utilize a Romanowsky-type 
stain (MDQ) for the evaluation of vaginal cytology in any macaque species. Finally, this study is the first to explore 
the possibility of using MDQ-stained vaginal cytologies to definitively identify the menses stage of the ovulatory 




There is currently no “gold standard” method by which macaques are determined to be within a specific 
stage of the active reproductive cycle. Previous macaque studies that examined the vaginal cytologies of multiple 
menstrual-cycle stages identified their study subjects to be within specific r productive stages through the use of one 
or more of the following diagnostic methods: hormonal assays;177 ovarian laparotomy examination;63, 177 rectal 
palpation;63, 165 and timed-collection practices (based on paired-menstruation dates).10, 63, 173, 183, 244 The current 
macaque study, by contrast, is the first to utilize established histologic parameters of th  reproductive tract10, 31, 267 to 
define the stage of the vaginal smears collected from various stages of th  active menstrual cycle. Given the 
accuracy with which these cytologies were able to be characterized to a specific mnstrual cycle stage, the cytologic 
descriptions of this report are likely to serve as a resource by which future vaginal cytology studies investigating 
specific stages of the macaque cycle can be compared. One potential limitation of these data however is that all the 
vaginal smears of the active menstrual cycle were collected from animals that were euthanized due to disease, 
trauma or as part of a research protocol of unrelated to the current study. Therefore, while the cytology descriptions 
as a whole are thought to be highly representative of the individual stages from which they are derived, it is 
plausible that some of the individual animals within this study could have individual cellular characteristics, as 
reported in Table 1, that contradict the results of other vaginal cytology studie .  
The MDQ stained vaginal cytologies of this study identified overall relative changes to the vaginal 
epithelial cell populations throughout the menstrual cycle that were highly comparable to the changes identified in 
previous macaque studies that utilized Pap-,165, 177, 183 Shorr-,10, 63 and H&E-stained173 vaginal cytologies. Specific 
observations regarding the individual stages that were made in both the current study and previous studies included: 
1) cell clumping was most prominent in the late-follicular stage;10, 177 2) the late-follicular, ovulatory, and earl-luteal 
stages of the active cycle were essentially indistinguishable;173, 177, 183 3) the menses stage was distinct from other 
stages as per the presence of erythrocytes;63, 177, 183 4) the menses stage had the lowest mean MV of all stages;173, 177, 
183 5) the early-follicular and late-luteal phases were cytologically distinct from the other stages;63 and 6) the early-
follicular and late-luteal stages had mean MVs that were nearly identical in value.10  
Only one previous vaginal cytology study was identified to contain any information that varied, to any real 
extent, from the what was observed in the MDQ study.10 In that Shorr-stained study, the MVs obtained from both 
follicular and both luteal stages were identified to be slightly lower (5-10 points/stage) than the MVs reported in the 




differences in the Shorr and MDQ stains with regard to their cut-off points for the differentiation of the intermediate 
and superficial cell types. However, it is also plausible that at least some the difference in the MVs may be 
accounted for by a cell-characterization bias that potentially existed between the two research groups conducting 
these studies. Regardless of the MV differences, the Shorr and MDQ studies were comparable with regard to the 
general, as well as several specific, cytologic changes throughout the cycle, as detailed above.  
It warrants mentioning that all of the Pap-stained vaginal cytology studies165, 177, 183 and one of the Shorr-
stained studies10 used for comparative purposes in this report were performed in cynomolgus macaque (Macaca 
fascicularis, a.k.a. Macaca irus) monkeys. The use of cynomolgus data was deemed necessary for the Pap-stain 
comparisons of this report in that there are no rhesus Pap-stain vaginal cytology studies identified which have 
compared more than two stages of the menstrual cycle. The comparison of the MDQ-stained rhesus macaque 
vaginal cytologies to the Pap-stained and Shorr-stained cynomolgus macaque vaginal cytologies constitutes a 
potential limitation to the comparative value of this report. However, this cross-specie  comparison is proposed to be 
both appropriate and relevant for two reasons. First, cynomolgus macaques hve a reproductive physiology that is 
identified to be “nearly identical” to that of the rhesus macaque.279 Second, all of the macaque vaginal cytologies 
studies that were reviewed for this report identified similar changes to the vaginal ep thelial cell populations across 
the menstrual cycle, regardless of the cytology stain-type and regardless of the macaque species.10, 63, 124, 165, 173, 177, 
183, 244   
Collectively, the information presented in the comparative discussions above suggest that MDQ-stained 
vaginal cytologies are equivalent to Pap-, Shorr-, and H&E-stained vaginal cytologies with regard to their ability to 
identify and differentiate the individual stages of the macaque menstrual cycle.   
The results of this study, as well as other studies, suggest that the presence of abundant erythrocytes63, 177, 
183  and occasional degenerate cells63 on vaginal cytology are highly specific parameters that can be used to diagnose 
the menses stage in actively cycling macaques. The results of the current stdy al o found that these same two 
parameters can be used to distinguish the vaginal cytologies of the menss stage from those of pregnant animals, and 
animals within the inactive phase of the reproductive cycle. However, caution is warranted in utilizing either of 
these two parameters as the sole means of diagnosing the menses stage given that: 1) degenerate cells were not 
identified in every menses stage vaginal cytology of this study; 2) erythrocytes were associated with the vaginal 




reported in the vaginal cytologies in some pregnant animals173; and 4) erythrocytes and degenerate cells were 
associated with the vaginal cytologies of the abortive animals in this study.  
Collectively this information suggests that the presence of erythrocytes on vaginal cytology (with or 
without the presence of degenerate cells) is a sensitive, though nonspecific mans, of identifying animals in the 
menses stage of the active cycle. As such, every vaginal cytology containing erythrocytes is a potential menses stage 
cytology, however other vaginal cytologic parameters must also be assessed and c rt i  donor-animal related 
information must be known before a menses stage diagnosis can be made with any appreciable degree of certainty. 
At a minimum, all menses-like vaginal cytologies (MLVCs) must be evaluated for the presence of macrophages and 
must have their MVs assessed. Donor-related information that is important to he accurate characterization of 
MLVCs includes the age, reproductive history, and menstruation cyclicity-pat erns of the donor as well at the date 
on which the vaginal smears were collected.       
In this study, macrophages were only rarely seen in the menses stag cy ologies but were readily identified 
within most abortive animal cytologies. As such, it is suggested that no MLVC identified to have more than the rare 
macrophage should be diagnosed as menses stage. For MLVCs that are questionable as to whether there are “rare” 
or “low” numbers of macrophages present on the slide, the use of additional vaginal cytology parameters may prove
helpful in differentiating between abortive and menses stage cytologies. Specifically, any MLVCs with poor staining 
characteristics and/or the moderate to high numbers of degenerate cells should not be given a diagnosis of menses 
stage, as data from this study suggest that both of these features are more consist nt with abortive animal vaginal 
cytologies. Finally, this study and a previous study have found that the mean MV of menses stage cytologies is 
lower that the MVs of most abortive cytologies and some anovulatory menstruation cytologies.63 Given this 
information and the findings of the current and previous studies,173, 183 it is suggested that no MLVC with a MV 
greater than 75 should be diagnosed as menses stage.  
While some anovulatory menstruation cytologies can be ruled out as being m nses stage based on their 
high MV values, there have been other anovulatory menstruation cytologies identifie  to have MVs and vaginal 
epithelial cell populations that were similar to those of menses stage animals.63 Given the potential similarities 
between the vaginal cytologies of some menses stage and anovulatory menstruation animals, the use of other 
diagnostic modalities, such as serial hormone analysis, would likely be of benefit in differentiating these two 




every research project. For research situations where the use of additional diagnostic modalities is limited, a 
practical means of minimizing confusion between anovulatory menstruation and the menses stage cytologies is to 
only collect vaginal smears from the animals that are most likely to be undergoing ovulatory menstrual cycles. 
Donor-related information is important to this process in that previous studies have found: 1) between 93 to 97% of 
the vaginal bleeding-events that occur in mature, reproductively-sound, rhesus macaques during the breeding season 
are associated with ovulatory menstrual cycles274, 278; 2) anovulatory cycles occur most frequently in rhesus 
macaques during the inactive phase of the year;63 nd 3) anovulatory cycles are commonly associated with macaques 
that have irregular menstrual cycling patterns or have prolonged intervals between cons cutive menstrual events.63, 
77, 278, 279 Based on these findings, it is proposed that MLVCs can be diagnosed as being menses stage cytologies with 
a high degree of certainty if the vaginal-swabs are obtained from rhesus macaques during the middle third of their 
breeding season and the animals used for these studies meet certain criteria. These criteria include: 1) the study 
animals must be undergoing regular menstruation events (~25-35 days in duration); 2) parous study animals must 
have recently produced offspring; and 3) nulliparous study anim ls must be of an age (~43 months old285) where 
most animals are expected to be undergoing regular ovulatory menstrual cycles.   
Although no erythrocytes were identified in the pregnant animal vaginal cytologies of this study, 
gestational-associated spotting is occasionally identified in pregnant macaques and a previous study has also 
reported erythrocytes to be a feature of some pregnant macaque cytologies.173 Thi  information, in conjunction with 
the finding that the vaginal epithelial cell populations of some pregnant animals in thi study resembled those of 
menses stage animals, makes it plausible that spotting-pregnant animals could be confused with menses stage 
animals if vaginal cytology is used as the sole means of diagnosis. It is therefore suggested that any animal 
producing a MLVC should undergo a thorough physical exam to include the use of diagnostic modalities (e.g., 
ultrasound examination) which can ensure study animals are not pregnant and can also rule out reproductive tract 
disease with a relatively high degree of accuracy.  
The only animal identified to have a reproductive tract disease in this study (polycystic ovaries), had a 
vaginal cytology that was wholly inconsistent with that of the menses stage. A pr vious report of another macaque 
with polycystic ovaries also reported comparable vaginal cytology findings.177 In that no other reproductive tract 
diseases (i.e., leiomyomas, endometriosis, and vaginitis) were identified in this study and there is no literature as to 




ability of vaginal cytology to differentiate menses stage animals from animals affected by reproductive tract disease. 
It therefore remains possible that macaques with hemorrhagic forms of repr ductive tract disease could produce 
vaginal cytologies that are consistent with those of the menses stage. To that, a thorough physical examination is 
suggested to be the likely best method of ruling out reproductive tract disease for ny animals producing MLVCs.       
In summary, this is the first study to provide descriptions of rhesus macaque vaginal cytologies from six 
histologically-defined menstrual cycle stages and three histologically-defined reproductively inactive states. 
Descriptions of vaginal cytologies were also obtained from pregnant animals and abortive animals in this study. 
While all of these descriptions have provided additional information to the field, th escriptions of the 
histologically-defined menstrual cycle stages are proposed to be the most significant for future studies as per the 
accuracy with which each stage was able to be characterized. Comparisons of the current study results to those of 
previous vaginal cytology studies identified the MDQ-staining technique to be capable of producing macaque 
vaginal cytologies that are of equivalent diagnostic utility to those produced using the Pap-, Shorr-, and H&E-
staining techniques. As MDQ-staining requires less processing time than do the other three staining methods, this 
finding is likely to be of benefit to any future vaginal cytology studies where a decreased time of vaginal cytology 
processing is desired or required. In support of the two hypotheses of this study, the menses stage vaginal cytologies 
were found to have characteristics that made them distinct from the vaginal cytologies of: 1) all other stages of the 
active-menstrual cycle; 2) inactive phase animals; 3) pregnant animals; 4) abortive animals; 5) an anovulatory-
menstruation animal; and 6) an animal with reproductive disease. These findings, along with the results of previous 
vaginal cytology studies, were then utilized to formulate a systematic approach by which the menses stage animals 
can be readily distinguished from animals in other reproductive stages/stat . Ultimately, the results of this study 
suggest that the menses stage of the rhesus macaque menstrual cycle can be identified with a relatively high degree 
of accuracy when MDQ vaginal cytology is paired with certain pieces of information regarding medical and 
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Chapter 4: Proliferation, Differentiation, and Radiosensitivity of Mammary Epithelial Cells Derived from 






There is evidence to suggest that many breast cancers may arise as a result of nop astic alterations to the 
mammary stem cells (MSCs) and/or the multipotent (bilineage) progenitor cells (MPCs) that exist within the normal 
mammary gland.71, 74, 133, 146, 158, 160, 209, 260 In efforts to facilitate research into this area of breast carcinogenesis, a cell 
culture technique known as mammosphere culture has been developed. This culture technique is capable of 
obtaining highly enriched populations of MSCs/MPCs from mammary gl nd tissues through the formation of free-
floating, spherical cell colonies (mammospheres).67, 71, 73, 85, 147, 196, 206, 230, 231, 243  
Beyond simply enriching for MSC/MPCs, mammosphere cultures have a number of additional properties 
which make them useful toward other aspects of mammary gland research. First, it has been demonstrated that when 
single-cell isolates are plated at low cell-densities in a mammosphere culture, most ofthe spheres in these cultures 
originate from the clonal proliferation of a single MSC or MPC.22, 71, 85, 147, 230, 243 In turn, mammosphere-forming 
ability has been utilized as a metric by which to estimate the ratio of MSCs/MPCs in mammary gland tissues as well 
as in cell cultures of mammary gland origin.71, 230, 243 Second, mammospheres of a MSC or MPC origin are capable 
of forming in vitro and in vivo bilineage-outgrowths comprised of b th epithelial and myoepithelial components.71, 
206, 230, 243 In this way mammosphere cultures provide another means by which to easily obtain and study the two 
principle cell populations of the mammary gland. Finally, most clonally-derived mammospheres contain only a few 
MSC/MPC-like cells capable of future mammosphere production (referred to here as mammosphere forming units 
(MFU)) while the bulk of the cells that make up these spheres are more phenotypically-restricted mammary gland 
cell types such as lineage-specific (epithelial or myoepithelial) progenitor cells and non-proliferative cells.71, 206, 230, 
243 This cellular arrangement is similar to the hierarchical organization of the normal mammary gland20, 139, 243, 270, 271 
and, therefore, intact mammospheres can potentially serve as an in vitro research model by which to study the 
physical and molecular interactions of the various cell populations comprising the mammary gland.71, 206, 230, 243  
Macaque monkeys have mammary glands that are developmentally, morphologically, and physiologically 
comparable to those of humans.56, 288 Macaques have also been identified to spontaneously develop preneoplastic 
and neoplastic mammary gland lesions that are highly similar to those of humans.291 In that further understanding of 




technique has recently been optimized for use with tissues obtained from the rhesus macaque (Macaca mulatta) 
(Chapter 2). The optimization study found that macaque mammospheres containells with MSC/MPC-like 
properties and also identified these spheres to have morphologic and physiologic characteristics that were 
comparable to mammospheres derived from human breast tissues. 
Exposure to ionizing radiation is an established cause of breast cancer in wome .4, 35, 47, 135, 142, 213, 271 Data 
obtained from the medical establishment and atomic bomb survivors has shown that the lifetime risk of developing 
breast cancer after radiation exposure is inversely correlated with age.4, 35, 47, 135, 142, 257 The population of females 
most frequently reported to be at the greatest risk are those individuals who were exposed to radiation at less than 20 
years of age. Other studies have also found that women who are exposd to radiation and then remain nulliparous, or 
who give birth to their first child late in life, are at greater risk of developing breast cancer than are similarly-
exposed women who undergo a first full term pregnancy at a younger age.32, 35, 141, 172, 213   
These relative-risk findings are of great interest with regard to the possible role of MSCs in radiation-
induced breast cancer. This is because the overall numbers of MSCs in the breast are proposed to decrease with age 
and with each successive pregnancy, as the MSCs undergo terminal differentiation throughout breast maturation.220, 
282 Collectively, the relative-risk data and MSC observations have been interpreted to suggest that the risk of 
radiation-induced breast cancer may be associated with the number of MSCs present within the breast at the time of 
irradiation and/or the duration of time for which MSCs are maintained as undifferentiated cells following irradiation. 
An alternative interpretation of these data, however, is that with age and/or pregnancy the breast may undergo 
biological alterations, even beyond those of MSC-terminal differentiation, that render “matured” MSCs and/or 
MPCs less susceptible to radiation-induced neoplastic change.27, 220        
 Identifying the mechanisms behind the increased sensitivity of young-n lliparous females to radiation-
induced breast cancer could ultimately also lead to insights into breast carcinogenesis as a whole as it is known that 
women who undergo an early-life full-term pregnancy also have a greatly diminished lifetime risk of developing the 
most-common spontaneous forms of non-hereditary breast cancer.6, 27, 65, 130, 140, 172, 220, 270   
Given the similarities in the risk factors for radiation-induced and spontaneous breast cancers, in 
conjunction with the knowledge that MSCs/MPCs are suspected to play a role in breast carcinogenesis, a logical 
first step toward understanding the parity-related risk factors associated with breast cancer is to look for differences 




multiparous females. While ideally this work would be performed using human breast tissues, studies of this nature 
are extremely unlikely as most human tissues are obtained as byproducts of reduction mammoplasties and young-
nulliparous breast tissue is seldom collected.22 Although rodent tissues can be easily collected from any 
demographic of animal, comparative studies using rodent tissues are not ideal in that there are significant 
developmental, physiological, and morphological differences known to exist between he mammary glands of 
humans and rodents.33, 56, 100, 129, 253, 279 Additionally, it is appreciated that the most common, spontaneous and 
radiation-induced forms of mammary gland neoplasia in rodents are derived from ifferent populations of mammary 
gland cells than are most human cancers.30, 33, 100, 181, 255 As such, rodent studies comparing differences in the 
nulliparous and multiparous mammary glands may not fully model the cellular mechanisms behind human breast 
carcinogenesis. Moreover, it has been proposed that data obtained from rodent studi s could even confound our 
understanding of some aspects of the human disease.30, 115, 213 
In light of the aforementioned limitations to human and rodent mammary tissues, an animal model known 
to have mammary glands highly similar to those of humans, the rhesus macaque, was utilized in the current study to 
compare the mammosphere potential between the nulliparous and multiparous m mmary gland. For these 
comparisons, in vivo mammary gland biopsies were collected from seven multiparous and seven young-nulliparous 
animals with the biopsy procedure for each animal synchronized to occur during the menses-stage of the menstrual 
cycle. The synchronization of the biopsy procedure to one particular stage of the menstrual cycle was undertaken 
here as previous macaque work has suggested that the mammosphere potential of he gland may be affected by the 
stage of the menstrual cycle (Chapter 2). Following collection, the tissues were processed as mammosphere cultures 
and then comparisons were made between the proliferative ability, differentiating c pabilities and the 
radiosensitivity of the cells derived from the young-nulliparous and multiparous mammary glands.    
The first major aim of this study was to quantify the number of cells capable of forming mammospheres for 
both the young-nulliparous and multiparous mammary glands. The hypothesis being that the young-nulliparous 
mammary gland would have a greater total number of cells with mammosphere forming ability than would the 
multiparous gland. The second major aim of this study was to compare the proliferative and differentiation 
capabilities of the cells comprising the nulliparous and multiparous mammospheres. The hypothesis being that the 
mammospheres derived from the young-nulliparous mammary gland woul be composed of cells with greater 




major aim of this study was to compare the effects of irradiation on the proliferative and differentiation abilities of 
the cells derived from the nulliparous and multiparous mammospheres. The hypothesis being that the cells derived 
from the nulliparous and multiparous mammospheres would demonstrate significant differences in their proliferative 
and/or differentiation abilities in response to irradiation.  
Materials and Methods 
Animal model.  Study animals were selected from approximately 600 adult and juvenile, Indian-origin 
female rhesus macaques (Macaca mulatta) within a breeding colony at The University of Texas, MD Anderson 
Cancer Center, Keeling Center for Comparative Medicine and Research (KCCMR) in Bastrop, TX. The KCCMR 
colony has been a closed colony since 1983 and has been documented through serological means to be Specific 
Pathogen Free (SPF) for Cercopithecine Herpesvirus 1, Simian Immunodeficiency V rus, Systemic T-lymphotrophic 
Virus and Simian Retroviruses 1, 2, and 5 since 1991. In vivo mam ary gland biopsies were collected from seven 
multiparous and seven nulliparous animals. All subjects were given a physical exam and were identified to be 
clinically healthy and in a nonlactating state prior to their inclusion into the study. All study animals had a Body 
Condition Score (BCS) that ranged between 2.5 and 3.5 out of a maximum score of 5, as determined by the 
consensus of two veterinarians utilizing published BCS parameters for the rhesus macaque.58  The multiparous 
females used for this study were housed in single-male/multi-female (harem) b eeding groups. The nulliparous 
animals used for this study were group-housed exclusively with other females. The husbandry of all animals utilized 
in this study was in full compliance with the recommendations provided in theGuide for the Care and Use of 
Laboratory Animals (ILAR) 182 and the KCCMR is fully accredited by the Association for Assessment and 
Accreditation of Laboratory Animal Care International (AAALACI). All tissue collections for this study were 
reviewed and approved through The University of Texas, MD Anderson Cancer Center Institutional Animal Care 
and Use Committee (IACUC).  
Mammary gland biopsy synchronization and collection. Biopsy collections were begun during the 
approximate midpoint of the breeding season for this colony and each biopsy was collected during the presumed 
menses stage of the menstrual cycle. All study animals had observable vaginal bleeding (interpreted as 
menstruation) occurring at the time of the biopsy procedure and each animal had the mammary biopsy procedure 
performed within 1-3 days of the onset of vaginal bleeding. Twovaginal cytology slides for each study animal were 




morphology was confirmed to be consistent with the menses stage of the menstrual cycle as previously described 
(Chapter 3).   
All of the study animals had also been identified to undergo repeated menstrual cycles at intervals 
consistent with those described of ovulatory menstrual cycles in the rhesus macaque (25-35 days).77, 274 This was 
done in efforts to decrease the possibility of acquiring mammary glandtissues from animals during an anovulatory 
menstrual cycle. The multiparous animals utilized in the study were observed to have had at least one prior episode 
of vaginal bleeding that occurred less than 33 days (range 27-32 days) prior to the date on which the mammary 
gland biopsy was collected. Similarly, the nulliparous animals used in the study were observed to have had at least 
two consecutive episodes of vaginal bleeding separated by less than 35 days (range 28-34 days), prior to the date on 
which the mammary gland biopsy was collected. A physical examination and ultraso nd examination was also 
performed on each study animal to further ensure that no other external or internal causes of vaginal bleeding (e.g., 
trauma, reproductive disease, pregnancy, early-term abortion) were present.  
In vivo mammary gland biopsy collection was performed as previously de cribed (Chapter 2).  In brief, 
each animal was anesthetized and aseptic surgical technique was utilized to collect a mammary gland biopsy from 
the craniolateral quadrant of the left mammary gland. The  biopsy was placed in an ice-cold solution of commercial 
media (Complete Epicult-B Basal Medium [Human]; StemCell Technologies, Vancouver, BC, Canada) 
supplemented with 5% fetal bovine serum (Fetal Bovine Serum-Advantage; Atlanta Biologicals, Flowery Branch, 
GA) and then immediately transferred to the laboratory for processing. Animals were recovered for 3-7 days in the 
veterinary clinic before being returned to their breeding groups.  
Initial processing of mammary gland tissues. All biopsies collected for the study had the initial digestion 
process begun within 30 minutes of collection (Day 0). A general outline of the procedures and work flow from this 
study are provided in Figure 1. A small portion of the biopsy was collected in 10% neutral buffered formalin for 
histologic examination and the remainder of the biopsy was weighed. Biopsies less than 600 mg were processed as a 
single sample while biopsies greater than 600 mg were divided into two similarly-weighted aliquots and processed 
separately. The mammary tissues obtained from each study animal were digested and dissociated into single-cell 
suspensions (Figure 1, A) utilizing optimized protocols and materials identical to those previously described for the 
rhesus macaque (Chapter 2). A standardized ratio of enzymatic solution to tissue weight was utilized to process all 





Figure 1. Schematic illustration of experimental procedures. A) Mammary gland tissue digested into single-cell 
suspension. B) 1 x 104 viable cells/ml plated and grown as spheres for 7 days (1o 10k). C) Resultant 1o 10k spheres 
counted and then plated in basement membrane extract (BME) and grown for 14 days; after 14 days spheres were 
evaluated for budding morphology. D) 1 x 105 viable cells/ml plated and grown as primary spheres for 7 days (1o 
100k). E) Conditioned media-1 collected from the 1o 100k cultures at Day 3 and Day 7. F) 1o 100k spheres 
dissociated back into single-cell suspensions. G) Irradiated and non-irradiated cells plated at 1 x 103 viable cells/ml 
and grown as secondary spheres for 7 days (2o 1k). H) Resultant 2o 1k spheres counted then plated in BME and 
grown for 14 days; after 14 days spheres were evaluated for budding morphology.  I) Irradiated and non-irradiated 
cells plated at 1 x 104 viable cells/ml and grown as secondary mammospheres for 4 days; after which the spheres 
were assessed for viability. J) Irradiated and non-irradiated cells plated at 3 x 103 viable cells/well and grown as 
colonies on collagen-coated plates for 14 days; after which the survival fraction of each well was assessed. K) 
Irradiated and non-irradiated cells plated at 1 x 104 viable cells/ml and grown as secondary spheres for 2 days; after 
which the cells were assayed for senescence.  Additional details for each process/assay are provided in the text. 
  
two separate aliquots, the cells derived from each digestion/dissociation process wer  combined into one vessel prior 
to cell counts or further processing.   
The cells obtained from the digestion/dissociation process were resuspended in a complete mammosphere 
media (CMM). The CMM consisted of a commercially-available cell culture medium (Coplete MammoCult 




hydrocortisone (both StemCell Technologies), penicillin-streptomycin-amphotericin solution (MP Biomedicals, 
Solon, OH) and L-glutamine solution (GlutaMAX; Life Technologies, Carlsbad, CA) as previously described 
(Chapter 2). The cells were confirmed to be present as a single-cell suspension, using techniques as previously 
described.71 Cell viability and cell counts were performed in triplicate for each sample, using the trypan blue 
exclusion assay (0.4% Trypan Blue Solution; Sigma Life Sciences, St. Louis,MO) and a hemocytometer. 
Primary mammospheres and conditioned media-1. On Day 0, the single-cell suspension created from 
mammary gland digestion/dissociation for each of the 14 animals was diluted with CMM to create 1 x 104 viable 
cells/ml (10k) suspensions and 1 x 105 viable cells/ml (100k) suspensions. Five ml aliquots of the 10k suspension 
(Figure 1, B) and 100k suspension (Figure 1, D) were plated into the individual wells of flat-bottom, 6-well 
ultralow-attachment plates (Corning, Corning, NY). A minimum of six wells were prepared for each suspension. 
The edges of the 10k and 100k plates were sealed with paraffin tape (Parafilm M, Fisher Scientific, Waltham, MA) 
and plates were placed in a 37oC, 5% CO2 incubator. At Day 3, the paraffin was removed from all plates and 2 ml of 
fresh CMM was added to the 10k cultures while the 100k cultures had approximately 80% of original media 
replaced with fresh media. The “conditioned media” removed from the 100k cultures was retained for later use as 
described below. The unsealed 10k and 100k plates were replaced in the incubator and llowed to grow undisturbed 
for 4 more days. On Day 7 the bulk of the cultured media was once again collected from the 100k suspensions and 
retained. The cultured media collected from the primary 100k mammospheres on Day 3 and on Day 7 was combined 
and processed into conditioned media-1 (CM1) (Figure 1, E) through centrifugation and filtration as previously 
described (Chapter 2).  
On Day 7, the average number of primary 10k (1o10k) mammospheres (≥ 40 μm in diameter) formed in 
each well was determined for all 14 animals. The mammosphere-forming efficiency (MFE), defined as the average 
number of mammospheres formed in each well divided by the number of viable cells initially plated per well 
(expressed as percentage), was also calculated for each of the suspensions produced. The intact 1o 0k spheres were 
then collected and encased in a standardized 12 mg/ml protein concentration of basement m brane extract 
((BME): BD Matrigel Matrix, High Concentration, Growth Factor Reduced; BD Biosciences, Bedford, MA) (Figure 
1, C) using techniques as previously described (Chapter 2). The BME-encased spheres were submerged in 3 ml of 
RPMI 1640 media (Mediatech, Manassas, VA) supplemented with 5% FBS, 1X L-glutamine Solution and 1X 




mammosphere budding potential (MBP), defined as the percentage of individual mammospheres that underwent 
“budding” differentiation, as previously described (Chapter β), was calculated for each animal (Figure 1,C). 
Mammospheres in direct contact with other spheres or in contact with the bottom of the well were not included in 
these counts. The same previously described parameters (Chapter 2) were also utilized to characterize the 
morphology of each budding sphere as well.      
Also on Day 7, the average diameter of the nulliparous and multiparous mammospheres (≥ 40 μm) in the 
primary 100k (1o100k) mammosphere cultures was determined from representative samples (Olympus IX51 
microscope, DP70 camera and DP Controller software Version 2002, cellSens imaging software Version 1.5, 
Olympus Corporation, Waltham, MA). The 1o100k mammospheres from 12 animals (6 multiparous and 6 
nulliparous) were collected using a 40 μm cell screen (Fisher Scientific) and then dissociated into single-cell 
suspensions (Figure 1, F) over a 20 minute period using 0.05% trypsin-EDTA solution (Life Technologies) and 
techniques as previously described (Chapter 2). Viable cell recovery (VCR), defined as the total number of viable 
cells recovered from the dissociation of a mammosphere culture divided by the number of viable cells originally 
plated for that culture (expressed as percentage), was calculated for the 1o100k mammosphere cultures of each 
animal.   
Irradiation. On Day 7, the single-cell suspensions derived from the dissociation of the 1o100k 
mammospheres were diluted into 10k suspensions using CMM supplemented with CM1 at a 4:1 ratio (CMM/CM1). 
Five ml aliquots of these single-cell suspensions were placed into 15 conical vials. The vials were then either mock-
irradiated (0 Gy) or irradiated with 2 Gy, 4 Gy, 8 Gy or 20 Gy of X-ray radiation using a cabinet X-ray irradiator 
(RS 2000 X-ray Biological irradiator,160 kV at a dose rate of 268 cGy/min; Rad Source Technologies, Inc. 
Suwanee, GA). Irradiation occurred within 1 hour of the time the cells w re initially dissociated.   
Secondary mammospheres. On Day 7, CMM/CM1 was used to dilute a portion of the 0 Gy and 4 Gy 
irradiated, single-cell suspensions into 1 x 103 viable cells/ml (1k) suspensions. Five ml aliquots of each suspension 
were plated into the individual wells of 6-well ultralow-attachment plates (Figure 1, G) for 12 study animals (six 
from each cohort). A minimum of 1 plate (6 wells) was prepared for each radiation dose. The plates were sealed 
with paraffin tape and placed in a 37oC, 5% CO2 incubator. Paraffin was removed from the plates at Day 10 and 
otherwise the cultures were allowed to grow undisturbed for 7 days in the incubator. On Day 14, the average number 




for each animal and then these spheres were then encased in BME, as described above for the 1o10k cultures. The 
BME-encased 2o1k spheres were incubated for an additional 14 days prior to being evaluated for bu ding 
differentiation and budding morphology (Figure 1, H).  
Viability assay. On Day 7, β00 μl aliquots of the 0 Gy, β Gy, 4 Gy, 8 Gy and β0 Gy irradiated, 10k 
suspensions were plated into the individual wells of a flat-bottom, 96-well ultralow-attachment plate (Corning) for 
12 study animals (six from each cohort). For each animal, a minimum of 8 wells were plated with each radiation 
dose. These plates were sealed with paraffin tape and were allowed to grow undisturbe  for 72 hours in a 37oC, 5% 
CO2 incubator. On Day 10, 20 μl of 10X alamarBlue® cell viability reagent (Life Technologies) was added to the 
cell suspensions and the plates were incubated overnight in a 37oC, 5% CO2 incubator. The fluorescence intensity 
(570 nm excitation/585 nm emission) of the individual wells was obtained the following morning using a plate 
reader (Victor3V multilabel counter, PerkinElmer Life and Analytical Sciences, Shelton, CT) (Figure 1, I).    
Clonogenic assay. On Day 7, RPMI/FBS was used to dilute a portion of the 0 Gy, 2 Gy, 4 y, 8 Gy and 20 
Gy irradiated, single-cell suspensions into 1k suspensions. Three ml aliquots of each suspension were plated into the 
individual wells of standard 6-well culture plates (Sigma-Aldrich) for 12 study animals (six from each cohort). Each 
of these plates had been previously coated with a bovine collagen solution (StemCell Technologies) as per the 
manufacturer’s instructions. For each animal, one plate (6 wells) of 0 Gy, two plates of 2 Gy, four plates of 4 Gy, 
eight plates of 8 Gy, and eight plates of 20 Gy irradiated cells were cultured (Figure 1-J). The plates were then 
placed in a 37oC, 5% CO2 incubator for 14 days. The original media was exchanged for fresh mdia on Day 14 and 
the wells were examined for colony growth and differentiation on both Day 17 and Day 21. On Day 21, the cells 
were fixed with a formalin solution and stained with crystal violet stain (Sigma-Aldrich) or immunostained with 
cytokeratin-18 (CK18) or α-smooth muscle actin (SMA) using methods and reagents identical to those previously 
described (Chapter 2). Growths were scored as a colony if an independent group of cells was composed of 50 or 
more cells. The total number of colonies/well was determined for each subject at all radiation doses.  The colony 
forming efficiency (CFE), defined as the total number of colonies/well divided by the number of viable cells initially 
plated/well (expressed as a percentage), was also calculated for each radiation dose. The individual colonies were 
further qualified as being epithelial colonies, myoepithelial colonies, or bilineage colonies (composed of both 
myoepithelial and epithelial cells) using parameters as previously described (Chapter 2). The total number of 




subject at all radiation doses as well. Finally, the colony differentiation-potential (CDP), defined as the number of 
bilineage-colonies/well divided by the total number of colonies/well (expressed as percentage), was also calculated 
for each radiation dose. 
Senescence assay. On Day 7, two 3 ml aliquots of the 0 Gy, 4 Gy, and 8 Gy irradiated 10k suspensions 
were plated into the individual wells of 6-well ultralow-attachment plates for 9 study animals (five multiparous and 
four nulliparous animals). These plates were then sealed with paraffin tape and lace  in a 37oC, 5% CO2 incubator.  
On Day 9, the two wells for each radiation dose were collected into a single coical vial and centrifuged at 80 x g 
for 1 minute. The supernatant was removed and the cells were fixed and stained for -galactosidase expression using 
a staining kit (Senescence -Galactosidase Staining Kit; Cell Signaling Technology, Danvers, MA) as per the 
manufacturer’s instructions. Following an overnight incubation in a γ7oC, 5% CO2 incubator, the cells and solution 
were placed into a dual-chambered, cytospin apparatus (Double cytology funnel,Fischer Scientific) and centrifuged 
at 200 x g for 8 minutes. Individual cells and cells that were part of 2-cell clusters and 3-cell clusters were then 
scored for the presence (senescence) or absence of blue dye within the cell cytoplasm (Figure 1-K). No clusters of 4 
or more cells were evaluated in this process. Two cytospin preparations were acquired for each animal at each 
radiation dose. Both preparations were each reviewed independently by two oarded veterinary pathologists. The 
percentage of senescent cells reported for each cytospin preparation was the average of the two pathologists’ scores.  
Cytokine analysis of conditioned media-1. Conditioned media-1 was collected from five nulliparous and 
five multiparous animals and was frozen at -80oC.  On the day of the assay, the CM1 was thawed and vortexed. The 
concentration of the cytokines GM-CSF, IFN ,IL-1 , IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p40), MIP-1α, 
MIP-1  and TNFα were assessed using a cytokine assay kit (Nonhuman Primate Cytokine kit; Millipore Corp., 
Billerica, MA). The assay was run overnight according to the manufacturer’s instructions and analyzed using the 
Luminex 200 system (Bio-Rad Corp., Hercules, CA). Acquisition gates were set at 8,000–15,000. Sample volume 
was β5 μl and all samples were run in duplicate. Manufacturer supplied cytokine standards were run on each plate 
and 50 events per bead were acquired. Mean fluorescence intensity was analyzed using the BioPlex manager 
software version 5.0 (Bio-Rad Corp.) and concentration values were generat d using a standard curve. The 
minimum detectable concentrations in pg/ml for each cytokine was as follows: IFN , TNFα and IL-8 (0.1); IL-8 
(0.2); IL-2, IL-6 and IL-10 (0.3); IL-1 and IL-13 (0.4); IL-8 (1.8); MIP-1α (γ.5); MIP1  (4.5); and IL-12p40 




Statistical analysis. Significant results are expressed as mean and standard deviation. Statistical 
significance for all data was set at P<0.05 unless otherwise indicated. Direct comparisons of differences between 
multiparous and nulliparous parameters were performed using a one-way ANOVA. Comparisons within the 
individual cohorts and across different radiation doses were performed using a repeated-measures ANOVA. All 
statistical tests were performed using IBM SPSS (version 22) software.   
Results 
Mammary gland biopsies. All 14 biopsies were identified to consist of grossly and microscopically 
normal-appearing nonlactating mammary gland tissue. The multiparous biopsies were thicker than the nulliparous 
biopsies and this difference was subjectively identified to be the result of increased amounts of adipose, fibrous 
connective tissue and interlobular stroma within the multiparous glands. The morphological differences identified 
between the two cohorts in this study were similar to what has been pr viously described (Chapter 2). Due in large 
part to the heterogeneous nature of the glandular tissue distribution in the mul iparous macaque mammary gland 
(Chapter 2), the biopsy weights often varied greatly between the multiparous subjects (Table 1).  Despite the 
variation, the weight of the average multiparous biopsy (725.8 mg ± 259.7) was statistically greater than that of 
nulliparous animals (456.3 mg ± 75.4). No correlation was identified between the biopsy weights and any of the 
metrics utilized to assess the mammosphere proliferation/differentiation potential (MFE, MBP, VCR, CFE and 
bCFE) for either cohort.       
The body weight of each study animal was used to extrapolate an “approximate-whole mammary gland 
weight” for one gland in each animal (~Mam wt (mg); Table 1). This calculation was based on data previously 
obtained from the same breeding colony which identified the mean weights of t e individual mammary glands in 
nulliparous and nonlactating-multiparous rhesus macaques to be 0.069 percentage of total body weight (%TBW) and 
0.093 %TBW, respectively (Chapter 2). Utilizing this measurement, the average biopsy weight of the nulliparous 
animals was found to represent a slightly greater, though nonsignificant, percentage of the approximate-total 
mammary gland weight for these animals (14.8%) as compared to the average biopsy weight of the multiparous 
animals (12.3%).   
The time required for the biopsies to obtain the optimal digestion point in the itial digestion step of the 
process varied by subject. Nulliparous digestion times ranged from 3.33 to 3.67 hours and multiparous digestion 




Table 1. Macaque, mammary biopsy and initial-digestion data for parity cohorts. Animal #: order in which the 
animals were processed for the study. Parity (reproductive status): M=multiparous; N=nulliparous. Infants: number 
of live births recorded for each animal. Age (yr): age of the animal (in years). Body wt (kg): total body weight of the 
animal in kg. ~Mam wt (mg): approximate weight of one whole mammary gland (in mg) for each animal based on 
calculations as described in the text. Biop wt (mg): weight of the biopsy (in mg) collected for each animal. Asterisk 
(*) denotes that sample was divided into two similarly-weighted aliquots and processed separately through the initial 
digestion and dissociation steps. % Gland: weight percentage of the biopsy as compared to the approximate weight 
of one whole mammary gland.  Fibrous (qualitative amount of fibrous connective tissue within the mammary biopsy 
as determined histologically): 0=minimal; 1=mild; 2= moderate. Digest time (h): time in hours required for the 
initial enzymatic digestion of the biopsy sample to obtain the “optimal digestion point”, as described in Chapter β. 
TVC (Total Viable Cell count): number of viable cells/mg of mammary tissue identified in the single-cell digests. 
%VC (Percentage of Viable Cells): percentage of viable cells to nonviable cells identified in th  si gle-cell digests.     
 
 
significantly, longer for multiparous biopsies (3.81 ± 0.32 hours) as compared to nulliparous biopsies (3.52 ± 0.18 
hours). When the data from both cohorts were analyzed collectively, increased digestion times were significantly 
correlated with greater amounts of fibrous tissue, increased age, and increased number of infants (Table 1). There 
was no correlation identified between digestion time and biopsy weight, or between digestion time and any of the 
metrics utilized to assess the mammosphere proliferation/differentiation potential for either cohort.       
The total number of viable cells/mg of tissue (TVC) obtained from the digestion and dissociation of the 
nulliparous mammary gland biopsies (17,155 ± 3060) was statistically greater than the TVC of the multiparous 
glands (12,805 ± 3257). The percentage of viable cells to nonviable cells (%VC) that was initially obtained from the 
tissue digests was similar between the two cohorts with nulliparous %VC ranging between 88.6 and 96.5% (mean 
91.4%) and multiparous %VC ranging between 84.4 and 95.1% (mean 90.8%). There was no correlation identified 
for the TVC or %VC values for either cohort with regard to time of digestion, degree of biopsy fibrosis, or weight of 
the biopsy sample (Table 1). Notably, the three large multiparous biopies that had to be processed as two similarly-
Animal # Parity Age (yr) Infants Body wt (kg) ~Mam wt (mg) Biop wt (mg) % Gland Fibrous Digest time (h) TVC %VC
1 M 6.58 2 5.41 5030 1222* 24.2 1 3.67 9625 90.2
2 M 7.58 2 5.96 5540 487 8.7 0 3.33 16,428 95.1
3 M 13.67 9 8.31 7730 525 6.8 1 3.67 8788 84.4
4 M 11.58 6 6.01 5580 788* 14.1 2 4 15,291 93.7
5 M 20.83 13 6.39 5940 588 9.9 2 4.33 12,755 94
6 M 13.92 9 8.04 7470 873* 11.7 1 3.67 10,423 86.2
7 N 3.83 0 4.65 3210 348 10.8 1 3.67 13,948 88.6
8 N 3.67 0 3.64 2510 427 17 1 3.33 14,066 90.3
9 N 3.83 0 4.44 3060 480 15.7 0 3.33 19,062 96.5
10 N 3.83 0 4.08 2810 447 15.9 1 3.67 16,051 89.7
11 N 4.75 0 4.91 3390 567 16.7 2 3.67 21,146 92.1
12 N 3.83 0 5.37 3700 397 10.7 1 3.33 20,592 92.3
13 M 14.00 9 5.83 5420 598 11 2 4 16,327 92.2




weighted aliquots had TVCs and %VCs that fell inside the range of the other four multiparous animals that were 
processed as a single aliquot.    
Primary mammospheres. Nulliparous animals produced statistically greater numbers of 1o10k 
spheres/well (270.6 ± 78.8 [mean 1o MFE =0.541%]) than did multiparous animals (8.7 ± 3.8 [mean 1o MFE 
=0.017%]). Nulliparous animals also had a statistically higher MBP of the 1o10k spheres (1o MBP =65.7 ± 5.3%) as 
compared the multiparous animals (1o MBP =49.6 ± 10.3%). The morphology of the 1o budding spheres in this 
study was similar to those previously described for non-pregnant female macaques (Chapter 2) and there was no 
variation in the morphological growth patterns of the spheres identified between the two cohorts.   
The average diameter of the nulliparous 1o100k mammospheres (60.7 ± β0.β μm; range 40-1ββ μm [n 
=354]) and multiparous 1o 00k mammospheres (54.7 ± 18.5 μm; range 40-148 μm [n =βγ1]) were not statistically 
different from one another. Although the confluent nature of the 1o100k mammosphere cultures prevented accurate 
quantification of the spheres, the nulliparous 1o100k cultures were subjectively more-densely populated when 
observed under the microscope. This observation was supported by the finding that the VCR of the nulliparous 
1o100k mammospheres (31.3 ± 4.0%) was statistically greater than the VCR of the multiparous 1o100k spheres (16.4 
± 1.0%).   
Secondary mammospheres. As presented in Figure 2,A, the nulliparous animals produced statistically 
greater numbers of 2o1k spheres/well than did the multiparous animals at both the 0 Gy (nulliparous (N) =68.2 ± 
24.0 [mean 2o MFE =1.36%]; multiparous (M) =17.8 ± 3.1 [mean 2o MFE =0.36%]) and 4 Gy (N =40.0 ± 10.6 
[mean 2o MFE =0.80%]; M =11.0 ± 1.8 [mean 2o MFE =0.22%]) radiation doses. The average number of 2o1k
spheres/well in the 0 Gy radiation-dose cultures was statistically higher than those of the 4 Gy radiation-dose 
cultures for both nulliparous and multiparous animals. However, there was no statistically significant interaction 
identified between the radiation dose and cohort, indicating that the nulliparous and multiparous animals both had 
similar rates of change (similar slopes) between the 0 Gy and 4 Gy radiation oses.   
As presented in Figure 2,B, there were no statistically significant differences between the nulliparous and 
multiparous animals with regard to the MBP of 2o1k spheres (2o MBP) at either the 0 Gy (N =45.3 ± 7.5%; M =36.6 
± 11.3%) or 4 Gy (N =35.9 ± 9.9%; M =31.2 ± 4.5%) radiation doses. There was a significant decrease in the 2o 
MBP between the 0 Gy and 4 Gy radiation doses for both nulliparous and multiparous animals, although as before, 





Figure 2. Secondary 1k (2o1k) nulliparous mammospheres have significantly greater MFE, but not MBP, than do 
2o1k multiparous mammospheres at 0 Gy and 4 Gy. A, Numbers of 2o1k mammospheres produced by the 
multiparous and nulliparous single-cell suspensions exposed to 0 Gy and 4 Gy irradiation. The x-axis represents the 
multiparous and nulliparous mammosphere cultures that were derived from single-cell suspensions exposed to 0 Gy 
and 4 Gy irradiation.  The y-axis represents the number of mammosphere  formed/well for six multiparous and six 
nulliparous animals. The mammospheres derived from these experiments were then utilized for the experiments 
described in Figure 2,B.   B, Percentage of the basement membrane extract (BME)-encased 2o1k mammospheres 
that underwent “budding” differentiation for multiparous and nulliparous animals.  The x-axis represents the 
multiparous and nulliparous, 0 Gy and 4 Gy mammospheres obtained from the Figure 2,A experiments that were 
encased in BME.  The y-axis is the percentage of the BME-encased sphere  identified to have undergone budding 
differentiation after 14 days in culture for six multiparous and six nulliparous animals.  
 
subjects. The budding morphology of the 2o spheres was similar to those previously described for non-pregnant 
female macaques (Chapter 2) and no variation in the morphological growth patterns of the spheres was identified 
between the two cohorts or between the 0 Gy and 4 Gy radiation doses for either cohort. 
Viability assay. Figure 3 shows the results of the cell viability assay for the nulliparous and multiparous 
cells plated under conditions that promoted mammosphere formation. The curves were based on the percentage of 
fluorescence absorbance of the samples within the wells. An increase in absorbance for this assay is correlated with 
greater numbers of viable cells. The 0 Gy culture wells for each subject was normalized to 100% absorbance and 
then the percentage absorbance for the 2 Gy, 4 Gy, 8 Gy, and 20 Gy mammospheres culture wells was calculated 
based on the values obtained for the 0 Gy samples. Both cohorts demonstrated a significant decrease in the 




there were no statistically significant differences in percentage absorbance identifie  between the nulliparous and 
multiparous animals for any radiation dose and the slopes of the two curves were imilar. 
 
                                                 
Figure 3. Nulliparous and multiparous mammosphere-derived cells have similar radiation survival curves when 
grown under mammosphere forming conditions. Radiation response curves of single-cell suspensions exposed to 
increasing doses of radiation and then plated under conditions that promoted the formation of mammospheres. The 
x-axis represents the multiparous and nulliparous mammosphere cultures derived from single-cell suspensions 
exposed to 0 Gy, 2 Gy, 4 Gy, 8 Gy, and 20 Gy irradiation.  The y-axis represents the percentage of viable cells 
present at each radiation dose for six multiparous and six nulliparous animals. The percentage of viable cells for this 
assay was based on the average fluorescence absorbance of the samples at each radiation dose s compared to the 0 
Gy dose of radiation which was normalized to represent 100% cell viability. Error bars epresent ± one standard 
deviation.   
 
Clonogenic assay.  Culture viability for this assay was confirmed by the observation that there was a 
general increase of the colony sizes in the 0 Gy, 2 Gy, 4 Gy, and 8 Gy cultures for subjects between the tenth and 
fourteenth day of the plating process. Figure 4 shows survival curves for the nulliparous and multiparous cells plated 
under conditions that promoted the formation of adherent cell colonies. For the t tal colony survival curves (Figure 
4,A), the total number of colonies/well present at the 0 Gy dose of radiation for each subject was designated to be 
100%. The total-colony survival fraction, defined as the total number of colonies/well for a particular radiation dose 
divided by the total number of colonies/well at the 0 Gy dose (expressed as a percentage), was calculated for each 




radiation survival curves and both the nulliparous and multiparous animals demonstrated a statistically significant 
decrease in the total number of colonies/well with each increasing radiation dose. There were, however, no statistical 
differences identified between the nulliparous and multiparous total-colony survival fractions at any radiation dose 
and the slopes of the two curves were similar.   
For the bilineage colony survival curves (Figure 4,B), the number of bilineage-colonies/well present at the 
0 Gy dose of radiation for each subject was designated to be 100% and the survival fraction of bilineage-colonies 
was then calculated at each radiation doses, as above, for each subject. Similar to the total-colony survival fraction 
results, there were no significant differences identified between the nulliparous and multiparous bilineage-colony 
survival fractions at any radiation dose and both cohorts demonstrated a statistically significant decrease in the 
number of bilineage colonies/well with each increasing radiation dose betwen 2 Gy and 20 Gy. Unlike the total-  
 
 
Figure 4. Nulliparous and multiparous mammosphere-derived cells have similar radiation survival curves when 
grown under conditions that form adherent colonies. Radiation response curves of single-cell suspensions exposed to 
increasing doses of radiation and then plated under conditions that promoted the formation of adherent colonies. For 
both graphs, the x-axis represents the multiparous and nulliparous cell cultures derived from single-cell suspensions 
exposed to 0 Gy, 2 Gy, 4 Gy, 8 Gy, and 20 Gy irradiation. A, the y-axis represents the total number of cell 
colonies/well present at each radiation dose divided by the total number of cell colonies/well at the 0 Gy dose of 
radiation (total-colony survival fraction). B, the y-axis represents the number of bilineage-cell colonies/well present 
at each radiation dose divided by the number of bilineage-cell colonies/well at the 0 Gy dose of radiation (bilineage-
colony survival fraction).  Both graphs are expressed as a logarithmic function of radiation dose. Error bars for both 




colony survival fraction results, the numbers of bilineage colonies at the 2 Gy radiation dose were slightly elevated, 
although statistically equivalent, to those of the 0 Gy radiation dose for both cohorts.   
Although the total-colony survival curves were similar between the cohorts, the mean CFE for the 
nulliparous animals (0 Gy =5.1%; 2 Gy =2.80%; 4 Gy =0.51%; 8 Gy =0.069%; and 20 Gy =0%) was statistically 
greater than the mean CFE of multiparous animals (0 Gy =2.0%; 2 Gy =1.12%; 4 Gy =0.20%; 8 Gy =0.012%; and 
20 Gy =0%) at all radiation doses other than 20 Gy. Likewise, the mean bCFE for the nulliparous animals (0 Gy 
=0.45%; 2 Gy =0.47%; 4 Gy =0.13%; 8 Gy =0.047%; and 20 Gy =0%) was statistically greater than the mean bCFE 
of multiparous animals (0 Gy =0.28%; 2 Gy =0.28%; 4 Gy =0.06%; 8 Gy =0.009%; and 20 Gy =0%) at all radiation 
doses other than 20 Gy.   
The percentage of colonies/well with bilineage potential, the CDP, was identified to vary with radiation 
dose and also by cohort (Table β; “% Bilineage (CDP)”). Specifically, the CDP was statistically greater with each 
increasing radiation dose within each cohort and there were statically significant differences in the CDP identified 
between the multiparous and nulliparous cohorts at the 0 Gy, 2 Gy, and 8 Gy radiation doses. Additionally, the rate  
Table 2.  The ratio of bilineage colonies varies significantly with increasing doses of radiation within each cohort 
and also between the multiparous and nulliparous cohorts.  Do e: radiation dose used for each clonogenic assay 
plate. Parity: M =multiparous; N =nulliparous. % Myoepithelial: percentage of total colonies/well identified to be 
composed of only myoepithelial-like cells. % Epithelial: percentage of total colonies/well identified to be composed 
of only epithelial-like cells. % Bilineage (CDP): percentage of total colonies/well identified to be composed of both 
myoepithelial-like and epithelial-like regions (the CDP). The numbers in the three previous columns represent the 
mean percentage of colonies ± one standard deviation. Superscript “a” (a) indicates a statistically significant 
difference in the CDP within the same cohort between radiation doses. Superscript “b” (b) indicates a statistically 
significant difference in the CDP between cohorts at the same radiation dose. NCDP/MCDP: the mean nulliparous 
CDP value (NCDP) of one particular radiation dose divided by the mean multiparous CDP value (MCDP) of the 
same radiation dose, expressed as a percentage. NA =not applicable.   
 
Dose Parity % Myoepithelial % Epithelial % Bilineage (CDP) NCDP/MCDP
0 Gy M 84.7 ± 3.1 1.3 ± 0.7 14.0 ± 3.4
a,b 
NA
0 Gy N 90.4 ± 2.5 1.0 ± 1.0 8.6 ± 2.2
a,b 
61.43
2 Gy M 73.3 ± 4.1 2.0 ± 1.3 24.7 ± 3.2
a,b
NA
2 Gy N 81.5 ± 2.3 1.9 ± 1.2 16.6 ± 1.7
a,b
67.21
4 Gy M 67.2 ± 4.4 2.5 ± 1.0 30.3 ± 4.5
a
NA
4 Gy N 71.1 ± 4.3 2.6 ± 1.0 26.3 ± 3.7
a
86.80
8 Gy M 35.4 ± 6.0 3.0 ± 2.5 61.6 ± 7.7
a,b
NA






(slope) of increase for the nulliparous CDP was identified to be statistically greater than that of the multiparous CDP 
between the 2 Gy and 4 Gy radiation doses as well as between the 4 Gy and 8 Gy radiation doses (Figure 5). 
Consistent with this last finding is the observation that although the multiparous CDP was greater than the 
nulliparous CDP at the 0 Gy, 2 Gy, and 4 Gy radiation doses, the mean CDPs of the cohorts become more similar in 
value with each increasing radiation dose, until, at the 8 Gy radiation dose the mean nulliparous CDP exceeded that 
of the mean multiparous CDP (Table β; “NCDP/MCDP” and Figure 5).  
 
Figure 5.  The slope of the nulliparous CDP curve is greater than the slope of the multiparous CDP curve between 2 
Gy and 8 Gy irradiation. The x-axis represents the multiparous and nulliparous cell cultures derived from single-cell 
suspensions exposed to 0 Gy, 2 Gy, 4 Gy, and 8 Gy irradiation and the  plated under conditions that promoted the 
formation of adherent colonies. The y-axis is the percentage of bilineage colonies present within each well for each 
cohort. The values on the y-axis correspond to the “% Bilineage (CDP)” in Table β.      
 
Senescence assay. A minimum of 1γβ cells per subject were evaluated for -galactosidase expression at 
each radiation dose although for most subjects there were enough cells present on th  slides to allow each radiation 
dose to be evaluated using a total 400 cells (200 cells per each cytospin preparation). As illustrated in Figure 6, the 




animals at the 0 Gy, 4 Gy, and 8 Gy radiation doses. There were, however, no statistically significant differences in 
the percentage of senescent cells between any of the radiation doses for either cohort. 
 
Figure 6.  The mammosphere-derived cells of multiparous animals contain greater ratios of senescent cells than do 
the mammosphere-derived cells of nulliparous animals, regardless of radiation dose. The x-axis represents the 
multiparous and nulliparous mammosphere cultures derived from single-cell suspensions exposed to 0 Gy, 4 Gy, 
and 8 Gy irradiation.  The y-axis is the percentage of cells that stained positive for -galactosidase expression, two 
days post-irradiation. 
 
Cytokine assay. Of the 14 cytokines evaluated in this study only interleukin-6 (IL-6) and interleukin-8 (IL-
8) were identified to be present in the CM1 in concentrations adequate for analysis. The concentrations of both IL-6  
and IL-8 were statistically higher in the multiparous CM1 (IL-6 =12.1 ± 2.8 pg/ml; IL-8 =233.8 ± 49.4 pg/ml) as 
compared to the nulliparous CM1 (IL-6 =7.8 ± 2.1 pg/ml; IL-8 =142.0 ± 33.4 pg/ml).     
Discussion 
This work compares the proliferative and differentiation potential of the cell populations w thin the 
mammary glands of young-nulliparous and multiparous primates. Mammosphere culture methodologies were 
utilized for this study as mammosphere forming ability has been correlated with the MSC and/or MPC composition 
of mammary glands in humans and rodents71, 230, 243 and the MSCs/MPCs are of particular interest due to their 




this study were identified to have both mammosphere-forming and bili eage-colony forming potential. It is therefore 
considered likely that the macaque mammosphere cultures are enriched for MSCs or, at the very least, MPCs. 
However, in that no xenotransplantation or FACS-based studies have yet been completed by which to estimate the 
percentage of macaque mammospheres that are of a MSC and/or MPC origin, the ndividual cells capable of 
mammosphere formation and/or bilineage-colony formation in this study have been intentionally referred to using 
the more generic term of “mammosphere forming units” or “MFUs”.  
The results of a previous research project suggested that mammary glands of young-nulliparous rhesu 
macaques have greater numbers of MFUs, and that the mammospheres derived from these MFUs have greater 
mammosphere potential (proliferation and differentiation capabilities), than do those of nonlactating-multiparous 
macaques (Chapter 2). However, it is notable that most of the mammary glands used in that project were 
opportunistically collected from animals euthanized due to illness, trauma, or as part of unrelated research projects, 
and it is possible that the conclusions of that project could have been confounded by factors related to the cause of 
death in these animals. Furthermore, in that the tissue collection process of that initial project occurred over a time 
span of several years, it is also possible that the results of that project could have been influenced by slight variations 
in tissue processing techniques that unknowingly occurred between the individual samples. The current research 
study was undertaken to reexamine the mammosphere potential between nulliparous and multiparous cohorts using 
a study design aimed at reducing the number of potential confounding variables. Specifically, the current project 
utilized a synchronized, in vivo biopsy procedure to collect tissue samples for the mammosphere assays. This 
approach allowed for the acquisition of mammary gland tissues from clinically healthy monkeys rather than relying 
on tissues derived from animals that were euthanized for health or research-r l ted reasons. This study design also 
allowed for the acquisition of mammary gland tissue over a relatively short period of time (six weeks) which was 
thought to likely improve the between-subject consistency with regard to the techniques and enzymatic solutions 
utilized to process the individual samples. Finally, this approach allowed for the collection of mammary gland 
tissues from a defined stage (menses stage) of the menstrual cycle.  
While the current study design minimized many of the potential variables that may have confounded results 
in the earlier project, there were still some limitations associated with this biopsy c llection process that merit 
discussion. The first limitation is that, per the study design, it was not possible to randomize the subjects included in 




reproductively cycling at the time of the collection process. As such, animals that had not yet begun to cycle 
regularly or multiparous animals that were already pregnant by the middle of the breeding season were excluded 
from the study. In essence, this study design selected against animals that tended to cycle either early or late in the 
breeding season. Randomization of subjects was further skewed in that most of the multiparous biopsies were 
collected earlier in the study than nulliparous biopsies in efforts to ensure that there would be enough regularly-
cycling multiparous subjects available for inclusion in the study. This was deemed necessary as the multiparous 
females, unlike the nulliparous animals, were housed with breeding males and with each passing week greater 
numbers of these animals became pregnant. Six of the seven multiparous biopsies were therefore obtained during the 
first two weeks of the biopsy collection process while six of the sevn nulliparous animals were collected between 
the third and fifth weeks of the collection process. While it is possible that differences in the timing of the biopsy 
procedures over the 6-week collection period could have influenced the mammosphere potential between individual 
animals, this was considered unlikely given that the biopsy collection process occurred at approximately the 
midpoint of the typical 24-week breeding season for this colony. Supportive of the proposition that there was 
minimal variation in the mammosphere potential of the colony subjects over the 6-week collection period is the 
finding that the one multiparous biopsy (Animal #13) and the one nulliparous biopsy (Animal #14) that were 
collected during the sixth week of the study had cell-isolation values (e.g., %VC and VCR) and mammosphere 
potential values (e.g., MFE and MBP) that were comparable to those of the other animals in their respective cohorts.  
A second limitation related to the current study-design is that, although efforts were made to collect 
biopsies only from animals in the menses stage of an ovulatory menstrual cycle, it is possible that some incidences 
of vaginal bleeding could have been menses associated with anovulatory cycles.63, 77, 165, 173, 274 This possibility is 
important in that animals undergoing anovulatory menstrual cycles often have sex hormone levels that are markedly 
different from animals undergoing an ovulatory cycle.63, 202, 244, 274, 278, 279 In that differences in sex hormone levels 
have been associated with variations in mammary gland physiology and morphology,50, 244 it is possible that some of 
the outlying data obtained from these studies could have resulted from the use of tissues collected from animals 
experiencing an anovulatory cycle. Although the ovulatory status of individual menstrual cycles in macaques can be 
confirmed by analyzing the blood sex-hormone concentrations of individual animals 2-3 times per week over several 
months duration,202, 274, 278 this approach was not attempted here. This is because over 600 animals were considered 




draws required for sex-hormone monitoring. Additionally, the routine removal of female animals from their 
breeding groups for multiple blood draws/week was undesirable as stresses as ociated with this process is likely to 
have decreased the fecundity rate of the breeding colony as a whole.3, 94, 148, 188, 202, 274, 279   
Anovulatory cycles do occur in macaques but have been reported to represent only between 3-8% of all 
menstrual cycles occurring during the breeding season in reproductively-sound, actively-cycling females that are 
housed under conditions similar to those of the KCCMR.274, 278 As to the question of reproductive soundness, all of 
the multiparous females included in the study had delivered a live infant in the breeding season prior to the onset of 
this project; and all of the nulliparous animals included in the study were of an age at which ovulatory menstrual 
cycles are expected to be occurring in the vast majority of individuals housed under conditions similar to those of 
the KCCMR.285 The reproductive soundness of most animals was likewise confirmed by a follow-up analysis which 
found that all of the study animals that remained part of the breeding colony (10 animals total; three multiparous and 
one nulliparous study animals were sold prior to this analysis) produced offspring during the breeding season 
immediately following this project. Based on this information, in addition to the information collected on each 
subject as to their cycling status and vaginal cytology, it is considered likely that most of the animals included in this 
study were undergoing ovulatory menstrual cycles at the time of mammary gland collection.   
In the current study, the mean biopsy weight of the multiparous animals was found to be significantly 
greater than those of the young-nulliparous animals. While the usefulness of biopsy weight as a sole metric by which 
to compare the mammary glands between the two cohorts is questionable, the individual biopsy weights were 
essential measurements toward calculating the TVC for each mammary biopsy. C n istent with previous 
comparisons made using mammary tissues from luteal/follicular-stage macaques (Chapter 2), the TVC of the 
nulliparous glands in this study were significantly greater than those of the multiparous glands. These results, in 
conjunction with the histological observations of the biopsies, suggest that the nulliparous mammary biopsies in this 
study contained larger ratios of glandular cells to stromal elements than did the multiparous mammary biopsies.         
The current study also identified a statistically higher 1o MFE in young-nulliparous subjects as compared to 
multiparous subjects; a finding that is once again similar to those of pr vious experiments (Chapter 2). Additionally, 
the young-nulliparous subjects were identified to have a statistically higher 1o 100k VCR than multiparous subjects. 
Collectively, the 1o MFE and VCR data suggest that the nulliparous biopsies have greater ratios of the glandular 




Possible limitations with regard to the accuracy of the 1o MFE data of this study warrant discussion at this 
time. The 1o MFE calculations for this study were based on mammosphere cultures plated at 10k, r her than 1k, cell 
densities. This is important in that while most mammospheres derived from rodent and human cell cultures plated at 
1k densities (or lower) originate from the clonal proliferation of a single MSC and/or MPC,22, 71, 85 there is little 
information as to frequency of clonal sphere formation in mammosphere cultures plated at higher (i.e., 10k) 
densities. As such, it is possible that some of the spheres produced within 10k cultures may not have been true 
mammospheres but rather “aggregate spheres”. Aggregate spheres being defined here as spheres derived from the 
aggregation and subsequent proliferation of two or more lineage-specific progenitor cells and/or more-differentiated 
cell types rather than being spheres formed through the proliferation of a single MSC or MPC alone. The presence 
of aggregate spheres is a potential study confounder in that if aggregate spheres repr s nt a substantial percentage of 
the spheres in a mammosphere culture this can lead to an overestimation of the MSC/MPC populations within the 
single-cell isolates being evaluated. In previous macaque studies (Chapter 2), and in experiments performed using 
four representative animals from the current study, the mean 1o MFE of 10k primary cultures was identified to be 
higher than those of 1k primary cultures by around 10.0% and 11.3%, respectively. In turn, it is possible that 
presence of aggregate spheres in the 10k cultures may have led to overestimation of the MFE in this study. 
However, what must also be appreciated is that the use of 1k density mammosphere cultures toward MFE 
calculations has been found to be problematic for primary mammosphere cultus derived from multiparous 
macaque glands in an earlier project (Chapter 2). As previously reported, the primary 1k cultures from multiparous 
macaque glands produced extremely low numbers of small, poorly-differentiating mammospheres which 
confounded attempts to accurately quantify the MFE or budding potential of hese cultures. Equally important is that 
this same project also found that the 1k cultures may actually underestimate he true MFE of the multiparous 
mammary gland by as much as 8% if the 1k cultures are not provided with growth factors (CM1) obtained from 
other mammosphere cultures. When the above observations as to the possible MFE-overestimations of 10k cultures 
and the possible MFE-underestimations of 1k cultures are considered in tandem, it appears likely that 10k 
mammosphere cultures provide estimates of the true 1o MFE of cell isolates to within 3-11% of their actual values.   
In spite of the imperfect nature of the 10k mammosphere assay to quantify the 1o MFE, it is proposed that 
the study data above still supports the conclusion that the mammary glands of young-nulliparous menstruating 




menstruating macaques as per the marked differences in the mean 1o MFEs between the two cohorts. Additionally, 
the 1o MFE results are supported by similar findings of a second metric, the VCR, which also was used to assess the 
primary mammosphere potential of the biopsies. Future research studies, utilizing other types of assays aimed at 
quantifying the 1o MFE, are likely to prove useful toward further refinement of the 1oMFE estimates in individual 
macaque mammary glands.    
The number of cells with mammosphere forming ability (CMFA) within each biopsy can be estimated 
using the TVC, 1o MFE, and the biopsy weight obtained from the individual subjects. As per these estimates, the 
mean CMFA of the young-nulliparous biopsies (41.2 x 103 cells) is approximately 24 times greater than that of the 
multiparous biopsies (1.7 x 103 cells). However, the relevance of the biopsy-CMFA as a metric for comparison 
between the cohorts is uncertain as the mean biopsy weight of the nulliparous animals represented a slightly greater 
percentage of the mean approximate-total mammary gland weight as compared to the biopsy weights of multiparous 
animals. In attempts to account for any discrepancies in the representative nature of the bi psy-CMFA, a whole-
gland CMFA for each animal can be extrapolated using the TVC, 1o MFE, and the approximate-whole mammary 
gland weight for each subject. As per these calculations, the mean CMFA of the young-nulliparous glands (29.3 x 
104 ± 11.5 x 104  cells) is approximately 23 times greater than the mean CMFA of the multiparous glands (1.28 x 104 
± 0.33 x 104 cells) for the study subjects. Collectively, the results of the biopsy-CMFA and whole-gland CMFA 
analyses suggest that the mammary glands of young-nulliparous animals have tatistically greater numbers of cells 
with mammosphere forming ability than do multiparous animals.   
In that the biopsy-CMFA and whole-gland CMFA data were both calculated using the 1o MFE for each 
animal, there are inherent limitations to the accuracy of these results, as previously discussed. In addition to this first 
limitation, however, it must also be appreciated that the whole-gland CMFA data was extrapolated using an 
approximate mammary gland weight for each animal and that the whole-gland CMFA was also calculated with the 
assumption that the 1oMFE was equivalent throughout the entire gland. In defense of using an approximate 
mammary gland weight to determine the whole-gland CMFA for this study is that: the mammary gland %TBW 
calculation used in this study was derived from data collected from animals originating from the same breeding 
colony; the variation in the mammary gland %TBW for each cohort was minimal (one standard deviation 
representing less than 6.5% of the value of the mean %TBW for either of th two cohorts); and the %TBW was 




support of the assumption that the 1o MFE is equivalent throughout the entire gland, is the fact that previous 
experiments found no significant differences in the 1o MFE of breast biopsies obtained from different quadrants of 
the mammary gland that were collected from actively-cycling monkeys during the breeding season (Chapter 2).  
The validity of the whole-gland CMFA data reported for the multiparous animals in this project is also 
supported by the finding that these CMFA ranges are in agreement with the whole-gland CMFA obtained from a 
menstruating multiparous macaque that was processed in a previous study (1.07 x 104 cells) (Chapter 2). While only 
a single menstruating monkey was obtained in that study, the whole-gland CMFA data from this animal are 
particularly valuable in that actual weight of the mammary gland was known and, also, because the tissues used to 
calculate the whole-gland CMFA of that subject were obtained from throughout t e entire gland. While the above 
arguments favor the inclusion of the whole-gland CMFA data in this report, it is the opinion of the author that the 
whole-gland CMFA be considered only a rough estimate and caution is warranted in its interpretation.   
In spite of the acknowledged limitation to the accuracy of these CMFA metrics, i  is proposed that the vast 
divide in whole-gland CMFA and biopsy-CMFA values between the two cohorts are of sufficient magnitude to 
reasonably conclude that the mammary glands of young-nulliparous menstruating macaques have significantly 
larger CMFAs than do those of multiparous menstruating macaques. Additional sudies in which large numbers of 
whole glands are collected and analyzed for mammosphere potential in menstruating monkeys will prove essential 
to further refining the quantification of the whole-gland CMFA for this species.    
The 1o MBP, 2o MFE (at 0 and 4 Gy), CFE (at 0, 2, 4 and 8 Gy) and bCFE (at 0, 2, 4 and 8 Gy) were 
significantly greater for the young-nulliparous animals as compared to the multiparous macaques. These results are 
similar to those previously found using non-irradiated tissues of luteal/follicular-stage macaques, although in that 
project the 2o MBP was also identified to be significantly greater for nulliparous females (Chapter 2). While 2o MBP 
for the animals in the current study were not found to be significantly different between the cohorts, the mean 2o 
MBP of nulliparous animals (0 Gy= 45.3%; 4 Gy= 35.9%) did trend higher than the mean 2o MBP of multiparous 
animals (0 Gy= 36.6%; 4 Gy= 31.2%). Collectively, these data suggest the mammospheres and sphere-derived cells 
obtained from young-nulliparous glands have a greater proliferative and differentiation potential over time, and/or 
throughout subsequent plating processes, as compared to the spheres and sphere- erived cells obtained from 




The CDP was also found to be significantly different between the nulliparous nd multiparous cohorts 
although prior to attempting interpretation of these results it is perhaps useful to review background information 
related to the CDP. Previous work using human and rodent tissues has found that most primary mammospheres of a 
MSC/MPC origin contain between 1-4 MFUs per sphere.71, 230, 243 Moreover, the vast majority of the cells 
comprising these mammospheres are of more-restricted phenotypes, such as lineage-specific progenitor cells and 
non-proliferative differentiated cells, which are incapable of independent mammosphere formation.71, 230, 243  In 
addition to being capable of forming mammospheres, the individual MFUs derived from dissociated mammospheres 
have also been shown to have the ability to form bilineage adherent colonies when plated in permissive 
environments such as that of the clonogenic assays.71, 230 In contrast, the mammosphere-derived cells that are of 
more restricted phenotypes are incapable of independent bilineage colony formation and these cells either form 
colonies of a single phenotype or fail to form colonies at all. Notably, aggregate spheres (as previously described) as 
well as spheres which are derived from the proliferation of linage-specific progenitor cells frequently lack any 
MFUs70 and therefore the cells obtained from the dissociation of these spheres have minimal ability to form 
mammospheres or bilineage colonies.   
In light of the above information, it can be appreciated that if single-cell isolate derived from 
mammosphere cultures of two different cohorts are compared, the cohort wit  the greatest ratios of MFUs will also 
be the cohort with the highest CDP. There are three potential ways that one cohort might have a CDP that is larger 
than that of another cohort. First, if one cohort has some inherent mechanism by which it can maintain greater 
numbers of MFUs per primary mammosphere than does the other cohort, this would result in a larger CDP for that 
cohort. Second, if the two cohorts have similar numbers of MFUs per mammosphere but one cohort produces 
smaller mammospheres (comprised of lesser numbers of cells) on average than the other cohort, this would also 
result in a larger CDP.  Finally, if a large percentage of the “mammospheres” in one cohort originate from a source 
other than the clonal replication of MSCs or MPCs (e.g., aggregate sphere formation), it is expected that this cohort 
would have a lower CDP than a second cohort in which more of the mammospheres were derived from 
MSCs/MPCs.    
In the current study, the mean multiparous CDP was identified to be significantly higher than the mean 
nulliparous CDP for the 0 Gy and 2 Gy cultures; a result consistent with he trend seen in an earlier experiment 




mammosphere size between the two study cohorts, and previous macaque studies suggest that that primary 
mammospheres of multiparous subjects typically contain smaller numbers of MFUs (1/sphere) than nulliparous 
subjects (3/sphere) (Chapter 2), the most plausible interpretation of these results is that a greater percentage of 
primary 100k multiparous mammospheres are derived from MSCs and/or MPCs as compared to primary 100k 
nulliparous mammospheres. Mechanistically, these CDP differences could occur if the nulliparous lineage-specific 
progenitor cells have a greater ability to proliferate on their own to form lineage-specific mammospheres than do the 
multiparous lineage-specific progenitor cells. Alternatively, these CDP differenc s could occur if the primary 100k 
nulliparous mammosphere cultures have a greater propensity to form agg eg te spheres than do the primary 100k 
multiparous mammosphere cultures.   
The results from other studies potentially provide some insight as to which of these two mechanisms is 
most likely responsible for the CDP differences identified above. Previous research using mammosphere cultures 
have found that an increase in cell-plating density is associated with an increase in the formation of aggregate 
spheres.70, 85 Additional experiments conducted using macaque tissues also found that that single-cell isolates 
derived from 100k mammosphere cultures had CDP values that were ~31% lower than those derived from 10k 
mammosphere cultures when each were plated at identical cell-densities in a clonogenic assay (Chapter 2). The most 
straightforward interpretation of the macaque CDP experiments, and one that is consistent with the aforementioned 
mammosphere studies, is that there are greater ratios of aggregate spheres pres nt in high-density (100k) 
mammosphere cultures. Of final importance to this discussion is that the VPC results of the current study found that 
nearly twice as many nulliparous, as multiparous, cells survived in the 100k primary cultures over a 7 day period.  
This last piece of information is remarkable in that although the 100k primary mammosphere cultures of both 
cohorts were initially plated at identical cell densities, the nulliparous cultures had a greater total number of cells in 
their culture plates, as compared to the multiparous cultures, within just a few days of the plating process. Viewed 
another way, the nulliparous 100k cultures were essentially higher-density plat ngs than those of the 100k 
multiparous cultures. In light of the above information and these findings, it is plausible that the cells of the 
nulliparous primary mammospheres cultures formed aggregate spheres in grater ratios than did the cells of the 
multiparous primary cultures. While it also remains possible that the CDP differences between the cohorts could be 
due to an increased potential of the nulliparous lineage-specific progenitor cells to clonally proliferate as spheres, 




formation as the primary mechanism responsible for the differences in CDP identified in this study will be explored 
as part of future research projects.   
The 2o MFE, 2o MBP, cell viability, survival fraction and budding morphology data utilized to compare the 
radiosensitivity between the nulliparous and multiparous cohorts produced a mixture of expected and unexpected 
findings. As anticipated, the 2o MFE, 2o MBP, cell viability and total-colony survival fraction values decreased 
significantly with each increasing radiation dose for both cohorts. Similarly, there was a significant decrease in the 
bilineage-colony survival fraction values with each increasing radiation dose between 2 Gy and 20 Gy for both the 
nulliparous and multiparous subjects, as was expected; although there was also radioresistance of the bilineage 
colonies to the 2 Gy radiation dose by both cohorts that had not been predicted. Most unexpected, however, was the 
finding that there were no statistically significant differences in radiosensitivity between the nulliparous and 
multiparous cohorts for any of the aforementioned metrics. Finally, while previous experiments (Chapter 2) 
suggested that there would be no appreciable differences in the budding morphology of the spheres between the 
cohorts, the fact that there were also no differences in budding morphol gy between the 0 Gy and 4 Gy-irradiated 
spheres within either cohort was surprising.  
Similar to the other metrics, the CDP data also identified changes within each cohort in response to 
irradiation. In particular, the CDP was identified to be significantly increased with each increasing radiation dose 
between 0 Gy and 8 Gy for both cohorts. One mechanism to possibly account for this observation is that irradiation 
could have stimulated the transformation of linage-specific progenitor cells and/or non-proliferative differentiated 
cells into bilineage-competent progenitor cells (dedifferentiation). This proposal is not completely unprecedented as 
radiation has been identified to drive dedifferentiation of hematopoietic cell populations in vivo89, 167, 168 and has also 
been shown to reprogram breast cancer cells into breast cancer stem cells in vitro.275 While the slight, nonsignificant, 
increase in the bCFE between the 0 Gy and 2 Gy cultures for the nulliparous cohort offers some support for 
dedifferentiation, the significant reduction in the bCFE of both cohorts at all rdiation doses beyond 2 Gy does not. 
Collectively, these study data and the fact that there is no literature identified which dire tly supports the rapid 
dedifferentiation of normal cell populations under in vitro conditions makes this mechanism appear unlikely. 
Furthermore, based on the current understanding of dedifferentiation as it applies to multistep principle of 




mammary gland epithelial cells would be capable of consistently dedifferentiating enough cells over just one cell-
culture generation to cause the profound CDP changes identified in this study.   
A more simplistic mechanism, and one that can account for the CDP changes in both cohorts throughout all 
radiation doses, is that the MSCs and/or MPCs may be more radioresistant than are the more phenotypically-
restricted cell populations in these cultures. A comparison of the total-colony survival curves and bilineage-colony 
survival curves, whose data are derived from the same clonogenic assay as the CDP metric, are supportive of this 
proposal. Prior to discussing this comparison, however, it is important to first understand a few specific aspects the 
survival curves themselves. First, the vast majority of the colonies formed in the clonogenic assays were comprised 
of a single phenotype of cells and therefore most of these colonies were likely derived from the more 
phenotypically-restricted cell phenotypes. In turn, it can be appreciated that the r diation-induced changes identified 
in the total-colony survival curves were largely dependent on the radiosensitivity of the more-restricted cell 
phenotypes within these assays. In contrast, only the colonies containing both epithelial and myoepithelial cells were 
quantified in the bilineage-colony survival curves. As such, it can be appreciated that the radiation-induced changes 
identified in the bilineage-colony survival curves is mostly dependent on the radiosensitivity of the MFUs within 
these assays. The finding that total-colony survival fractions were significantly lower than the bilineage-colony 
survival fractions at the 2 Gy, 4 Gy, and 8 Gy radiation doses for both cohorts (Figure 4,A and 4,B) suggests that 
there is an overall greater radioresistance of the MFUs as compared to the more-phentypically restricted cell types. 
In addition to these results, there is also abundant literature in support of the proposition that stem cells/early-
progenitor cells (i.e., MPCs) are more radioresistant than are other proliferative cell populations in mammary gland 
epithelial cultures12, 40, 175, 293 and breast cancer cell lines.6, 68, 198, 275, 282, 299   
Unlike any of the previous metrics, the CDP data identified significant differences i radiosensitivity 
between the cohorts. Specifically, the slope of nulliparous CDP response to irradiation was found to be significantly 
greater than that of the multiparous CDP between the 2 Gy and 8 Gy radiation oses. These differences are 
especially intriguing when it is appreciated that the trends of the bilineage-colony survival curves largely mirrored 
the CDP changes but those of the total-colony survival curves did not. In short, these observations collectively 
suggest that the CDP variability between the cohorts is primarily due to differences in the radiosensitivity of the 
MFU populations of the cultures and, furthermore, that the MFUs of nulliparous subjects are more resistant to the 




epithelial cell lines12, 40, 175, 293 and breast cancer cell lines6, 68, 198, 275, 282, 299 have suggested that gradients of 
radiosensitivity are likely to exist between the stem and progenitor cell popu ati ns. In turn, it is plausible that the 
CDP differences of this study could occur if the mammosphere cultures of the two cohorts were comprised of 
different ratios of the same proliferative cell populations and/or if there were proliferative cell populations that were 
unique to the mammosphere cultures of only one of the two cohorts.   
There is at least one aspect of the study data which supports the proposition that the two cohorts vary in 
regard to the proliferative cell populations that comprise their secondary mammospheres cultures. Specifically, when 
the 2o MFE data of each cohort is compared to other mammosphere-potential metrics within their respective cohorts 
there are notable differences between the nulliparous and multiparous subject . For the nulliparous subjects, the 2o 
MFE demonstrated a statistically positive correlation with the 2o MBP at both 0 Gy and 4 Gy irradiation doses.  
Stated another way, the individual nulliparous cultures that produced the great st number of secondary 
mammospheres also had the highest number of mammospheres capable of budding, even when exposed to 4 Gy 
radiation. This suggest that most nulliparous secondary mammospheres originate from a highly radioresistant 
population of cells with good differentiation potential; a finding consistent with hat might be expected if most 
nulliparous mammospheres were of a MSC origin. The multiparous subjects, by contrast, had no significant 
correlation between the 2o MFE and 2o MBP at 0 Gy and had a statistically negative correlation between the 2o MFE 
and 2o MBP at 4 Gy. As the secondary multiparous mammospheres were less consistent with regard to 
differentiation potential and radiosensitivity, it is plausible that the cellular origin of the multiparous mammospheres 
is more heterogeneous in nature than that of the nulliparous spheres. Stated anoth r way, the multiparous secondary 
mammosphere properties are consistent with what might be expected if these mammospheres were frequently 
derived from an assortment of progenitor cell populations of variable radiosensitivity rather than being of a primary 
MSC origin.      
While it is possible that the differences in radiosensitivity between the nulliparous nd multiparous subjects 
could be entirely due to variable ratios of proliferative cell populations common to both cohorts, it is also not 
unreasonable to think that there may exist novel progenitor cell populations within the multiparous macaque 
mammary glands as a result of the maturation/lactation process.220 In support of this contention, studies have found 
that parous rodent glands contain a mammosphere-competent population of bilineage proliferative cells, termed 




As to date, there have been no studies which have attempted to look for a similar parity-induced cell population 
within monkey mammary glands, it remains a possibility that a PIMEC-like population could also exist in the glands 
of parous macaques. The potential existence of macaque PIMECs, along with the prospect that these cells could 
contribute to CDP radioresistance-differences between the nulliparous and multiparo s subjects,220 warrants 
investigation and will be explored as part of future research projects.  
As to why some of the clonogenic assay-derived metrics (CDP and bilineage-colony survival curves) 
suggested differences in radiosensitivity between the cohorts, but the 2o MFE, 2o MBP, cell viability or budding 
morphology metrics did not, is potentially due to the different culture conditi s used for these assays. Specifically, 
the fact that the latter metrics were all derived from cells grown as secondary mammospheres under presumed 
hypoxic conditions (paraffin-wrapped culture plates) could have confounded the results of these assays. Previous 
experiments have found that normal mammary cells,198 as well as breast cancer-cell lines,125 grown under conditions 
that promote mammosphere formation are more radioresistant than are the same c ll populations grown as adherent 
(monolayer) colonies. Additionally, other studies have shown that hypoxic conditions can increase the 
radioresistance of cancer cells in vivo191, 193, 210, 246 as well as increase the radioresistance of cancer cells grown as 
spheroid colonies in vitro.91, 212, 247, 248 Finally, there are data from the current study that also support the proposition 
that cells plated under hypoxic mammosphere culture conditions (2o MFE) are less affected by irradiation than are 
cells plated under adherent colonies in normoxic conditions (CFE/bCFE). In particular, the current study found that 
while the average 4 Gy 2o MFE values were around 60% of the value of the average 0 Gy 2o MFE, the average 4 Gy 
CFE and bCFE values were only around 10% and 25.2% of value of the average 0 Gy CFE and bCFE, respectively. 
In light of this information, it is proposed that differences in radiosensitivity between the mammary gland-derived 
cells of the two cohorts likely exist, as supported by the CDP data, but that the detection of these differences in the 
2o MFE, 2o MBP, and cell viability assays are possibly being obscured by radiation-blunting culture conditions.  
As there were no differences in the budding morphology identified between cohorts, or even between the 
individual radiation doses within either cohort, it is proposed that there may be limitations to the sensitivity of this 
metric even beyond those imposed by the mammosphere culture conditions. In particular, it is possible that the 
BME-medium used for the MBP assay may artifactually limit the differentiation potential of the spheres to only a 
few morphologic manifestations and/or the parameters currently being used to qualify the budding morphology of 




Xenograft experiments, in which cells derived from primary mammospheres are irradiated and then 
immediately transplanted into the fat pads of immunodeficient mice, are likely to be an effective method for 
determining whether mammosphere culture conditions and/or the use of BME-medium are obscuring the detection 
of differences in radiosensitivity between cohorts. Pilot studies using xe ograft transplantation to compare 
multiparous and nulliparous macaque mammosphere-derived cells for differences in radiosensitivity are currently 
funded and underway. 
Senescence, as generally defined, is a permanent, non-proliferative state that is identified in proliferative 
somatic cell populations undergoing certain types of stress.8, 80, 119 A number of cellular modifications are associated 
with the senescent phenotype8, 125, 137, 211 and some of these changes have been exploited toward the identification of 
individual cells and cell cultures undergoing senescence. On a general level, senescent c lls are known to increase 
their secretion of IL-6 and IL-8 as part of a senescence-associated secretory ph noty e (SASP). The SASP has been 
proposed to be a physiologic alteration that senescent cells undergo to maintain their non-proliferative cellular state 
and also to promote their own in vivo clearance through the stimulation and/or activation of inflammatory cells.8, 137, 
211 Additionally, senescent cells are also known to have an increase in senescenc -associated -galactosidase 
activity. While this alteration is of undetermined mechanistic importance to the senescence phenotype, the 
intracellular accumulation of -galactosidase has been used to distinguish senescent cells from other non-
proliferative cell populations such as apoptotic cells or cells within the quiescent phases of the cell-cycle.8, 125, 137, 211 
Immunohistochemical assay kits capable of identifying intracellular -galactosidase have previously been utilized to 
detect senescence in cells within intact mammospheres125 as well as in individual cells acquired from the 
dissociation of mammospheres.67   
In the current study the CM1 obtained from multiparous primary mammosphere cultures had significantly 
higher concentrations of IL-6 and IL-8 as compared to the CM1 derived from young-nulliparous primary cultures.  
Likewise, the -galactosidase assay performed on non-irradiated (0 Gy) cells derived from the early secondary 
mammosphere cultures identified -galactosidase staining in a significantly larger percentage of multiparous cells as 
compared to the cells of young-nulliparous animals. Collectively these data suggest that cells derived from 
multiparous mammary glands are more prone to undergo senescence than are cells acquired from young-nulliparous 




directly from the mammary gland while the -galactosidase assay suggest that these differences also persist in the 
cells comprising the mammospheres as well.   
Senescence is reported to occur in vitro when cell cultures undergo stresses such as when cells are not 
provided with the proper substratum, when media exchanges are prolonged, or when cultures are maintained in 
environments with inappropriately high oxygen levels.137, 211 In that the mammosphere cultures of the two cohorts 
were processed identically and no correlation was identified between the senescence metrics and any of the biopsy 
parameters (e.g., biopsy weight, digestion time, %VC, etc.), it is considered unlikely that in vitro stresses played a 
significant role in the increased incidence of senescence in the multiparous animals.   
An increased incidence of in vivo senescence of various cells types has been positively correlated with 
advancing age in mice, monkeys, and humans.118, 137 As increased age was found to be statistically positively 
correlated with -galactosidase expression in the multiparous individuals of this study, i  is possible that age may be 
the primary factor related to the differences in senescence identified between the two cohorts. What must also be 
appreciated here, however, is that the biopsies used in this study were obtain d from animals in an active breeding 
colony and age is also significantly positively correlated with parity in he multiparous subjects. This information is 
important as increased parity was even more highly associated with -galactosidase expression (P<0.01) than was 
increased age (P<0.05) in the multiparous subjects. While no literature can be identified in support of the proposal 
that increased parity is associated with an increase in cellular senescence, there is lik wise no evidence to the 
contrary. In turn, it is possible that with each pregnancy the macaque mammary gland may undergo some form of 
maturation that increases the overall susceptibility of these cells to enter the senescence stat  upon being stressed.   
It is interesting that increased senescence was highly correlated with increased parity in the multiparous 
macaques of this report given that the numbers of rodent PIMECs, as previously described, were also identified to 
increase with each successive pregnancy.24, 172, 273 Although no PIMEC-like cells have yet been identified within 
parous macaque glands and none of the aforementioned rodent studies looked for any differences in senescence 
between the parous and nulliparous mammary cells, it is tempting to speculate that parous macaques might also have 
a PIMEC-like population that is prone to undergo senescence which could account for the differences in -
galactosidase expression between the animals of the multiparous cohort. This possibility further validates the 
previously mentioned need for investigations into the potential existence of PIMEC-like cells within the parous 




An increased incidence of senescence in human mammosphere-derived cells has previously been 
associated with a decrease in the MFE of mammospheres cultures.67 Thi  finding is of importance as it suggests that 
the differences identified in the MFEs between the two cohorts of this study is not necessarily due to a difference in 
the numbers of MSCs/MPCs between the cultures. Rather, this information suggests that the MFE differences of the 
cohorts could be due, in part or in whole, to a propensity for the MSCs/MPCs of multiparous cultures to undergo 
senescence with a greater frequency than those of nulliparous cultures. Unfortunately, none of the assays performed 
in this study were capable of determining if the MFUs, or the more-diff rentiated cell types, were the population of 
cells most prone to senescence. However, this information is crucial to understa ing the full implications of the 
MFE differences identified between the cohorts and future experiments utilizing technologies such as Fluorescent 
Activated Cell Sorting (FACS) are warranted to help determine the specific proliferative-cell populations most 
prone to senescence in each of these cohorts.      
The lack of a significant increase in -galactosidase expression within either study cohort in response to 
increasing doses of radiation was unexpected. This is because -galactosidase assays had previously been utilized to 
compare the incidence of senescence within various populations of mammosphere-derived cells67 and had also been 
utilized to document increases in cellular senescence associated with exposur to ionizing radiation in a variety of 
cell types.119, 125 The lack of significant findings was most surprising, however, in that pilot experiments using 
multiparous macaque mammospheres suggested that notable increases in -galactosidase staining would likely be 
evident at radiation doses greater than 4 Gy. In retrospect, it appears as if the vast majority of the senescent-prone 
cells in the current study were stimulated into senescence prior to irradiation through the stress of the mammosphere 
dissociation process (background senescence). Furthermore, in that there was no appreciable trend identified 
between irradiation and -galactosidase expression in the multiparous cultures of the current study, it is believed that 
the results of the pilot experiments are best accounted for by random sample vriation. Compared to the multiparous 
cultures, the nulliparous cultures showed less variation in the levels of senescence between individual subjects and 
had an overall lower incidence of background senescence. Likely as a result of these two properties, there was an 
appreciable, though nonsignificant, trend for -galactosidase expression to increase with increasing radiation dose 
within the nulliparous cultures (Figure 6). While the trend of nulliparous cultures is consistent with the proposition 
that irradiation can stimulate senescence within mammosphere-derived cells, the experimental design of this study 




microscopy imaging to evaluate intact, size-matched, irradiated mammospheres are likely to be more effective at 
evaluating differences in radiosensitivity between the cohorts, and these techniques will be attempted in future 
studies.    
Ideally, this study would have been able to identify differences in the overall mammosphere potential, 
senescence, and radiosensitivity as a function of both age and parity. Unfortunately, the use of tissues from breeding 
colony animals confounds this distinction as age and parity are highly correlated. In only one assay, -galactosidase 
expression, was there any difference noted between age and parity within the multiparous cohort. Additional 
information crucial to deciphering the individual roles that age and parity may play in mammosphere potential, 
senescence, and radiosensitivity will have to come from future studies comparing: 1) variably- aged nulliparous 
animals; 2) parity-matched animals of different ages; 3) and age-matched parous and nulliparous animals. As these 
data are currently lacking, the most that can be definitively stated at this time wi h regard to age and parity is that 
there are appreciable differences in the mammary gland-derived cells of the yung-nulliparous and older 
multiparous macaques.                
The first aim of this project was achieved and, as expected, the 1o MFE, VCR, and CMFA data showed that 
during the menses-stage of the menstrual cycle the mammary glands of young-nulliparous monkeys contains larger 
ratios and larger numbers of cells capable of in vitro mammosphere formation than do the multiparous mammary 
glands. It is possible that the ability of the nulliparous cohort to form greate  numbers of mammospheres than 
multiparous cohorts is simply due to increased numbers of MFUs within the glands of these subjects. This 
conclusion is consistent with the results of some rodent studies which have identified nulliparous mammary glands 
to have significantly greater numbers of MSC-like cells than those of similarly-aged parous animals.28, 235 However, 
there are also some study data to suggest that there may also be innate differences in the proliferative cell types that 
constitute the MFU populations between the two cohorts. In turn, future st dies are needed to determine: 1) if a 
PIMEC-like proliferative cell population exist in parous macaque glands; 2) if the proliferative cell populations of 
the two cohorts are made up of different ratios of the same types of proliferative cells; or 3) if equal ratios of same 
proliferative cell populations exist between the two cohorts, but the multiparous MFU are more prone to undergo 
senescence than are the nulliparous MFUs.  
The second aim of this project was likewise achieved. Specifically, the 2o MFE and CFE/bCFE study data 




proliferative potential in subsequent cell-culture assays as compared to the cells drived from multiparous 
mammospheres. Additionally, the 1o MBE study results demonstrated that the primary mammospheres derived from 
young-nulliparous primates have greater in vitro differentiation potential as compared to the multiparous 
mammospheres. Although the 2o MBE was not significantly different between the cohorts, there was a trend for the 
nulliparous subjects to have greater numbers of budding mammosphere  as compared to multiparous subjects.  
Future studies utilizing greater numbers of subjects and/or xenotransplantation experiments may prove useful to 
determining whether nulliparous secondary mammospheres routinely maintain  st tistically greater differentiation-
potential (2o MBE) over time as compared to multiparous spheres. Future studies to explore differences in the MFU 
populations between the two cohorts, as mentioned above, are also likely to provide valuable insight into the 
mechanisms behind the variation in mammosphere potential and differentiation.  
The third aim of this study was achieved as there were significant differences in radiosensitivity identified 
between the cohorts as per the CDP metrics. These CDP results were also supported by similar, although 
nonsignificant, changes to the data from the bilineage-survival colony assa . Finally, the analysis of the CDP, CFE, 
and bCFE data for both study cohorts indicated that the MFUs are likely more radioresistant than are the other, 
more-phenotypically restricted, cell types typically obtained from the dissociation of mammospheres. Collectively, 
the results of these experiments suggest that greater ratios of the young-nulliparous MFUs are capable of continued 
proliferation in the clonogenic assays following irradiation, as compared to the multiparous MFUs. Unexpectedly, 
there were no significant differences in radiosensitivity identified betwe n the cohorts in any of the assays that 
utilized intact mammospheres or which examined cells that were maintained within mammosphere culture 
conditions following irradiation. As previously discussed, the lack of differences in radiosensitivity between the 
cohorts in these latter assays is likely to have been a research artifact related to the culture conditions in which these 
particular experiments were performed. Xenotransplantation studies will be used in th  future to reexamine the 
radiosensitivity of the mammosphere-derived cells between the two cohorts.        
Differences in the overall incidence of senescence were also identified between the two cohorts of this 
study. The increased incidence of senescence in multiparous cells likely p ayed at least some part in the decreased 
mammosphere production, proliferation, and differentiation rates of the multiparous cohort. The increased incidence 




a mechanism by which the body minimizes tumorigenesis of initiated cells8, 125, 137, 211 and at least one study has 
associated increased senescence with a decreased risk of mammary cancers in rod nts.23  
In summary, the MSCs and MPCs (MFUs) of the human breast are though t  be common cells-of-origin 
for breast cancers. Human mammosphere cultures have previously been utiliz d to study the MFUs and, recently, 
macaque mammosphere cultures have been demonstrated to produce mammospheres and MFUs which are 
comparable to those described in humans. The current study identified a number of diff ences between multiparous 
macaques and young-nulliparous macaques that are of potential interest to breast cancer research with regard to 
parity-related risk factors. First, multiparous macaque mammary glands were identified to have lower ratios and 
numbers of MFUs than young-nulliparous macaque glands. Second, the prolif rative and differentiation potentials of 
the multiparous mammospheres were identified to be lower than those of young-nulliparous mammospheres. Third, 
the MFUs derived from multiparous mammospheres were identified to be more radiosensitive than the young-
nulliparous MFUs, as per some assays. Finally, the multiparous mammosphere cultures were identified to have 
higher rates of senescence than the mammosphere cultures of young-nulliparous cultures. Collectively, the findings 
that young-nulliparous mammary glands have increased numbers of potential cellular targets (MFUs) for 
mutagenesis, and that these cells are more prone to proliferate (i.e., lower incid nce of senescence) following their 
removal from a homeostatic niche (i.e., mammary gland or mammosphere ) or after irradiation, could be reasonably 
expected to make nulliparous subjects more susceptible to radiation-induced cancers as compared to multiparous 
subjects.  This expectation is consistent with what is known to be the case in humans and, as such, the data from this 
study has potentially provided the first direct insight as to the cellular mechanisms responsible for the increased risk 
of breast carcinogenesis in young nulliparous women exposed to radiation. In addition to these findings, the current 
study is also novel in that it demonstrated, for the first time, the feasibility and utility of the macaque mammosphere 
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  The overarching goal of the work comprising this dissertation was to develop novel methods by which to 
explore parity-related risk factors in breast carcinogenesis. Viewed through a broad lens, this project can be 
considered an overall success. However, when inspected at a more refined level, there are numerous questions and 
limitations related to the study results that have yet to be overcome. The results,conclusions, and limitations for 
each aspect of this research project are provided in detail within their respective chapters. It is the goal of the current 
chapter to provide a summary of the research advances achieved throughout this project and, where applicable, 
address the setbacks to the research process. The ongoing studies related to this work will also be discussed, as will 
the plans for future experiments utilizing the methods that were developed in this project. 
Research Summary 
The first arm of this project sought to modify, optimize, and validate an established in vitro research model 
(mammosphere culture assay) for use in the rhesus macaque (Macaca mulatta). This task was undertaken in that 
while both rodent-based and human-based mammosphere research have contributed to the general knowledge of 
breast biology and carcinogenesis, there remain critical questions as to these aspects of research that are arguably 
best explored using nonhuman primate (NHP) models. The initial work of this project produced an exceedingly-
detailed macaque mammosphere protocol that was demonstrated to be highly reproducible. Through the 
optimization process, two novel modifications, the use of conditioned media an  hypoxic plating conditions, were 
identified and added to the classical mammosphere protocol. Experiments showed t at in vivo mammary gland 
biopsies collected from macaques could be utilized for the production of mammosphere cultures and also 
demonstrated, through mammosphere culture results, the physiologic/morphologic homogeneity of biopsies 
collected from throughout the rhesus macaque mammary gland. Finally, the first-ever reported rhesus macaque 
mammary gland weights were collected in this project.  
Following this initial work, macaque mammospheres were validated to have similar properties to the 
mammospheres identified in other species. Specifically, it was shown that macaque mammospheres: 1) could be 




and myoepithelial) potential; and 4) contain cells that, on their own, have the bilineage potential. In short, this work 
suggested that the macaque mammospheres contain mammary stem cell-like cel s. 
 Macaque mammospheres were also validated to be relevant models for human breast research by 
demonstrating that rhesus macaque mammospheres are comparable to human mam ospheres. Most significantly, 
macaque and human mammospheres were shown to be similar with regard to: 1) size of the spheres; 2) numbers of 
mammary stem cell-like cells per sphere; 3) immunogenic staining patterns; 4) proliferative potential; 5) 
differentiation potential; 6) bilineage potential; and 7) lactogenic potential. 
Another arm of this project utilized the optimized macaque mammosphere protocol t  explore the 
proliferative and differentiation potential (collectively referred to as mammosphere potential) of mammary epithelial 
cells acquired from rhesus macaques of various demographics. Through these studies it was demonstrated that cells 
derived from the nulliparous animals have an overall greater mammosphere pot ntial than do cells derived from 
multiparous animals. While not as definitively conclusive, there were also differences in mammosphere potential 
noted between animals in different phases of the reproductive cycle. Finally, these studies also produced a few 
results to suggest that age may also play a role with regard to mammosphere potential.    
An additional aspect of these demographic comparisons was a study to look for differences in the 
morphological manifestations of mammospheres suspended in basement membrane ext act. Other than in a few 
pregnant animals, there were essentially no appreciable differences identified in morphology between the cohorts. 
However, this study did produce a highly-comprehensive review as to the morphological and physiological 
transformation of mammospheres over time. Through this work a number of novel observations related to 
mammosphere growth and differentiation were identified that are likely to be relevant and useful to mammosphere-
based research across all species. Finally, a novel conditioned media (created using the stromal elements of the 
mammary gland) was also utilized in these experiments, and where it was shown to be capable of altering the 
morphological and physiological growth potential of the spheres.   
In that the results of the earlier studies suggested that the mammosphere potential of mac que mammary 
glands is directly associated with the phase of the reproductive cycle, the third arm of this research project sought to 
identify a minimally-invasive method by which to synchronize tissue collections. Specifically, a novel rapid-staining 
technique for vaginal cytology was evaluated for its ability to definitively ident fy the menses stage of the ovulatory 




the accurate diagnosis of the menses stage. In spite of this setback, the research literature collectively suggested that 
synchronization of tissue collections to the menses stage could be achieved with relatively high accuracy in study 
animals that: 1) are regularly-cycling; 2) have vaginal bleeding during breeding season; 3) are clinically healthy 
otherwise; 4) produce a vaginal cytology that is consistent with the menses stage. Beyond identifying a supportive 
role for vaginal cytology in the synchronization of tissue collections, thi  study was also determined to be a success 
in that it showed a rapid-staining technique could produce vaginal cytologies that were equivalent in their stage-
diagnostic abilities to those of more labor-intensive stains.     
The final arm of this project utilized the cumulative information gained from the previous work to perform 
a study comparing the mammary epithelial cell populations of young-nulliparous nd multiparous animals with 
regard to mammosphere potential and radiosensitivity. The impetus for this work was that young-nulliparous girls 
are appreciated to have a higher lifetime risk of breast carcinogenesis following irradiation as compared to parous 
women. This study found that, as compared to multiparous macaques, the mammary epithelial cell populations 
derived from young-nulliparous animals had: 1) greater proliferation potential; 2) greater differentiation potential; 3) 
lower overall rates of cellular senescence; and 4) less radiosensitivity. These collective findings were taken to 
suggest that the mammary glands of young-nulliparous macaques have larger numbers of mammary stem cell-like 
cells than do the glands of multiparous macaques. Given that mammary stem cells, and progenitor cells with 
mammary stem cell-like properties, are thought to be common cells-of-origin for many breast cancers, the findings 
of the young-nulliparous macaques were concluded to be consistent with those of a population at an increased risk 
of breast cancer initiation. Importantly, this conclusion is similar to what is known to be the case in young-
nulliparous girls. In short, it is suggested that this study may have provided the most informative insight, to date, as 
to the possible mechanisms (i.e., increased numbers of cellular targets, incrased esistance to cellular senescence) 
involved with the increased risk of radiation-induced cancers in young-n lliparous girls.      
Ongoing Research and Future Directions 
The research performed as part of this dissertation utilized rhesus macaque mammary tissues exclusively. 
However, it was always considered likely that the techniques and general info mation acquired from this project 
would also be applicable to other closely-related primate species as well. The initial results of a grant-funded 
research project aimed at investigating the protective effects of phytoestrogens on cynomolgus macaque (Macaca 




primate research centers of Wake Forest University and Bogor Agricultural University (Indonesia), have found that 
the mammary gland weights and the rates of mammosphere growth/differentiation of the cynomolgus macaque fall 
within the parameters identified for the rhesus macaque. With the continued collection and processing of samples 
from this ongoing project, it is expected that the staining characteristics of he mammospheres will also be 
demonstrated to be similar between the two species. In short, it appears as if the methods and parameters developed 
for this study are likely to be useful to a wide range of projects involving NHPs. 
The initial successes of the macaque mammosphere project have subsequently led to he procurement of 
additional grant funds for use in future macaque mammosphere studies. Some of these funds have been targeted 
toward further validation of the macaque mammosphere model. The validation studies will involve 
xenotransplantation experiments in which mammospheres, and mammosphere-derived cells, will be placed in the 
cleared-fat pads of immune-deficient mice with the goal of producing rhesus macaque mammary outgrowths in the 
mice. Xenotransplantation experiments are currently considered to be the “gold-standard” by which mammospheres 
are confirmed to contain mammary stem cells. Although the data from this project collectively supports the proposal 
that the bulk of proliferative cells responsible for the formation of macaque mammospheres are mammary stem 
cells, the author of this dissertation has taken a conservative approach and will refer to these proliferative cell 
populations as mammary stem cell-like cells and/or mammosphere forming units (MFUs) until such time the 
xenotransplantation studies can be completed.   
Additional funds from the current grant award will be used toward macaque mammosphere 
characterization. This process will involve the use of fluorescent-activated cell sorting (FACs) modalities to identify 
cell-surface markers associated with the mammosphere-derived cells. The purpose of these experiments is twofold at 
this time. The first goal of these studies is to attempt to identify cell surface mark rs that have previously been 
identified in the mammosphere cultures of other species. Identification of these specific cell-surface markers in the 
macaque mammospheres would further validate this model, and especially so if the cell-surface markers identified 
to be characteristic of human mammospheres can also be identified in the macaque mammospheres. The second goal 
of these studies is to characterize and compare the cells obtained from young-nulliparous and multiparous macaque 
mammosphere cultures. Any difference identified between the two cohorts is likely to be of some benefit to the 
overall understanding of the mammary gland maturation process. However, one specific objective of this study will 




mammary epithelial cells (PIMECs) identified within the mammary gland of parous rodents. In the studies 
mentioned above, which directly compared the multiparous and young-nulliparous nimals, there were some data to 
suggest that the cell populations responsible for mammosphere formation may be v riable between the cohorts and 
the existence of a PIMEC-like population in the multiparous animals was proposed as a possibility to explain the 
observed differences. 
The remaining funds from the current grant award will be utilized to expand on the previous research which 
looked for differences in radiosensitivity between the mammary epithelial cel  populations of multiparous and 
young-nulliparous macaques. In the initial study, differences in radiosensitivity were identified between the two 
cohorts in some of the assays in which the irradiated cells were allowed to un ergo differentiation on collagen-
coated plates. However, in that same study there were no significant differences identified between the two cohorts 
when the irradiated cells were maintained under culture conditions that promoted ammosphere formation. While 
these observations have been proposed to be an artifact of the mammosphere culture conditions, what is still not 
known, is if the results of the collagen-coated plates are actually representative of the in vivo differentiation-
potential of mammary gland cells. In the upcoming studies, xenotransplantation of irradiated cells, as well as 
xenotransplantation of mammospheres derived from irradiated cells, will be used to assess differences in the post-
radiation proliferation and differentiation potentials between the multiparous and you g-nulliparous macaques. 
These studies will additionally look for neoplastic features (breast carcinogenesis) within the mammary gland 
outgrowths and these results will likewise be compared between the cohorts.     
The genetic and morphologic similarities between humans and macaques, in addition to the fact that 
macaque mammary tissues can be readily obtained from essentially every demographic of animal, endow macaque 
mammosphere cultures with the potential to provide information about certain aspects of breast biology and 
carcinogenesis that is difficult, or even impossible, to assess utilizing either human or rodent mammosphere assays. 
Furthermore, given the fact that in vivo biopsies can be utilized for mammosphere cultures, and the mammosphere 
potential of biopsies has been recognized to be homogeneous throughout the gland, it is plausible that the 
mammosphere potential of individual animals could be monitored over time through the collection of multiple 
biopsies. This within-subject longitudinal comparison is an especially attractive study-design here in that this 
approach can minimize the confounding variables that are often associated with using a genetically diverse research 




In light of this potential, future macaque studies on breast carcinogenesis are of interest and could be 
designed so that individual animals have multiple biopsies collected at specific time points. The mammosphere-
cultures derived from each of these biopsies could then be exposed to radiation (or another carcinogen). After a 
period of in vivo or in vitro growth, the cells collected from different time points could be compared to look for any 
differences in their susceptibility to undergo breast carcinogenesis. The e comparisons could be performed across 
different stages of the menstrual cycle or across different phases of the reproductive cycle (i.e., pregnancy, 
lactation). Furthermore, studies of this nature could also be performed to look for differences in the susceptibility of 
the mammary epithelial cells to undergo breast carcinogenesis in nulliparity, rimiparity and multiparity.   
Other future projects of interest involve studies into the use of conditioned media to alter mammosphere 
potential, and/or possibly alter the susceptibility of the mammospheres to breast carcinogenesis. Two different types 
of conditioned media were utilized in the experiments of this dissertation. Conditioned media-1 (CM1) was 
mammosphere media that was collected from first-generation mammospheres grown at high densities. The CM1 
was utilized in an autologous fashion in the previous experiments to promote the growth of low density, second-
generation mammospheres. Conditioned media-2 (CM2) is a conditioned media that was made from the stromal 
elements of the gland that were collected from necropsied animals. The CM2 was utilized in an autologous fashion 
in the previous experiments to promote lactational differentiation of the mammospheres suspended in basement 
membrane extract. The previous studies on cellular senescence have identified significant differences in the cytokine 
levels of the CM1 between multiparous and young-nulliparous animals. As the mammosphere potentials of these 
two cohorts have also been identified to be significantly different, it is plausib e that if CM1 acquired from the 
nulliparous mammosphere cultures was supplemented into the multiparous mammosphere cultures that there might 
be alterations to the mammosphere potential of the multiparous cohort. Initial experiments related to these types of 
studies could simply look for differences in proliferation and differentiation potential in the mammosphere cultures 
of one cohort (e.g., nulliparous) to which CM1 from another cohort (e.g., multiparous) had been added. Additional 
studies could also be performed using FACS to look for up-regulation or down-regulation of cell-surface markers 
that coincide with the addition of the “foreign” CM1. As there are a multitude of cohorts that could be used for this 
process (e.g., menses stage-nulliparous animals, luteal stage-multiparo s animals, lactating primiparous animals, 
first-trimester pregnancies, second-trimester pregnancies, etc.) the number of possible permutations for these studies 




mammospheres suspended in basement membrane extract. It is considered likely that through this process, 
information related to the changes of the mammary gland epithelium throug out growth, development and lactation 
would be identified which could enhance the scientific knowledge of mammary gland biology in general. 
Furthermore, these same types of studies could also be performed on cells exposed to radiation (or another 
carcinogen) to identify if the CM1 or CM2 from any particular cohort is protective of carcinogen-induced neoplastic 
alterations. This work is particularly intriguing, in that if a cohort can be identified to have CM1 and/or CM2 that is 
protective, it may be possible to identify the molecular mechanisms responsible for th se actions and utilize it as a 
preventative or therapeutic treatment for cancers.     
In closing, the cumulative work comprising this dissertation is considered an overall success in that it has 
established a basic foundation for future NHP mammosphere work and has addition lly identified novel information 
related to macaque biology, mammary gland biology, and possibly breast carcinogenesis. The results of the initial 
macaque mammosphere study have been deemed worthy of additional fina cial support by a granting body and 
further validation, characterization, and investigation of the mammosphere assay will begin in the near future. 
Finally, even prior to the publication of these results, this work has inspired investigators to undertake the use of 
mammosphere methods in their research. It is my sincere hope that the information contained in this dissertation will 















Abbreviations and Definitions of Terms for the Metrics Utilized to Gauge Mammosphere Potential 
bCFE (bilineage-colony forming efficiency): used to assess the ability of single cells to form bilineage colonies 
(containing both myoepithelial and epithelial components) of greater than 50 cells on collagen-coated plates (two-
dimensional bilineage proliferation). Calculated as the average number of bilineage colonies formed in each well 
divided by the number of viable cells initially plated per well (expressed as percentage). For this project bCFE was 
only evaluated on cells obtained from the dissociation of primary mammospheres.  
Biopsy-CMFA (numbers of cells with mammosphere forming ability in individual biopsies): used to assess the 
number of cells within each biopsy that are capable of forming mammospheres in mammosphere culture. Calculated 
using the TVC, 1o MFE, and the biopsy weight obtained from the individual subjects. 
CDP (colony differentiation-potential): used to assess the differentiation abilities of colonies formed by single cells 
on collagen-coated plates (two-dimensional differentiation). Calculated as the number of bilineage colonies/well 
divided by the total-number of colonies/well (expressed as percentage). For this project CDP was only evaluated on 
cells obtained from the dissociation of primary mammospheres.   
CFE (colony forming efficiency): used to assess the ability of single cells to form colonies of greater than 50 cells 
on collagen-coated plated (two-dimensional proliferation). Calculated as the average number of colonies formed in 
each well divided by the number of viable cells initially plated per well (expressed a  percentage). For this project 
CFE was only evaluated on cells obtained from the dissociation of primary mammospheres.    
MBP (mammosphere budding-potential): used to assess the ability of individual mammospheres to produce ductal 
and alveolar outgrowths (budding) from the main sphere body when suspended in basement membrane extract 
(three-dimensional differentiation). Calculated as the number of budding sphere  divided by the total number of 
spheres (expressed as a percentage) within a single “bleb” of basement membrane extract. For this project MBP was 
evaluated on spheres obtained directly from the single cell isolates derived from mam ary gland tissues (1o MBP) 
as well as from spheres obtained from the single cell isolates derived from primary mammospheres (2o MBP).    
MDP (mammosphere differentiation-potential): used to assess the bilineage differentiation abilities of individual 
mammospheres on collagen-coated plates (two-dimensional differentiation). Calculated as th  number of bilineage 




evaluated on secondary mammospheres.                                                                                                                                   
MFE (mammosphere-forming efficiency): used to assess the mammosphere forming abilities of single cells plated 
under mammosphere culture conditions. Calculated as the average number of mammospheres (≥ 40 μm in diameter) 
formed in each well divided by the number of viable cells initially plated per well (expressed as percentage). For this 
project MFE was evaluated on cells obtained directly from the dissociation of mammary gland tissues (1o MFE) as 
well as from cells dissociated from primary mammospheres (2o MFE), secondary mammospheres (3o MFE), and 
tertiary mammospheres (4o MFE).                                                                                                                                       
TVC (total number of viable cells/mg of tissue): used to assess the number of viable cells obtained from the 
digestion and dissociation of mammary gland tissues and mammospheres. Calculated using the trypan blue 
exclusion assay as observed using a hemocytometer.                                                                                                            
VCR (viable cell recovery): used to assess the number of cells recovered from the dissociation of intact 
mammospheres. Calculated as the total number of viable cells recovered from the dissociation of a mammosphere 
culture divided by the number of viable cells originally plated for that culture (expressed as a percentage). For this 
project VCR was utilized to quantitate the number of cells obtained from the dissociation of primary mammospheres 
to estimate the numbers of mammospheres produced in the 100k cultures and to compare the effectiveness of the 
mammosphere dissociation process at Day 7 and Day 10 of primary mammosphere growth.                                           
Whole-gland-CMFA (numbers of cells with mammosphere forming ability in one mammary gl nd of individual 
animals): used to estimate the number of cells that are capable of forming mammospheres in mammosphere culture 
within one mammary gland of individual subjects. Calculated using the TVC, 1o MFE, and the approximate-whole 
mammary gland weight for each subject.   
 
